
<html lang="en"     class="pb-page"  data-request-id="0c17fa53-f44a-4805-b356-3345e1df35e4"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2010.53.issue-1;article:article:10.1021/jm900803q"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="In Vivo Positron Emission Tomography (PET) Imaging of Mesenchymal−Epithelial Transition (MET) Receptor" /></meta><meta name="dc.Creator" content="Chunying  Wu" /></meta><meta name="dc.Creator" content="Zhe  Tang" /></meta><meta name="dc.Creator" content="Weiwen  Fan" /></meta><meta name="dc.Creator" content="Wenxia  Zhu" /></meta><meta name="dc.Creator" content="Changning  Wang" /></meta><meta name="dc.Creator" content="Edurado  Somoza" /></meta><meta name="dc.Creator" content="Norbert  Owino" /></meta><meta name="dc.Creator" content="Ruoshi  Li" /></meta><meta name="dc.Creator" content="Patrick C.  Ma" /></meta><meta name="dc.Creator" content="Yanming  Wang" /></meta><meta name="dc.Description" content="We report the radiosynthesis and evaluation of 3-[3,5-dimethyl-4-(4-[11C]methylpiperazinecarbonyl)-1H-pyrrol-2-ylmethylene]-2-oxo-2,3-dihydro-1H-indole-5-sulfonic acid (3-chlorophenyl)methylamide, ..." /></meta><meta name="Description" content="We report the radiosynthesis and evaluation of 3-[3,5-dimethyl-4-(4-[11C]methylpiperazinecarbonyl)-1H-pyrrol-2-ylmethylene]-2-oxo-2,3-dihydro-1H-indole-5-sulfonic acid (3-chlorophenyl)methylamide, ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="December 7, 2009" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm900803q" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2009 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm900803q" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm900803q" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm900803q" /></link>
        
    
    

<title>In Vivo Positron Emission Tomography (PET) Imaging of Mesenchymal−Epithelial Transition (MET) Receptor | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm900803q" /></meta><meta property="og:title" content="In Vivo Positron Emission Tomography (PET) Imaging of Mesenchymal−Epithelial Transition (MET) Receptor" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm900803q/production/images/large/jm-2009-00803q_0005.jpeg" /></meta><meta property="og:description" content="We report the radiosynthesis and evaluation of 3-[3,5-dimethyl-4-(4-[11C]methylpiperazinecarbonyl)-1H-pyrrol-2-ylmethylene]-2-oxo-2,3-dihydro-1H-indole-5-sulfonic acid (3-chlorophenyl)methylamide, termed [11C]SU11274 ([11C]14) for in vivo imaging of mesenchymal−epithelial transition (MET) receptor by positron emission tomography (PET). Following the synthesis of the precursor (13) that was achieved in 10 steps with a total yield of 9.7%, [11C]14 was obtained through radiomethylation in a range of 5−10% radiochemical yield and over 95% radiochemical purity. For in vivo PET studies, two human lung cancer xenograft models were established using MET-positive NCI-H1975 and MET-negative NCI-H520 cell lines. Quantitative [11C]14-PET studies showed that the tumor uptake of [11C]14 in the NCI-H1975 xenografts was significantly higher than that in the NCI-H520 xenografts, which is consistent with their corresponding immunohistochemical tissue staining patterns of MET receptors from the same animals. These studies demonstrated that [11C]14-PET is an appropriate imaging marker for quantification of MET receptor in vivo, which can facilitate efficacy evaluation in the clinical development of MET-targeted cancer therapeutics." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm900803q"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm900803q">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm900803q&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm900803q&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm900803q&amp;href=/doi/10.1021/jm900803q" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2010</span><span class="cit-fg-volume">, 53</span><span class="cit-fg-issue">, 1</span><span class="cit-fg-pageRange">, 139-146</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/53/1" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm9007278" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm9010093" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">In Vivo Positron Emission Tomography (PET) Imaging of Mesenchymal−Epithelial Transition (MET) Receptor</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Chunying++Wu">Chunying Wu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zhe++Tang">Zhe Tang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Weiwen++Fan">Weiwen Fan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wenxia++Zhu">Wenxia Zhu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Changning++Wang">Changning Wang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Edurado++Somoza">Edurado Somoza</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Norbert++Owino">Norbert Owino</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ruoshi++Li">Ruoshi Li</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Patrick+C.++Ma">Patrick C. Ma</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yanming++Wang">Yanming Wang</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Division of Radiopharmaceutical Science, Case Center for Imaging Research, Department of Radiology, Case Western Reserve University, Cleveland, Ohio 44106</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Division of Hematology/Oncology, Department of Medicine, Case Western Reserve University, University Hospitals Case Medical Center, and Case Comprehensive Cancer Center, Cleveland, Ohio 44106</span></div><div class="corresp-info"><strong>*</strong>To whom correspondence should be addressed. Phone: +1-216-844-3288. Fax: +1-216-844-8062. E-mail: <a href="/cdn-cgi/l/email-protection#2b524a454642454c055c4a454c6b484a584e054e4f5e"><span class="__cf_email__" data-cfemail="b1c8d0dfdcd8dfd69fc6d0dfd6f1d2d0c2d49fd4d5c4">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm900803q&amp;href=/doi/10.1021%2Fjm900803q" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2010</span></span><span class="cit-volume">, 53</span><span class="cit-issue">, 1</span><span class="cit-pageRange">, 139–146</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">December 7, 2009</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>4 June 2009</li><li><span class="item_label"><b>Published</b> online</span>7 December 2009</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 14 January 2010</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm900803q" title="DOI URL">https://doi.org/10.1021/jm900803q</a></div><div class="article_header-article-copyright"><strong>Copyright © 2009 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D139%26pageCount%3D8%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DChunying%2BWu%252C%2BZhe%2BTang%252C%2BWeiwen%2BFan%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D53%26issueNum%3D1%26contentID%3Djm900803q%26title%3DIn%2BVivo%2BPositron%2BEmission%2BTomography%2B%2528PET%2529%2BImaging%2Bof%2BMesenchymal%25E2%2588%2592Epithelial%2BTransition%2B%2528MET%2529%2BReceptor%26numPages%3D8%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D146%26publicationDate%3DJanuary%2B2010">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm900803q"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2714</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">17</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm900803q" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;In Vivo Positron Emission Tomography (PET) Imaging of Mesenchymal−Epithelial Transition (MET) Receptor&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Chunying&quot;,&quot;last_name&quot;:&quot;Wu&quot;},{&quot;first_name&quot;:&quot;Zhe&quot;,&quot;last_name&quot;:&quot;Tang&quot;},{&quot;first_name&quot;:&quot;Weiwen&quot;,&quot;last_name&quot;:&quot;Fan&quot;},{&quot;first_name&quot;:&quot;Wenxia&quot;,&quot;last_name&quot;:&quot;Zhu&quot;},{&quot;first_name&quot;:&quot;Changning&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Edurado&quot;,&quot;last_name&quot;:&quot;Somoza&quot;},{&quot;first_name&quot;:&quot;Norbert&quot;,&quot;last_name&quot;:&quot;Owino&quot;},{&quot;first_name&quot;:&quot;Ruoshi&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Patrick&quot;,&quot;last_name&quot;:&quot;C. Ma&quot;},{&quot;first_name&quot;:&quot;Yanming&quot;,&quot;last_name&quot;:&quot;Wang&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2009&quot;,&quot;month&quot;:&quot;12&quot;,&quot;day&quot;:&quot;07&quot;,&quot;issue&quot;:&quot;1&quot;,&quot;volume&quot;:&quot;53&quot;,&quot;pages&quot;:&quot;139-146&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm900803q&quot;},&quot;abstract&quot;:&quot;We report the radiosynthesis and evaluation of 3-[3,5-dimethyl-4-(4-[11C]methylpiperazinecarbonyl)-1H-pyrrol-2-ylmethylene]-2-oxo-2,3-dihydro-1H-indole-5-sulfonic acid (3-chlorophenyl)methylamide, termed [11C]SU11274 ([11C]14) for in vivo imaging of mesenchymal−epithelial transition (MET) receptor by positron emission tomography (PET). Following the synthesis of the precursor (13) that was achieved in 10 steps with a total yield of 9.7%, [11C]14 was obtained through radiomethylation in a range of 5−10% radiochemical yield and over 95% radiochemical purity. For in vivo PET studies, two human lung cancer xenograft models were established using MET-positive NCI-H1975 and MET-negative NCI-H520 cell lines. Quantitative [11C]14-PET studies showed that the tumor uptake of [11C]14 in the NCI-H1975 xenografts was significantly higher than that in the NCI-H520 xenografts, which is consistent with their corresponding immunohistochemical tissue staining patterns of MET receptors from the same animals. These studies demon&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm900803q&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm900803q" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm900803q&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm900803q" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm900803q&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm900803q" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm900803q&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm900803q&amp;href=/doi/10.1021/jm900803q" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm900803q" /></input><a href="/doi/pdf/10.1021/jm900803q" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm900803q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm900803q%26sid%3Dliteratum%253Aachs%26pmid%3D19968287%26genre%3Darticle%26aulast%3DWu%26date%3D2010%26atitle%3DIn%2BVivo%2BPositron%2BEmission%2BTomography%2B%2528PET%2529%2BImaging%2Bof%2BMesenchymal%25E2%2588%2592Epithelial%2BTransition%2B%2528MET%2529%2BReceptor%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D53%26issue%3D1%26spage%3D139%26epage%3D146%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=290997" title="Biological imaging">Biological imaging</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/53/1" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm900803q/production/images/medium/jm-2009-00803q_0005.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm900803q/production/images/large/jm-2009-00803q_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900803q&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">We report the radiosynthesis and evaluation of 3-[3,5-dimethyl-4-(4-[<sup>11</sup>C]methylpiperazinecarbonyl)-1<i>H</i>-pyrrol-2-ylmethylene]-2-oxo-2,3-dihydro-1<i>H</i>-indole-5-sulfonic acid (3-chlorophenyl)methylamide, termed [<sup>11</sup>C]SU11274 ([<sup>11</sup>C]<b>14</b>) for in vivo imaging of mesenchymal−epithelial transition (MET) receptor by positron emission tomography (PET). Following the synthesis of the precursor (<b>13</b>) that was achieved in 10 steps with a total yield of 9.7%, [<sup>11</sup>C]<b>14</b> was obtained through radiomethylation in a range of 5−10% radiochemical yield and over 95% radiochemical purity. For in vivo PET studies, two human lung cancer xenograft models were established using MET-positive NCI-H1975 and MET-negative NCI-H520 cell lines. Quantitative [<sup>11</sup>C]<b>14</b>-PET studies showed that the tumor uptake of [<sup>11</sup>C]<b>14</b> in the NCI-H1975 xenografts was significantly higher than that in the NCI-H520 xenografts, which is consistent with their corresponding immunohistochemical tissue staining patterns of MET receptors from the same animals. These studies demonstrated that [<sup>11</sup>C]<b>14</b>-PET is an appropriate imaging marker for quantification of MET receptor in vivo, which can facilitate efficacy evaluation in the clinical development of MET-targeted cancer therapeutics.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">1 Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46235" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46235" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Cancer therapy for humans has entered into a new era of molecular medicine.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> To date, a series of small molecule inhibitors such as imatinib,<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> gefitinib, erlotinib, lapatinib,<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> sunitinib,<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> and sorafenib<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> have been approved by the U.S. Food and Drug Administration for cancer therapies that target various receptor tyrosine kinases (RTKs<a class="ref internalNav" href="#fnabbrev" aria-label="a">a</a>). <div class="NLM_fn" id="fnabbrev">a<p class="last">Abbreviations: EGFR, epidermal growth factor receptor; MET, mesenchymal−epithelial transition; MRI, magnetic resonance imaging; PET, positron emission tomography; RTK, receptor tyrosine kinases; SMP, small-molecule probe; SPECT, single photon emission computed tomography.</p></div> An important RTK that plays a prominent role in regulating invasive cellular oncogenic signaling is mesenchymal−epithelial transition (MET) receptor.<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6, 7)</a> Upon binding of its natural ligand hepatocyte growth factor/scatter factor, MET is phosphorylated at a number of juxtamembrane and cytoplasmic kinase phosphoepitopes, resulting in signal transduction and regulation of multitudes of cellular mitogenic and motogenic processes such as cell growth, proliferation, and survival.<a onclick="showRef(event, 'ref6 ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref6 ref8 ref9">(6, 8, 9)</a> Overexpression or mutation of MET results in activation of oncogenic signaling pathways and leads to up-regulation of diverse tumor cell functions.<a onclick="showRef(event, 'ref7 ref10'); return false;" href="javascript:void(0);" class="ref ref7 ref10">(7, 10)</a> Mounting evidence has validated MET receptor as a novel target for anticancer therapy.<a onclick="showRef(event, 'ref11 ref12 ref13 ref14 ref15 ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref13 ref14 ref15 ref16 ref17">(11-17)</a></div><div class="NLM_p">For efficacy evaluation of various MET-targeted anticancer therapies currently under development, it is critical to develop an imaging tool that permits detection and quantification of MET expression in vivo. Although invasive biopsy provides spatially and temporally static information about the expression of MET, it is often not feasible in clinical trials, especially in lung tumors. Therefore, there is an urgent need to develop noninvasive molecular imaging techniques to assay and quantify the putative molecular targets such as MET in human subjects. For this reason, several imaging modalities have been explored for in vivo imaging of MET expression. Magnetic resonance imaging (MRI) together with Doppler ultrasound were first used to measure blood oxygenation level, which was found to correlate with MET activity in vivo.<a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18, 19)</a> An anti-MET contrast agent was also evaluated on the basis of a superparamagnetic iron oxide for MRI imaging of MET expression.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> In addition, PET and single photon emission computed tomography (SPECT) were used in combination with anti-Met monoclonal antibodies that were radiolabeled with either zirconium-89 for PET or iodine-125 for SPECT.<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21, 22)</a></div><div class="NLM_p">To date, several small molecule MET inhibitors have been developed.<a onclick="showRef(event, 'ref11 ref17 ref23 ref24 ref25 ref26 ref27 ref28 ref29 ref30 ref31 ref32 ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref11 ref17 ref23 ref24 ref25 ref26 ref27 ref28 ref29 ref30 ref31 ref32 ref33 ref34">(11, 17, 23-34)</a> Among them, 3-[3,5-dimethyl-4-(4-[<sup>11</sup>C]methylpiperazinecarbonyl)-1<i>H</i>-pyrrol-2-ylmethylene]-2-oxo-2,3-dihydro-1<i>H</i>-indole-5-sulfonic acid (3-chlorophenyl)methylamide, <b>14</b> (SU11274), is a specific, reversible MET inhibitor that induces apoptosis in cells transformed by oncogenic MET and translocated promoter region-MET tyrosine kinase.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Compound <b>14</b> inhibits the catalytic activity of MET with an IC<sub>50</sub> of 20 nM and a selectivity at least 1 order of magnitude higher than that for a variety of other tyrosine kinases.<a onclick="showRef(event, 'ref11 ref35'); return false;" href="javascript:void(0);" class="ref ref11 ref35">(11, 35)</a> Inhibition of the MET kinase activity by <b>14</b> leads to time- and dose-dependent reduction of cell growth by inducing G1 cell cycle arrest and apoptosis. In addition, <b>14</b> possesses a structure that permits direct radiolabeling with positron-emitting carbon-11 that will not cause any alternation of the authentic structure. Thus, the binding properties and pharmacokinetics of <b>14</b> will be preserved. These binding affinity and specificity as well as its flexibility for radiolabeling make <b>14</b> a promising small-molecule probe (SMP) for PET imaging of MET expression. Compared to immuno-PET imaging, SMP-PET imaging holds several advantages: (1) SMPs can be directly radiolabeled with a clearly defined structure so that the pharmacokinetics, toxicity, and metabolism can be precisely determined; (2) SMP PET provides a more quantitative capacity than immuno-PET; (3) the structures of SMP can be readily modified for optimal imaging outcomes. In this study we report the first multistep synthetic approach to the production of [<sup>11</sup>C]<b>14</b>. We also investigated the potential of [<sup>11</sup>C]<b>14</b> for PET imaging of MET expression in vivo in human lung cancer xenografts (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm900803q/production/images/medium/jm-2009-00803q_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm900803q/production/images/large/jm-2009-00803q_0001.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. [<sup>11</sup>C]<b>14</b>-PET imaging of lung cancer xenografts. Coronal micro-PET images of nude mouse pair xenografted with NCI-H520 (animal on the left) and NCI-H1975 (animal on the right). Mice were injected with 18.5 MBq of [<sup>11</sup>C]<b>14</b> via the tail vein, and dynamic scanning was performed for 90 min thereafter as detailed in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. Image planes have been chosen for illustration where both the left and right tumors are visible. The locations of the lung cancer tumor xenografts are highlighted by yellow arrows.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm900803q/production/images/large/jm-2009-00803q_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900803q&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">2 Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16353" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16353" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3">2.1 Synthesis of the Labeling Precursor</h3><div class="NLM_p">The synthesis of the [<sup>11</sup>C]<b>14</b> labeling precursor is described in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. The 2-oxo-2,3-dihydro-1<i>H</i>-indole-5-sulfonic acid (<b>3</b>) was first prepared starting from the commercially available 1,3-dihydroindolin-2-one (<b>1</b>). Sulfonation of <b>1</b> yielded 2-oxo-2,3-dihydro-1<i>H</i>-indole-5-sulfonic acid (<b>2</b>), which underwent amidation of the sulfonyl chloride group to yield the indole sulfonamide (<b>3</b>).<a onclick="showRef(event, 'ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref36 ref37">(36, 37)</a> The oxime (<b>5</b>) was then prepared from <i>tert</i>-butyl acetoacetate (<b>4</b>) based on previously reported procedures.<a onclick="showRef(event, 'ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref38 ref39">(38, 39)</a> Knorr reaction of <b>5</b> with ethyl 3-oxobutyrate (<b>6</b>) in the presence of zinc dust gave 3,5-dimethyl-1<i>H</i>-pyrrole-2,4-dicarboxylic acid 2-<i>tert</i>-butyl ester 4-ethyl ester (<b>7</b>) in quantitative yield. The decarboxylation of the pyrrole <b>7</b> under acidic conditions (hydrochloric acid/ethanol) yielded 2,4-dimethyl-1<i>H</i>-pyrrole-3-carboxylic acid ethyl ester (<b>8</b>), which underwent Vilsmeier formylation to give the key intermediate 5-formyl-2,4-dimethyl-1<i>H</i>-pyrrole-3-carboxylic acid ethyl ether (<b>9</b>) for the aldol condensation of the oxindole and pyrrole aldehyde moieties. Basic hydrolysis of <b>9</b> yielded 5-formyl-2,4-dimethyl-1<i>H</i>-pyrrole-3-carboxylic acid (<b>10</b>). Amidation of <b>10</b> with piperazine-1-carboxylic acid <i>tert</i>-butyl ester in the presence of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride and hydroxybenzotriazole yielded the functionalized pyrrole aldehyde 4-(5-formyl-2,4-dimethyl-1<i>H</i>-pyrrole-3-carbony)piperazine-1-carboxylic acid <i>tert</i>-butyl ester (<b>11</b>). Coupling of the pyrrole aldehyde <b>11</b> and oxindole sulfonamide <b>3</b> in the presence of pyrrolidine yielded 4-(5-{5-[3-chlorophenyl)methyl sulfomyl]-2-oxodihydroindol-3-yllidenemethyl}-2,4-dimethyl-1<i>H</i>-pyrrole-3-carbonyl)piperazine-1-carboxylic acid <i>tert</i>-butyl ester (<b>12</b>). Further decarboxylation of <b>12</b> with hydrochloric acid in ethyl acetate afforded the precursor 3-[3,5-dimethyl-4-(piperazine-1-carbonyl)-1<i>H</i>-pyrrol-2-ylmethylene]-2-oxo-2,3-dihyro-1<i>H</i>-indole-5-sulfonic acid (3-chlorophenyl)methylamide hydrochloride (<b>13</b>) for <sup>11</sup>C radiolabeling of <b>14</b>.<a onclick="showRef(event, 'ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref40 ref41">(40, 41)</a></div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm900803q/production/images/medium/jm-2009-00803q_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm900803q/production/images/large/jm-2009-00803q_0006.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of the <sup>11</sup>C Radiolabeling Precursor <b>13</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm900803q/production/images/large/jm-2009-00803q_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900803q&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5">2.2 Radiosynthesis of [<sup>11</sup>C]<b>14</b></h3><div class="NLM_p">The radiosynthesis of [<sup>11</sup>C]<b>14</b> was accomplished through direct methylation of <b>13</b> with [<sup>11</sup>C]methyl iodide in the presence of potassium carbonate (see Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). After reaction for 10 min at 140 °C, the resulting mixture was subjected to a purification procedure using solid-phase extraction on C-18 Sep-Pak cartridge prior to semipreparative HPLC purification. The overall radiochemical yield of [<sup>11</sup>C]<b>14</b> was 5−10% decay corrected to the activity of [<sup>11</sup>C]methyl iodide trapped. [<sup>11</sup>C]<b>14</b> was obtained with radiochemical purity of over 98% and a specific activity of 0.3−0.5 Ci/mmol at the end of synthesis. The radiochemical identity of [<sup>11</sup>C]<b>14</b> was verified by co-injection with the nonradioactive cold standard which was commercially purchased from Sigma-Aldrich (St. Louis, MO).</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm900803q/production/images/medium/jm-2009-00803q_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm900803q/production/images/large/jm-2009-00803q_0007.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Radiosynthesis of [<sup>11</sup>C]<b>14</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm900803q/production/images/large/jm-2009-00803q_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900803q&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7">2.3 Preparation of Human Lung Cancer Xenografts and in Vivo Micro-PET/MRI Studies</h3><div class="NLM_p">For in vivo imaging studies, murine xenograft tumor models were established from two different human lung cancer cell lines, NCI-H1975 (high MET expression) and NCI-H520 (negligible MET expression).<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> The human lung cancer xenografts were established as described in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. For each imaging study, a pair of mice was used and placed on the same bed under anesthesia. After initial localization scans, [<sup>11</sup>C]<b>14</b> (500 μCi, 18.5 MBq) was then administrated through tail vein injection into each of the two mice. Dynamic micro-PET imaging was performed immediately for 90 min of duration. The mice were kept on the same bed and transferred to the 9.4 T MRI scanner. T2-weighted MRI images were acquired for 30 min. Following micro-PET and MRI scans, images from both modalities were coregistered for quantitative measurements of [<sup>11</sup>C]<b>14</b> concentration in each of the tumor regions. The radioactivity concentrations were determined as standard uptake value (SUV) in each region of interest through 90 min of the PET scan (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).</div><figure id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm900803q/production/images/medium/jm-2009-00803q_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm900803q/production/images/large/jm-2009-00803q_0002.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Pharmacokinetic profile of [<sup><b>11</b></sup>C]<b>14</b>-PET imaging of lung cancer xenografts. The average radioactivity−time curve in terms of SUV during the time period of [<sup>11</sup>C]<b>14</b>-PET imaging of each of the lung cancer xenografts was plotted as illustrated. The radiotracer uptake level in NCI-H1975 xenograft is higher than that in the control xenograft NCI-H520 (<i>p</i> = 0.000 19). Regions of interest were manually drawn by creating a volume of interest in the tumor region based on MR images. <i>p</i> < 0.05 indicates statistical significance.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm900803q/production/images/large/jm-2009-00803q_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900803q&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8">2.4 Correlation of MET Expression by ex Vivo Bioassay</h3><div class="NLM_p">Following imaging studies, the tumor tissues were harvested for immunohistochemical staining for correlation with the [<sup>11</sup>C]<b>14</b>-PET imaging results. Thus, immunoblotting and the respective H&E staining of both tumor xenografts were first conducted for comparison of MET expression. As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>, NCI-H1975 cells express high levels of both MET and epidermal growth factor receptor (EGFR), which are phosphorylated under serum-stimulated conditions. On the other hand, NCI-H520 expresses negligible levels of MET and EGFR. The two cell lines were used to establish tumor xenografts in nude mice. In addition, immunohistochemical analysis of MET expression was conducted (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). In NCI-H520 xenograft, negligible MET expression was observed (0 to 1+) (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>a,b). On the other hand, MET expression was seen at a much higher level (3+) in the NCI-H1975 xenograft (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>c,d), and significant membranous localization of the MET staining is evident in this cell line as well (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>d, yellow arrows). These results are in concordance with the cell line expression data under cell culture conditions.</div><figure id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm900803q/production/images/medium/jm-2009-00803q_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm900803q/production/images/large/jm-2009-00803q_0003.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Murine xenograft models of human NCI-H1975 and NCI-H520 lung cancer cell lines. Expression of MET and EGFR in the NCI-H1975 and NCI-H520 human lung cancer cell lines is shown here. The two lung cancer cell lines were cultured in regular growth media in cell culture, with the cell lysates collected for SDS−PAGE and immunoblotting using phospho-MET and total MET antibodies as described in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. Immunoblotting using antiphospho-EGFR and anti-EGFR antibodies was also performed for comparison. Actin antibody was used as a protein loading control. H&E staining of the xenografts is also shown here (40X).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm900803q/production/images/large/jm-2009-00803q_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900803q&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm900803q/production/images/medium/jm-2009-00803q_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm900803q/production/images/large/jm-2009-00803q_0004.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Immunohistochemical analysis of MET receptor expression in tumor xenograft of human lung cancer (NCI-H1975 and H520) in vivo. The expression of MET receptor in the lung cancer xenografts established was evaluated using immunohistochemistry of the xenograft formalin-fixed paraffin-embedded sections using anti-MET primary antibody as described in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm900803q/production/images/large/jm-2009-00803q_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900803q&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">3 Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85751" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85751" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">As a linear compound, <b>14</b> consists of three functionalized heterocyclic components: oxindole, pyrrole, and piperazine. The methyl group on the nucleophilic nitrogen of the piperazine ring is uniquely suited as a radiolabeling site. This is due to the fact that the <i>N</i>-methyl group can be readily replaced by a [<sup>11</sup>C]methyl group through direct radiomethylation with [<sup>11</sup>C]methyl iodide without causing any structural alternation. For this reason, we designed <b>13</b> with no methyl group on the piperazine ring as the radiolabeling precursor, which is otherwise identical to <b>14</b>, the final product. Because of this structural variation, the chemical synthesis of <b>13</b> warrants design of a new synthetic approach that is different from the previously reported approach to <b>14</b>. The synthetic approach we have developed consists of the following three steps: (1) preparation of the oxindole core; (2) preparation of functionalized pyrrole aldehyde unit; (3) aldol condensation of the oxindole and pyrrole aldehyde units to furnish the indolinone.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Starting from commercially available 2-oxindole, the total synthesis of <b>13</b> was achieved in 10 steps with a combined yield of 9.7%. By use of this synthetic route, large quantities of <b>13</b> can be obtained, which can be stored as the HCl salt for long periods without decomposition.</div><div class="NLM_p">The radiosynthesis of [<sup>11</sup>C]<b>14</b> was achieved through direct radiomethylation using [<sup>11</sup>C]methyl iodide, which was prepared through reduction of [<sup>11</sup>C]CO<sub>2</sub> generated by an on-site cyclotron. Although there are a total of five nitrogens present in <b>13</b>, only the unsubstituted nitrogen in the unconjugated piperazine ring can be methylated by [<sup>11</sup>C]methyl iodide in the presence of potassium carbonate. The radiomethylation was carried out at elevated temperature (140 °C) in DMF for 10 min. The [<sup>11</sup>C]<b>14</b> product was purified by HPLC with a radiochemical purity of >95% and a radiochemical yield of 5−10% after decay correction.</div><div class="NLM_p">The in vivo imaging studies were carried out in two lung cancer xenograft mouse models, which were prepared with NCI-H520 and NCI-H1975 lung adenocarcinama cells. H1975 cells express high level of wild-type MET without genomic amplification. In contrast, MET expression in H520 cells is negligible. Thus, use of both xenografts allowed us to determine the specificity of [<sup>11</sup>C]<b>14</b>-PET imaging in vivo. As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>, time−radioactivity curves were determined in both xenograft tumor models, which showed that the uptake of the [<sup>11</sup>C]<b>14</b> in the NCI-H1975 xenograft was significantly higher than in the NCI-H520 xenograft (<i>p</i> = 0.000 19). Compared to NCI-H520 xenograft mice, the NCI-H1975 xenograft mice exhibited an increased tumor uptake of [<sup>11</sup>C]<b>14</b> throughout the entire measurement period of 90 min. At 10 min postinjection of [<sup>11</sup>C]<b>14</b>, the radioactivity concentration in NCI-H1975 mice was 1.35-fold higher than that in NCI-H520 mice. Moreover, at 65 min postinjection, the radioactivity concentration ratio of H1975/H520 reached a statistically significant and enhanced ratio of 2.1 and peaked at 2.6 at 80 min postinjection. Hence, our results suggest that [<sup>11</sup>C]<b>14</b>-PET is a specific imaging marker that can differentiate and quantify MET expression in vivo.</div><div class="NLM_p">Immediately following completion of the micro-PET imaging, the tumor xenografts were dissected and MET expression in tumor tissues of both xenograft mouse models was evaluated through immunoblotting and immunohistochemical staining using antihuman MET antibody (Figures <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a> and <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). The results confirmed that NCI-H1975 xenograft tumor cells expressed a readily detectable high level of MET receptor, with both membranous and cytoplasm localization discernible through standard immunohistochemistry using antihuman MET antibody. On the other hand, NCI-H520 xenograft tumor cells showed negligible MET expression level and specifically no membranous MET localization was seen. These results are consistent with the imaging data and thus demonstrate that [<sup>11</sup>C]<b>14</b>-PET is a promising imaging marker of MET expression.</div><div class="NLM_p last">In summary, we successfully developed an efficient radiochemical synthesis of [<sup>11</sup>C]<b>14</b>. Micro-PET studies demonstrated that the tumor uptake of [<sup>11</sup>C]<b>14</b> is consistent with the levels of MET expression in the xenograft tumor models. The [<sup>11</sup>C]<b>14</b>-PET imaging results correlated well with the MET immunohistochemistry bioassay results, suggesting that [<sup>11</sup>C]<b>14</b>-PET is a valid imaging marker for in vivo quantification of MET expression. These results justify further development of [<sup>11</sup>C]<b>14</b> and its analogues as molecular imaging probes for efficacy evaluation of MET-targeted cancer therapy.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">4 Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08522" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08522" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11">4.1 General Remarkers</h3><div class="NLM_p last">All chemicals were purchased from Sigma-Aldrich (St. Louis, MO) and used without further purification unless otherwise specified. <sup>1</sup>H NMR spectra were recorded on a Bruker AMX 400 MHz spectrometer using 5 mm NMR tubes (Wilmad 528-PP) in CDCl<sub>3</sub> or DMSO-<i>d</i><sub>6</sub> (Sigma-Aldrich or Cambridge Isotopes) solutions at room temperature. Chemical shifts are reported as δ values relative to internal tetramethylsilane (TMS). HR-ESIMS were recorded under the electron spray ionization (ESI) condition. <sup>13</sup>C NMR spectra were recorded on an Oxford AS 100 MHz spectrometer using 5 mm NMR tubes (Wilmad 528-PP) in CDCl<sub>3</sub> or DMSO-<i>d</i><sub>6</sub> (Sigma-Aldrich or Cambridge Isotopes). Six-week-old female Ncr-nu (Nude) mice were purchased from Charles River Laboratories (Wilmington, MA) and hosted in a pathogen-free animal facility at Case Western Reserve University, Cleveland, OH. Analytical radio-TLC was performed on silica gel F-254 aluminum plates, with visualization under UV (254 nm). Chemical and radiochemical purity was determined by an Agilent 1100 series high pressure liquid chromatography (HPLC) system equipped with UV and Bioscan flow count detectors. The purities of all the intermediates and final product were >95%. Micro-PET imaging was conducted under an R4 micro-PET system (Siemens Medical Solutions, Knoxville, TN). MRI imaging was performed on a Bruker Biospec 9.4 T MRI scanner to produce high resolution images as roadmaps for micro-PET imaging.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12">4.2 Synthesis of 2-Oxo-2,3-dihydro-1<i>H</i>-indole-5-sulfonic Acid (<b>2</b>)</h3><div class="NLM_p last">Chlorosulfonic acid (27 mL, 406 mmol) was slowly added to a solution of 1,3 dihydroindolin-2-one (<b>1</b>, 13.3 g, 100 mmol) at room temperature. The reaction mixture was stirred at room temperature for 1.5 h followed by stirring for another 1 h at 68 °C in a water bath. The reaction mixture was then cooled to room temperature and poured into water. The solid precipitate was filtered, washed with water, and dried to yield 2-oxo-2,3-dihydro-1<i>H</i>-indole-5-sulfonic acid (<b>2</b>, 11.0 g, 50% yield), which was used without further purification.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13">4.3 Synthesis of 2-Oxo-2,3-dihydro-1<i>H</i>-indole-5-sulfonic Acid (<b>3</b>)</h3><div class="NLM_p last">To a solution of compound <b>2</b> (4.2 g, 18.2 mmol) dissolved in dry ethanol (10 mL), 3-chlorophenylamine (3.0 g, 21 mmol) was added. The resulting solution was stirred at room temperature for 12 h. The reaction mixture was then concentrated and recrystallized from dichloromethane to give 2-oxo-2,3-dihydro-1<i>H</i>-indole-5-sulfonic acid (<b>3</b>, 4.3 g 70% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): 10.89 (br, s, NH), 6.92−7.16 (m, 7H, aromatic H), 3.53 (s, 2H, CH<sub>2</sub>), 3.08 (s, 3H, CH<sub>3</sub>).</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14">4.4 Synthesis of <i>tert</i>-Butyl 2-Hydroximino-3-oxobutyrate (<b>5</b>)</h3><div class="NLM_p last"><i>tert</i>-Butyl 3-oxobutanoate (40 mL, 241 mmol) was dissolved in acetic acid (80 mL) in a round-bottomed flask, and the mixture was cooled in an ice bath to about 10 °C. Sodium nitrite (18 g, 261 mmol) was added over 1 h while keeping the temperature under 15 °C. The cold bath was removed and the mixture was allowed to stir for 3.5 h at room temperature to give a crude solution of <i>tert</i>-butyl 2-hydroximino-3-oxobutyrate (<b>5</b>) which was used in the next step without further purification.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15">4.5 Synthesis of 3,5-Dimethyl-1<i>H</i>-pyrrole-2,4-dicarboxylic Acid 2-<i>tert</i>-Butyl Ester 4-Ethyl Ester (<b>7</b>)</h3><div class="NLM_p last">To a stirred mixture of ethyl 3-oxobutyrate (<b>6</b>, 10 mL, 79 mmol) and acetic acid (100 mL) in an oil bath, zinc dust (50 g 0.76 mol) was added portionwise. The mixture was heated to 60 °C. At this temperature, the crude <i>tert</i>-butyl 2-hydroximinooxobutyrate precipitated slowly. The temperature was then increased to 75 °C for 1 h, and then the reaction mixture was poured into water (40 mL). The precipitate was collected by filtration to yield 3,5-dimethyl-1<i>H</i>-pyrrole-2,4-dicarboxylic acid 2-<i>tert</i>-butyl ester-4-ethyl ester (<b>7</b>) in quantitative yield as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): 9.47 (br, s, 1H, NH), 4.29 (q, 2H, CH<sub>2</sub>), 2.52, 2.54 (2s, 6H, 2CH<sub>3</sub>), 1.58 (s, 9H, 3CH<sub>3</sub>), 1.36 (t, 3H, CH<sub>3</sub>). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>SO): 165.8, 161.6, 138.7, 130.2, 119.4, 113.6, 81.4, 59.6, 28.7, 14.7, 14.6, 12.3. Retention time: 5.98 min (HPLC C-18 column, acetonitrile/DMGA (5 mM, pH 7.4) = 80:20 (v:v)).</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16">4.6 Synthesis of 2,4-Dimethyl-1<i>H</i>-pyrrole-3-carboxylic Acid Ester (<b>8</b>)</h3><div class="NLM_p last">A solution of the product <b>7</b> (18 g, 67 mmol) dissolved in ethanol (78 mL) was stirred vigorously as hydrochloric acid (10 N, 3.6 mL) was slowly added at 20 °C. Then the reaction mixture was heated to 67 °C for 1 h, cooled to 5 °C, and poured into ice water. The solid was collected by filtration and washed with water to yield 2,4-dimethyl-1<i>H</i>-pyrrole-3-carboxylic acid ester (<b>8</b>, 10 g, 89% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): 10.48 (br, s, 1H, NH), 6.35 (s, 1H, CH), 4.10 (q, 2H, CH<sub>2</sub>), 2.35, 2.15 (2s, 2CH<sub>3</sub>), 1.21 (t, 3H, CH<sub>3</sub>). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): 166.0, 135.9, 120.1, 115.4, 110.2, 58.9, 15.1, 14.2, 13.3. Retention time: 3.42 min (HPLC C-18 column, acetonitrile/DMGA (5 mM, pH 7.4) = 80:20 (v:v), flow rate 1.0 mL/min).</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17">4.7 Synthesis of 5-Formyl-2,4-dimethyl-1<i>H</i>-pyrrole-3-carboxylic Acid Ethyl Ester (<b>9</b>)</h3><div class="NLM_p last">Phosphorus oxychloride (2.8 mL, 30 mmol) was added dropwise to a solution of dimethylformamide (2.3 mL, 30 mmol) in dry dichloromethane (50 mL) in an ice bath. After 30 min compound <b>8</b> (3.5 g, 21 mmol) was slowly added. The mixture was heated at 40 °C for 2 h, cooled to 10 °C, followed by addition of ice−water (10 mL) and hydrochloric acid (10 N, 10 mL) with vigorous stirring. The mixture was allowed to stand at room temperature for 12 h until the layers were separated. The aqueous layer was adjusted to pH 12−13 with potassium hydroxide (10 N), while the temperature was maintained at 55 °C. The reaction mixture was then cooled to 10 °C in an ice bath and stirred for another hour. The solid formed was collected by filtration and washed with water to yield 5-formyl-2,4-dimethyl-1<i>H</i>-pyrrole-3-carboxylic acid ethyl ester (<b>9</b>, 3.7 g, 91%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): 10.79 (s, 1H, NH), 9.60 (s, 1H, CHO), 4.31 (q, 2H, CH<sub>2</sub>), 2.56, 2.60 (2s, 2CH<sub>3</sub>), 1.38 (t, 3H, CH<sub>3</sub>). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): 177.6, 165.3, 144.4, 136.9, 128.5, 114.4, 59.9, 14.6, 14.5, 10.9. Retention time: 3.35 min (HPLC C-18 column, acetonitrile/DMGA (5 mM, pH 7.4) = 80:20 (v:v), flow rate 1.0 mL/min).</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18">4.8 Synthesis of 5-Formyl-2,4-dimethyl-1<i>H</i>-pyrrole-3-carboxylic Acid (<b>10</b>)</h3><div class="NLM_p last">A mixture of compound <b>9</b> (3.0 g, 15.4 mmol), potassium hydroxide pellet (1.2 g, 16.5 mmol), methanol (8 mL), and water (50 mL) was heated at 100 °C for 2 h and subsequently cooled to 8 °C in an ice bath. The reaction product was extracted with dichloromethane. The aqueous portion was acidified to pH 4 with hydrochloric acid (10 N). The product was collected by filtration, washed with water, and dried over MgSO<sub>4</sub> to yield 5-formyl-2,4-dimethyl-1<i>H</i>-pyrrole-3-carboxylic acid (<b>10</b>, 2.4 g, 94% yield) as a yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): 12.07 (s, 1H, NH), 9.60 (s, 1H, CHO), 3.33 (s, 1H, COOH), 2.39, δ 2.43 (2s, 2CH<sub>3</sub>). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): 178.4, 166.6, 143.4, 134.7, 128.8, 114.0, 14.3, 11.1. Retention time: 2.33 min (HPLC, C-18 column, acetonitrile/DMGA (5 mM, pH 7.4) = 80:20 (v:v), flow rate 1.0 mL/min).</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19">4.9 Synthesis of 4-(5-Formyl-2,4-dimethyl-1<i>H</i>-pyrrole-3-carbonyl)piperazine-1-carboxylic Acid <i>tert</i>-Butyl Ester (<b>11</b>)</h3><div class="NLM_p last">A solution of compound <b>10</b> (2.0 g, 12 mmol) dissolved in dimethylformamide (40 mL) was stirred at room temperature while <i>N</i>-(3-dimethylaminopropyl)-<i>N</i>-ethylcarbodiimide hydrochloride (3.5 g, 18 mmol), hydroxybenzotriazole hydrate (2.4 g, 18 mmol), triethylamine (15 mL), and 1-Boc-piperazine (2.8 g, 15 mmol) were added. The reaction mixture was stirred at room temperature for 12 h and then diluted with water (30 mL), brine (20 mL), saturated sodium carbonate (30 mL). The pH of the resultant mixture was adjusted to 10 with sodium hydroxide (10 N) and extracted with 10% methanol in dichloromethane. The organic extract was dried over anhydrous sodium sulfate and rotary-evaporated to dryness. The dry product was treated with toluene (19 mL) and rotary-evaporated again to dryness. The residue was triturated with hexane/diethyl ether, 3:1 v/v (15 mL), then washed with ethyl acetate to give 4-(5-formyl-2,4-dimethyl-1<i>H</i>-pyrrole-3-carbonyl)piperazine-1-carboxylic acid <i>tert</i>-butyl ester (<b>11</b>, 2.5 g, 63%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): 11.86 (s, 1H, NH), 9.48 (s, 1H, CHO), 3.30 (br, s, 8H, piperazy ring), 2.18, 2.13 (2s, 2CH<sub>3</sub>), 1.36 (s, 9H, 3CH<sub>3</sub>). <sup>13</sup>C NMR (150 MHz, CD<sub>3</sub>SO): 177.8, 166.0, 161.7, 154.4, 136.4, 128.6, 119.3, 79.8, 45.2, 28.6, 21.9, 12.4, 9.9. Retention time: 2.92 min (HPLC C-18 column, acetonitrile/DMGA (5 mM, pH 7.4) = 80:20 (v:v), flow rate 1.0 mL/min).</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20">4.10 Synthesis of 4-(5-{5-[3-Chlorophenyl)methylsulfomyl]-2-oxodihydroindol-3-yllidenemethyl}-2,4-dimethyl-1<i>H</i>-pyrrole-3-carbonyl)piperazine-1-carboxylic Acid <i>tert</i>-Butyl Ester (<b>12</b>)</h3><div class="NLM_p last">A mixture of compounds <b>3</b> (1.0 g, 2.9 mmol) and <b>11</b> (1.2 g, 3.6 mmol) and pyrrolidine (3 mL) was dissolved in ethanol and heated to 90 °C for 5 h. After the reaction mixture was cooled to room temperature, the precipitate was filtered, washed with ethanol, and dried to yield 4-(5-{5-[3-chlorophenyl)methylsulfomyl]-2-oxodihydroindol-3-yllidenemethyl}-2,4-dimethyl-1<i>H</i>-pyrrole-3-carbonyl)piperazine-1-carboxylic acid <i>tert</i>-butyl ester (<b>12</b>, 1.5 g, 78% yield). <sup>1</sup>H NMR (400 MHz, DMSO): δ 7.65−6.95 (m, 7H, aromatic-H and 1H, olefinic-H), 3.30 (m, 8H, piperazyl-H), 3.15 (s, 3H, CH<sub>3</sub>), 2.29, 2.35 (2s, 2CH<sub>3</sub>), 1.47 (s, 9H, 3CH<sub>3</sub>). <sup>13</sup>C NMR (100 MHz, DMSO; 100 MHz, CD<sub>3</sub>SO): δ 170.3, 166.0, 154.5, 143.6, 142.4, 136.1, 133.5, 131.2, 131.0, 128.8, 127.5, 127.0, 127.0, δ126.7, 126.6, 126.6, 125.3, 121.0, 118.7, 113.5, 110.0, 79.9, 28.7, 13.2, 10.9. Retention time: 5.10 min (HPLC C-18 column, acetonitrile/DMGA (5 mM, pH 7.4) = 80:20 (v:v), flow rate 1.0 mL/min). HR-ESIMS: <i>m</i>/<i>z</i> calcd for C<sub>32</sub>H<sub>37</sub>N<sub>5</sub>O<sub>6</sub>SCl<sup>+</sup> (M + H<sup>+</sup>) 654.214 76, found 654.214 99; <i>m</i>/<i>z</i> calcd for C<sub>32</sub>H<sub>37</sub>N<sub>5</sub>O<sub>6</sub>SCl<sup>+</sup> (M + Na<sup>+</sup>) 676.196 70, found 676.196 97.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21">4.11 Synthesis of 3-[3,5-Dimethyl-4-(piperazine-1-carbonyl)-1<i>H</i>-pyrrol-2-ylmethylene]-2-oxo-2,3-dihyro-1<i>H</i>-indole-5-sulfonic Acid (3-Chlorophenyl)methylamide Hydrochloride (<b>13</b>)</h3><div class="NLM_p last">4-(5-{5-[3-Chlorophenyl)methylsulfomyl]-2-oxo-dihydroindol-3-yllidenemethyl}-2,4-dimethyl-1<i>H</i>-pyrrole-3-carbonyl)piperazine-1-carboxylic acid <i>tert</i>-butyl ester (<b>12</b>, 150 mg, 0.22 mmol) was suspended in 5 mL of ethyl acetate, and 5 mL of hydrochloric acid/ethyl acetate (4 M) was added at ice-cold temperature. After the solution was allowed to stand for 1 h at room temperature, the solvent was evaporated under vacuum, yielding 3-[3,5-dimethyl-4-(piperazine-1-carbonyl)-1<i>H</i>-pyrrol-2-ylmethylene]-2-oxo-2,3-dihyro-1<i>H</i>-indole-5-sulfonic acid (3-chlorophenyl)methylamide hydrochloride (<b>13</b>) as a yellow solid (100 mg, 74%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) 2.30, 2.43 (2 × s, 2 × 3H, 2 × CH<sub>3</sub>); 3.18 (s, 3H, CH<sub>3</sub>); 3.40 (m, 8H, piperazyl-H); 7.00−7.70 (m, 7H, aromatic-H and 1H, olefinic-H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) 3.08 (s, 3H, CH<sub>3</sub>); 3.53 (s, 2H, CH<sub>2</sub>); 6.92−7.16 (m, 7H, H-aromatic); 10.89 (br, s, NH). HR-ESIMS: <i>m</i>/<i>z</i> calcd for C<sub>27</sub>H<sub>29</sub>N<sub>5</sub>O<sub>4</sub>SCl<sup>+</sup> (M − Cl), 554.16233; found 554.16248. Retention time: 6.08 min (HPLC C-18 column, acetonitrile/DMGA (5 mM, pH 7.4) = 80:20 (v:v)).</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22">4.12 Radiosynthesis of [<sup>11</sup>C]<b>14</b></h3><div class="NLM_p last">The cyclotron-made [<sup>11</sup>C]carbon dioxide was converted to [<sup>11</sup>C]methyl iodide by reduction with lithium aluminum hydride and hydroiodide.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> The labeled methyl iodide [<sup>11</sup>C]CH<sub>3</sub>I was concurrently distilled and trapped in a dry 5 mL conical reaction vial cooled in an ice bath which was previously filled with a solution of 2 mg of <b>13</b> and 10 mg of potassium carbonate dissolved in 0.3 mL dimethylformamide. Trapping of [<sup>11</sup>C]methyl iodide was monitored by measuring the activity in the isotope calibrator until the maximal value was attained. The reaction mixture was sealed and heated at 140 °C for 10 min in a heating block, cooled to room temperature, and diluted with water. The radiolabeled reaction mixture was passed through a Waters C-18 Sep-Pak cartridge previous conditioned with ethanol and then water to remove the nonorganic impurities. The Sep-Pak cartridge was washed with 10 mL of water and dried with a rapid air bolus, and the radiolabeled product was eluted with ethanol, loaded onto a preparative HPLC (Luna 5 μm C18 250mm × 10 mm) column, and eluted with acetonitrile and water (flow rate 3 mL/min (8:2 v/v)). The retention time was 6.08 min (HPLC C-18 column, acetonitrile/DMGA (5 mM, pH 7.4) = 80:20 (v:v)). The radiochemical purity of [<sup>11</sup>C]<b>14</b> was >95% as determined by radio-HPLC, and the total synthesis time was 30−40 min from the end of bombardment (EOB).</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23">4.13 Lung Cancer Cell Culture and in Vivo Nude Mouse Xenograft Model</h3><div class="NLM_p last">Lung cancer xenografts with NCI-H520 and NCI-H1975 lung adenocarcinoma cells were established for this imaging study. Both the NCI-H520 and NCI-H1975 cell lines were obtained from American Type Culture Collection (ATCC, Manassas, VA) and grown in RPMI-1640 media (Hyclone, Logan, UT) supplemented with 10% (v/v) fetal bovine serum under standard cell culture conditions. Six-week-old female Ncr-nu (Nude) mice were purchased from Charles River Laboratories (Wilmington, MA) and hosted in the pathogen-free animal facility at Case Western Reserve University. In vivo animal studies were performed according to institution-approved protocols and guidelines. Xenografts of the NCI-H1975 and NCI-H520 lung cancer cells were established by intradermally injecting 3 × 10<sup>6</sup> viable cells in RPMI 1640 media into the flank/leg region of nude mice to produce subcutaneous tumors.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> Body weight was recorded for each animal twice weekly to monitor potential toxicities. Tumor xenografts were subsequently dissected and harvested at the end of the experiments after completion of the imaging studies and formalin-fixed and stained with hematoxylin and eosin (H&E) using standard techniques.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24">4.14 Micro-PET/MRI imaging</h3><div class="NLM_p">A pair of xenograft model mice was placed on a plastic bed that was suitable for both PET and MRI scanning following anesthesia with 2.0% isoflurane delivered in oxygen gas with a nosecone. The micro-PET experiment was performed on a Concord R4 micro-PET scanner (Siemens Medical Solutions, Knoxville, TN). Transmission scans were acquired for 10 min by using a <sup>57</sup>Co source which was subsequently used for attenuation correction. [<sup>11</sup>C]<b>14</b> (18.5 MBq) was then injected into the tail vein. The image acquisition started immediately after the injection. The dynamic imaging was collected for 90 min in a list mode. PET images were reconstructed into a 128 × 128 matrix with 0.8 mm slice thickness. Twelve frames were acquired within the scan duration starting from 10 min (frames 0−5) to 5 min (6−11) during the experiment.</div><div class="NLM_p last">Following micro-PET imaging, the animals were immediately transferred to a Bruker Biospec 9.4 T MRI scanner under anesthesia to produce high resolution images as roadmaps for micro-PET imaging. The entire animal bed was moved to minimize movement of the animals between the MRI and PET scans. After initial localization scans, the two mice were simultaneously scanned using T2-weighted imaging. Each animal’s respiration rate was monitored, and the animal’s core body temperature was also maintained at 37 ± 2 °C throughout the scanning procedure. High-resolution anatomic MR images of the tumor region were acquired using contiguous multislice 2D spin echo and 3D gradient echo techniques.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25">4.15 Quantitative Image Analysis</h3><div class="NLM_p last">Following micro-PET and MRI imaging, we conducted quantitative image analysis in order to evaluate the in vivo pharmacokinetic profiles of [<sup>11</sup>C]<b>14</b> in xenograft tumor tissues. The micro-PET images were registered with MR images to ensure the consistency of the anatomical localization of [<sup>11</sup>C]<b>14</b> in tumor tissue. Volumes of interest (VOI) of the xenografts were then defined and delineated in 3D on MR images. The coregistered images were used for quantitative image analysis to determine [<sup>11</sup>C]<b>14</b> uptake and retention associated with tumor tissues. To generate a radioactivity versus time curve, the mean radioactivity in the VOI was calculated, corrected for <sup>11</sup>C decay, plotted, and expressed in terms of standard uptake volume [(μCi/cm<sup>3</sup>)/(μCi/g)] as a function of time.</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26">4.16 Ex Vivo Bioassay of MET Expression</h3><div class="NLM_p last">For the in vitro cellular protein expression analysis, the lung cancer cell lines were cultured under regular growth conditions to exponential growth phase. Cellular proteins were extracted from whole cells as previously described.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Immunoblotting was performed as previously described<a onclick="showRef(event, 'ref16 ref44'); return false;" href="javascript:void(0);" class="ref ref16 ref44">(16, 44)</a> using the following primary antibodies as indicated: p-MET [Y1234/1235] (Cell Signaling Technology, Danvers, MA), MET (C-12, Santa Cruz Biotechnology, Santa Cruz, CA), p-EGFR[Y1068] (Cell Signaling), EGFR (Santa Cruz Biotechnology), and actin (Santa Cruz Biotechnology). Following MRI and micro-PET studies, the animals bearing the lung cancer xenografts were sacrificed in accordance with institutional guidelines, and the xenograft tumors were dissected and harvested under standard techniques. The xenografts were then formalin-fixed in 5% formalin for 16 h, processed for hematoxylin and eosin (H&E) staining as well as immunohistochemical staining using rabbit polyclonal primary antibody against total MET (C-12, Santa Cruz Biotechnology) at 1:100 dilution as previously described.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Isotype matched rabbit IgG was used as negative control treatment as well. The immunohistochemistry was performed using the Tissue Procurement and Histology Core Facility of the Case Comprehensive Cancer Center.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i28"><a href="/doi/suppl/10.1021/jm900803q">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75846" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75846" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Table listing the analytical data for compounds <b>7</b>−<b>13</b>; spectra of HPLC, HRMS, <sup>1</sup>HNMR, and <sup>13</sup>C NMR. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm900803q/suppl_file/jm900803q_si_001.pdf">jm900803q_si_001.pdf (2.61 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm900803q" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78635" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78635" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yanming Wang</span> - <span class="hlFld-Affiliation affiliation">Division of Radiopharmaceutical Science, Case Center for Imaging Research, Department of Radiology, Case Western Reserve University, Cleveland, Ohio 44106</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#641d050a090d0a034a13050a0324070517014a010011"><span class="__cf_email__" data-cfemail="e29b838c8f8b8c85cc95838c85a281839187cc878697">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chunying Wu</span> - <span class="hlFld-Affiliation affiliation">Division of Radiopharmaceutical Science, Case Center for Imaging Research, Department of Radiology, Case Western Reserve University, Cleveland, Ohio 44106</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhe Tang</span> - <span class="hlFld-Affiliation affiliation">Division of Hematology/Oncology, Department of Medicine, Case Western Reserve University, University Hospitals Case Medical Center, and Case Comprehensive Cancer Center, Cleveland, Ohio 44106</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Weiwen Fan</span> - <span class="hlFld-Affiliation affiliation">Division of Hematology/Oncology, Department of Medicine, Case Western Reserve University, University Hospitals Case Medical Center, and Case Comprehensive Cancer Center, Cleveland, Ohio 44106</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wenxia Zhu</span> - <span class="hlFld-Affiliation affiliation">Division of Radiopharmaceutical Science, Case Center for Imaging Research, Department of Radiology, Case Western Reserve University, Cleveland, Ohio 44106</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Changning Wang</span> - <span class="hlFld-Affiliation affiliation">Division of Radiopharmaceutical Science, Case Center for Imaging Research, Department of Radiology, Case Western Reserve University, Cleveland, Ohio 44106</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Edurado Somoza</span> - <span class="hlFld-Affiliation affiliation">Division of Radiopharmaceutical Science, Case Center for Imaging Research, Department of Radiology, Case Western Reserve University, Cleveland, Ohio 44106</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Norbert Owino</span> - <span class="hlFld-Affiliation affiliation">Division of Radiopharmaceutical Science, Case Center for Imaging Research, Department of Radiology, Case Western Reserve University, Cleveland, Ohio 44106</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ruoshi Li</span> - <span class="hlFld-Affiliation affiliation">Division of Radiopharmaceutical Science, Case Center for Imaging Research, Department of Radiology, Case Western Reserve University, Cleveland, Ohio 44106</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Patrick C. Ma</span> - <span class="hlFld-Affiliation affiliation">Division of Hematology/Oncology, Department of Medicine, Case Western Reserve University, University Hospitals Case Medical Center, and Case Comprehensive Cancer Center, Cleveland, Ohio 44106</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i27">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62670" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62670" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Dr. George Bakale for proofreading the manuscript. This work is supported by Case Center for Imaging Research and Case Comprehensive Cancer Center. P.C.M. is supported by NIH/National Cancer Institute—K08 Mentored Clinical Scientist Career Development Award (Grant 5K08CA102545-04) and the Sol Siegal Lung Cancer Research in Honor of Molly Siegal Grant Program.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i29">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20836" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20836" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 44 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Sun, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiller, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spinola, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minna, J. D.</span><span> </span><span class="NLM_article-title">New molecularly targeted therapies for lung cancer</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">2740</span><span class="NLM_x">–</span> <span class="NLM_lpage">2750</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2007&pages=2740-2750&author=S.+Sunauthor=J.+H.+Schillerauthor=M.+Spinolaauthor=J.+D.+Minna&title=New+molecularly+targeted+therapies+for+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DS.%26aulast%3DSchiller%26aufirst%3DJ.%2BH.%26aulast%3DSpinola%26aufirst%3DM.%26aulast%3DMinna%26aufirst%3DJ.%2BD.%26atitle%3DNew%2520molecularly%2520targeted%2520therapies%2520for%2520lung%2520cancer%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2007%26volume%3D117%26spage%3D2740%26epage%3D2750" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Savage, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antman, K. H.</span><span> </span><span class="NLM_article-title">Imatinib mesylate—a new oral targeted therapy</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">346</span><span class="NLM_x">, </span> <span class="NLM_fpage">683</span><span class="NLM_x">–</span> <span class="NLM_lpage">693</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm900803q&amp;key=10.1056%2FNEJMra013339" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm900803q&amp;key=11870247" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm900803q&amp;key=1%3ACAS%3A528%3ADC%252BD38XhsFOjsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=346&publication_year=2002&pages=683-693&author=D.+G.+Savageauthor=K.+H.+Antman&title=Imatinib+mesylate%E2%80%94a+new+oral+targeted+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Imatinib mesylate - a new oral targeted therapy</span></div><div class="casAuthors">Savage, David G.; Antman, Karen H.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">346</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">683-693</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review.  Imatinib mesylate is an inhibitor of specific protein Tyr kinases that was targeted to the platelet-derived growth factor receptor.  It is highly active and has an acceptable level of toxicity when given alone for the treatment of chronic-phase chronic myelogenous leukemia (CML) and gastrointestinal stromal tumors.  Imatinib has also limited activity against blast-phase CML and relapsed Philadelphia-chromosome-pos. acute lymphoblastic leukemia, conditions resistant to std. chemotherapy and even to allogeneic stem cell transplantation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXP-6mujVB5LVg90H21EOLACvtfcHk0ligNNBWBvmoYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhsFOjsro%253D&md5=2274455b28cbb1642b4f1282acc1c42c</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1056%2FNEJMra013339&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra013339%26sid%3Dliteratum%253Aachs%26aulast%3DSavage%26aufirst%3DD.%2BG.%26aulast%3DAntman%26aufirst%3DK.%2BH.%26atitle%3DImatinib%2520mesylate%25E2%2580%2594a%2520new%2520oral%2520targeted%2520therapy%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2002%26volume%3D346%26spage%3D683%26epage%3D693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Ryan, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ibrahim, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ko, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sridhara, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Justice, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pazdur, R.</span><span> </span><span class="NLM_article-title">FDA drug approval summary: lapatinib in combination with capecitabine for previously treated metastatic breast cancer that overexpresses HER-2</span> <span class="citation_source-journal">Oncologist</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1114</span><span class="NLM_x">–</span> <span class="NLM_lpage">1119</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=1114-1119&author=Q.+Ryanauthor=A.+Ibrahimauthor=M.+H.+Cohenauthor=J.+Johnsonauthor=C.+W.+Koauthor=R.+Sridharaauthor=R.+Justiceauthor=R.+Pazdur&title=FDA+drug+approval+summary%3A+lapatinib+in+combination+with+capecitabine+for+previously+treated+metastatic+breast+cancer+that+overexpresses+HER-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRyan%26aufirst%3DQ.%26aulast%3DIbrahim%26aufirst%3DA.%26aulast%3DCohen%26aufirst%3DM.%2BH.%26aulast%3DJohnson%26aufirst%3DJ.%26aulast%3DKo%26aufirst%3DC.%2BW.%26aulast%3DSridhara%26aufirst%3DR.%26aulast%3DJustice%26aufirst%3DR.%26aulast%3DPazdur%26aufirst%3DR.%26atitle%3DFDA%2520drug%2520approval%2520summary%253A%2520lapatinib%2520in%2520combination%2520with%2520capecitabine%2520for%2520previously%2520treated%2520metastatic%2520breast%2520cancer%2520that%2520overexpresses%2520HER-2%26jtitle%3DOncologist%26date%3D2008%26volume%3D13%26spage%3D1114%26epage%3D1119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Goodman, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rock, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dagher, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramchandani, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobburu, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Booth, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verbois, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morse, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chidambaram, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, J. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahjoob, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Justice, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pazdur, R.</span><span> </span><span class="NLM_article-title">Approval summary: sunitinib for the treatment of imatinib refractory or intolerant gastrointestinal stromal tumors and advanced renal cell carcinoma</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1367</span><span class="NLM_x">–</span> <span class="NLM_lpage">1373</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm900803q&amp;key=10.1158%2F1078-0432.CCR-06-2328" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm900803q&amp;key=17332278" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm900803q&amp;key=1%3ACAS%3A528%3ADC%252BD2sXitlSjsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=1367-1373&author=V.+L.+Goodmanauthor=E.+P.+Rockauthor=R.+Dagherauthor=R.+P.+Ramchandaniauthor=S.+Abrahamauthor=J.+V.+Gobburuauthor=B.+P.+Boothauthor=S.+L.+Verboisauthor=D.+E.+Morseauthor=C.+Y.+Liangauthor=N.+Chidambaramauthor=J.+X.+Jiangauthor=S.+Tangauthor=K.+Mahjoobauthor=R.+Justiceauthor=R.+Pazdur&title=Approval+summary%3A+sunitinib+for+the+treatment+of+imatinib+refractory+or+intolerant+gastrointestinal+stromal+tumors+and+advanced+renal+cell+carcinoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Approval Summary: Sunitinib for the Treatment of Imatinib Refractory or Intolerant Gastrointestinal Stromal Tumors and Advanced Renal Cell Carcinoma</span></div><div class="casAuthors">Goodman, Vicki L.; Rock, Edwin P.; Dagher, Ramzi; Ramchandani, Roshni P.; Abraham, Sophia; Gobburu, Jogarao V. S.; Booth, Brian P.; Verbois, S. Leigh; Morse, David E.; Liang, Cheng Yi; Chidambaram, Nallaperumal; Jiang, Janet X.; Tang, Shenghui; Mahjoob, Kooros; Justice, Robert; Pazdur, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1367-1373</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Purpose: To describe the Food and Drug Administration (FDA) review and approval of sunitinib malate (Sutent).  Sunitinib received regular approval for the treatment of gastrointestinal stromal tumor (GIST) after disease progression or intolerance to imatinib mesylate (Gleevec).  Addnl., sunitinib received accelerated approval for the treatment of advanced renal cell carcinoma.  Exptl. Design: For the GIST indication, FDA reviewed data from a randomized, placebo-controlled trial with supportive evidence from a single-arm study.  For the advanced renal cell carcinoma indication, FDA reviewed data from two single-arm studies of patients with cytokine-refractory metastatic renal cell carcinoma.  Results: In patients with imatinib refractory or intolerant GIST, time-to-tumor progression of sunitinib-treated patients was superior to that of placebo-treated patients.  Median time-to-tumor progression of sunitinib-treated patients was 27.3 wk, compared with 6.4 wk for placebo-treated patients (P < 0.0001).  Partial responses were obsd. in 6.8% of sunitinib-treated patients.  In patients with metastatic renal cell carcinoma, partial responses were obsd. in 25.5% (95% confidence interval, 17.5, 34.9) and 36.5% (95% confidence interval, 24.7, 49.6) of patients treated with sunitinib. Median response durations were 27.1 and 54 wk.  The most common adverse events attributed to sunitinib included diarrhea, mucositis, skin abnormalities, and altered taste.  Redns. in left ventricular ejection fraction and severe hypertension were also more common in sunitinib-treated patients.  Conclusions: On Jan. 26, 2006, the FDA approved sunitinib for the treatment of patients with imatinib refractory or intolerant GIST.  Accelerated approval was granted for the treatment of advanced renal cell carcinoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphXuKPm_-9xrVg90H21EOLACvtfcHk0lgCvGb80tGWzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXitlSjsbc%253D&md5=baa2be61674d19588b831222672f13f5</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-06-2328&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-06-2328%26sid%3Dliteratum%253Aachs%26aulast%3DGoodman%26aufirst%3DV.%2BL.%26aulast%3DRock%26aufirst%3DE.%2BP.%26aulast%3DDagher%26aufirst%3DR.%26aulast%3DRamchandani%26aufirst%3DR.%2BP.%26aulast%3DAbraham%26aufirst%3DS.%26aulast%3DGobburu%26aufirst%3DJ.%2BV.%26aulast%3DBooth%26aufirst%3DB.%2BP.%26aulast%3DVerbois%26aufirst%3DS.%2BL.%26aulast%3DMorse%26aufirst%3DD.%2BE.%26aulast%3DLiang%26aufirst%3DC.%2BY.%26aulast%3DChidambaram%26aufirst%3DN.%26aulast%3DJiang%26aufirst%3DJ.%2BX.%26aulast%3DTang%26aufirst%3DS.%26aulast%3DMahjoob%26aufirst%3DK.%26aulast%3DJustice%26aufirst%3DR.%26aulast%3DPazdur%26aufirst%3DR.%26atitle%3DApproval%2520summary%253A%2520sunitinib%2520for%2520the%2520treatment%2520of%2520imatinib%2520refractory%2520or%2520intolerant%2520gastrointestinal%2520stromal%2520tumors%2520and%2520advanced%2520renal%2520cell%2520carcinoma%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2007%26volume%3D13%26spage%3D1367%26epage%3D1373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Wilhelm, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowinger, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simantov, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelley, S.</span><span> </span><span class="NLM_article-title">Discovery and development of sorafenib: a multikinase inhibitor for treating cancer</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">835</span><span class="NLM_x">–</span> <span class="NLM_lpage">844</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm900803q&amp;key=10.1038%2Fnrd2130" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm900803q&amp;key=17016424" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm900803q&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVajsbbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=835-844&author=S.+Wilhelmauthor=C.+Carterauthor=M.+Lynchauthor=T.+Lowingerauthor=J.+Dumasauthor=R.+A.+Smithauthor=B.+Schwartzauthor=R.+Simantovauthor=S.+Kelley&title=Discovery+and+development+of+sorafenib%3A+a+multikinase+inhibitor+for+treating+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and development of sorafenib: a multikinase inhibitor for treating cancer</span></div><div class="casAuthors">Wilhelm, Scott; Carter, Christopher; Lynch, Mark; Lowinger, Timothy; Dumas, Jacques; Smith, Roger A.; Schwartz, Brian; Simantov, Ronit; Kelley, Susan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">835-844</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Since the mol. revolution of the 1980s, knowledge of the etiol. of cancer has increased considerably, which has led to the discovery and development of targeted therapies tailored to inhibit cancer-specific pathways.  The introduction and refinement of rapid, high-throughput screening technologies over the past decade has greatly facilitated this targeted discovery and development process.  Here, the authors describe the discovery and continuing development of sorafenib (previously known as BAY 43-9006), the first oral multikinase inhibitor that targets Raf and affects tumor signaling and the tumor vasculature.  The discovery cycle of sorafenib (Nexavar; Bayer Pharmaceuticals) - from initial screening for a lead compd. to FDA approval for the treatment of advanced renal cell carcinoma in Dec. 2005 - was completed in just 11 years, with approval being received ∼5 years after the initiation of the first Phase I trial.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6WjjfgNSCtbVg90H21EOLACvtfcHk0lgCvGb80tGWzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVajsbbM&md5=490d4995170f3a7270ae9bbdd24b12e5</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnrd2130&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2130%26sid%3Dliteratum%253Aachs%26aulast%3DWilhelm%26aufirst%3DS.%26aulast%3DCarter%26aufirst%3DC.%26aulast%3DLynch%26aufirst%3DM.%26aulast%3DLowinger%26aufirst%3DT.%26aulast%3DDumas%26aufirst%3DJ.%26aulast%3DSmith%26aufirst%3DR.%2BA.%26aulast%3DSchwartz%26aufirst%3DB.%26aulast%3DSimantov%26aufirst%3DR.%26aulast%3DKelley%26aufirst%3DS.%26atitle%3DDiscovery%2520and%2520development%2520of%2520sorafenib%253A%2520a%2520multikinase%2520inhibitor%2520for%2520treating%2520cancer%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2006%26volume%3D5%26spage%3D835%26epage%3D844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Birchmeier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birchmeier, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gherardi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vande Woude, G. F.</span><span> </span><span class="NLM_article-title">Met, metastasis, motility and more</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">915</span><span class="NLM_x">–</span> <span class="NLM_lpage">925</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm900803q&amp;key=10.1038%2Fnrm1261" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm900803q&amp;key=14685170" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm900803q&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpvFeju7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2003&pages=915-925&author=C.+Birchmeierauthor=W.+Birchmeierauthor=E.+Gherardiauthor=G.+F.+Vande+Woude&title=Met%2C+metastasis%2C+motility+and+more"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Met, metastasis, motility and more</span></div><div class="casAuthors">Birchmeier, Carmen; Birhcmeier, Walter; Gherardi, Ermanno; Vande Woude, George F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">915-925</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Hepatocyte growth factor. scatter factor and its receptor, the tyrosine kinase Met, arose late in evolution and are unique to vertebrates.  In spite of this, Met uses mols. such as Gab1 - homologues of which are present in Caenorhabditis elegans and Drosophila melanogaster - for downstream signalling. Pivotal roles for Met in development and cancer have been established: Met controls cell migration and growth in embryogenesis; it also controls growth, invasion and metastasis in cancer cells; and activating Met mutations predispose to human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoG_-6XRpZ-sLVg90H21EOLACvtfcHk0liLEF8Efjhrkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpvFeju7s%253D&md5=ff5a02c73415784480c628fe65299a81</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnrm1261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm1261%26sid%3Dliteratum%253Aachs%26aulast%3DBirchmeier%26aufirst%3DC.%26aulast%3DBirchmeier%26aufirst%3DW.%26aulast%3DGherardi%26aufirst%3DE.%26aulast%3DVande%2BWoude%26aufirst%3DG.%2BF.%26atitle%3DMet%252C%2520metastasis%252C%2520motility%2520and%2520more%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2003%26volume%3D4%26spage%3D915%26epage%3D925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Ma, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maulik, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salgia, R.</span><span> </span><span class="NLM_article-title">c-Met: structure, functions and potential for therapeutic inhibition</span> <span class="citation_source-journal">Cancer Metastasis Rev</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">309</span><span class="NLM_x">–</span> <span class="NLM_lpage">325</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm900803q&amp;key=10.1023%2FA%3A1023768811842" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm900803q&amp;key=12884908" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm900803q&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjslyiurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=309-325&author=P.+C.+Maauthor=G.+Maulikauthor=J.+Christensenauthor=R.+Salgia&title=c-Met%3A+structure%2C+functions+and+potential+for+therapeutic+inhibition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">c-Met: Structure, functions and potential for therapeutic inhibition</span></div><div class="casAuthors">Ma, Patrick C.; Maulik, Gautam; Christensen, James; Salgia, Ravi</div><div class="citationInfo"><span class="NLM_cas:title">Cancer and Metastasis Reviews</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">309-325</span>CODEN:
                <span class="NLM_cas:coden">CMRED4</span>;
        ISSN:<span class="NLM_cas:issn">0167-7659</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic Publishers</span>)
        </div><div class="casAbstract">A review.  Studies on signal transduction pathways have generated various promising mol. targets for therapeutic inhibition in cancer therapy.  Receptor tyrosine kinases represent an important class of such therapeutic targets.  C-Met is a receptor tyrosine kinase that has been shown to be overexpressed and/or mutated in a variety of malignancies.  A no. of c-Met activating mutations, many of which are located in the tyrosine kinase domain, have been detected in various solid tumors and have been implicated in invasion and metastasis of tumor cells.  It is known that stimulation of c-Met via its natural ligand, hepatocyte growth factor (also known as scatter factor, HGF/SF) results in a plethora of biol. and biochem. effects in the cell.  Activation of c-Met signaling can lead to scattering, angiogenesis, proliferation, enhanced cell motility, invasion, and eventual metastasis.  In this review, the role of c-Met dysregulation in tumor progression and metastasis is discussed in detail with particular emphasis on c-Met mutations.  Moreover, we summarize current knowledge on various pathways of c-Met signal transduction, highlighting the central role in the cytoskeletal functions.  In this summary is included recent data in our lab. indicating that phosphorylation of focal adhesion proteins, such as paxillin, p125FAK, and PYK2, occurs in response to c-Met stimulation in lung cancer cells.  Most importantly, current data on c-Met suggest that when mutated or overexpressed in malignant cells, c-Met would serve as an important therapeutic target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9rIdb5Ao4a7Vg90H21EOLACvtfcHk0liLEF8Efjhrkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjslyiurY%253D&md5=7b7bf60da872071a39ce313efd32fd1f</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1023%2FA%3A1023768811842&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1023768811842%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DP.%2BC.%26aulast%3DMaulik%26aufirst%3DG.%26aulast%3DChristensen%26aufirst%3DJ.%26aulast%3DSalgia%26aufirst%3DR.%26atitle%3Dc-Met%253A%2520structure%252C%2520functions%2520and%2520potential%2520for%2520therapeutic%2520inhibition%26jtitle%3DCancer%2520Metastasis%2520Rev%26date%3D2003%26volume%3D22%26spage%3D309%26epage%3D325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Birchmeier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gherardi, E.</span><span> </span><span class="NLM_article-title">Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase</span> <span class="citation_source-journal">Trends Cell Biol</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">404</span><span class="NLM_x">–</span> <span class="NLM_lpage">410</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm900803q&amp;key=10.1016%2FS0962-8924%2898%2901359-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm900803q&amp;key=9789329" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm900803q&amp;key=1%3ACAS%3A528%3ADyaK1cXmvFWjur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1998&pages=404-410&author=C.+Birchmeierauthor=E.+Gherardi&title=Developmental+roles+of+HGF%2FSF+and+its+receptor%2C+the+c-Met+tyrosine+kinase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase</span></div><div class="casAuthors">Birchmeier, Carmen; Gherardi, Ermanno</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Cell Biology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">404-410</span>CODEN:
                <span class="NLM_cas:coden">TCBIEK</span>;
        ISSN:<span class="NLM_cas:issn">0962-8924</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review with 60 refs., discussing the main features of HGF/SF and its receptor, the product of the c-met protooncogene, and their role in embryogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4W8ZYocgc4bVg90H21EOLACvtfcHk0liLEF8Efjhrkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmvFWjur8%253D&md5=5e0560f3eae9ddd2931cbe3d3a84d555</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2FS0962-8924%2898%2901359-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0962-8924%252898%252901359-2%26sid%3Dliteratum%253Aachs%26aulast%3DBirchmeier%26aufirst%3DC.%26aulast%3DGherardi%26aufirst%3DE.%26atitle%3DDevelopmental%2520roles%2520of%2520HGF%252FSF%2520and%2520its%2520receptor%252C%2520the%2520c-Met%2520tyrosine%2520kinase%26jtitle%3DTrends%2520Cell%2520Biol%26date%3D1998%26volume%3D8%26spage%3D404%26epage%3D410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Rosario, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birchmeier, W.</span><span> </span><span class="NLM_article-title">How to make tubes: signaling by the Met receptor tyrosine kinase</span> <span class="citation_source-journal">Trends Cell Biol</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">328</span><span class="NLM_x">–</span> <span class="NLM_lpage">335</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm900803q&amp;key=10.1016%2FS0962-8924%2803%2900104-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm900803q&amp;key=12791299" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm900803q&amp;key=1%3ACAS%3A528%3ADC%252BD3sXkt1aqsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=328-335&author=M.+Rosarioauthor=W.+Birchmeier&title=How+to+make+tubes%3A+signaling+by+the+Met+receptor+tyrosine+kinase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">How to make tubes: signaling by the Met receptor tyrosine kinase</span></div><div class="casAuthors">Rosario, Marta; Birchmeier, Walter</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Cell Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">328-335</span>CODEN:
                <span class="NLM_cas:coden">TCBIEK</span>;
        ISSN:<span class="NLM_cas:issn">0962-8924</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Hepatocyte growth factor/scatter factor (HGF/SF), acting through the receptor tyrosine kinase Met, stimulates cells derived from a variety of different organs to form elongated hollow tubules when grown in 3-dimensional gels.  In vivo data also indicate a role for HGF/SF and Met in tubule formation during liver and kidney regeneration and mammary gland formation.  Activation of Met results in the recruitment of a myriad of signal transducers that regulate dissocn. of adherens junctions and the stimulation of cellular motility, survival, proliferation, and morphogenesis during tubule formation.  Among these many signal transducers, the Gab1 adaptor protein and its effector, the SHP2 tyrosine phosphatase, have been found to be crucial for tubulogenesis and for the sustained stimulation of the ERK/MAP kinase pathway.  Here, we discuss the contribution of these and other signaling pathways and the role of HGF/SF and Met in the formation of epithelial cell tubules both in vitro in branching-morphogenesis assays and in vivo during organogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGommZXQu8RmWLVg90H21EOLACvtfcHk0liLEF8Efjhrkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXkt1aqsrw%253D&md5=e08657de76e99d6c71ce3c4753ffd900</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2FS0962-8924%2803%2900104-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0962-8924%252803%252900104-1%26sid%3Dliteratum%253Aachs%26aulast%3DRosario%26aufirst%3DM.%26aulast%3DBirchmeier%26aufirst%3DW.%26atitle%3DHow%2520to%2520make%2520tubes%253A%2520signaling%2520by%2520the%2520Met%2520receptor%2520tyrosine%2520kinase%26jtitle%3DTrends%2520Cell%2520Biol%26date%3D2003%26volume%3D13%26spage%3D328%26epage%3D335" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Dietrich, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uppalapati, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seiwert, T. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, P. C.</span><span> </span><span class="NLM_article-title">Role of c-MET in upper aerodigestive malignancies—from biology to novel therapies</span> <span class="citation_source-journal">J. Environ. Pathol., Toxicol. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">149</span><span class="NLM_x">–</span> <span class="NLM_lpage">162</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2005&pages=149-162&author=S.+Dietrichauthor=R.+Uppalapatiauthor=T.+Y.+Seiwertauthor=P.+C.+Ma&title=Role+of+c-MET+in+upper+aerodigestive+malignancies%E2%80%94from+biology+to+novel+therapies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDietrich%26aufirst%3DS.%26aulast%3DUppalapati%26aufirst%3DR.%26aulast%3DSeiwert%26aufirst%3DT.%2BY.%26aulast%3DMa%26aufirst%3DP.%2BC.%26atitle%3DRole%2520of%2520c-MET%2520in%2520upper%2520aerodigestive%2520malignancies%25E2%2580%2594from%2520biology%2520to%2520novel%2520therapies%26jtitle%3DJ.%2520Environ.%2520Pathol.%252C%2520Toxicol.%2520Oncol.%26date%3D2005%26volume%3D24%26spage%3D149%26epage%3D162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Sattler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pride, Y. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gramlich, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinnan, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shirazian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podar, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salgia, R.</span><span> </span><span class="NLM_article-title">A novel small molecule met inhibitor induces apoptosis in cells transformed by the oncogenic TPR-MET tyrosine kinase</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">5462</span><span class="NLM_x">–</span> <span class="NLM_lpage">5469</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm900803q&amp;key=14500382" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm900803q&amp;key=1%3ACAS%3A528%3ADC%252BD3sXntleku7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=5462-5469&author=M.+Sattlerauthor=Y.+B.+Prideauthor=P.+Maauthor=J.+L.+Gramlichauthor=S.+C.+Chuauthor=L.+A.+Quinnanauthor=S.+Shirazianauthor=C.+Liangauthor=K.+Podarauthor=J.+G.+Christensenauthor=R.+Salgia&title=A+novel+small+molecule+met+inhibitor+induces+apoptosis+in+cells+transformed+by+the+oncogenic+TPR-MET+tyrosine+kinase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">A Novel Small Molecule Met Inhibitor Induces Apoptosis in Cells Transformed by the Oncogenic TPR-MET Tyrosine Kinase</span></div><div class="casAuthors">Sattler, Martin; Pride, Yuri B.; Ma, Patrick; Gramlich, Jessica L.; Chu, Stephanie C.; Quinnan, Laura A.; Shirazian, Sheri; Liang, Congxin; Podar, Klaus; Christensen, James G.; Salgia, Ravi</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5462-5469</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The Met receptor tyrosine kinase has been shown to be overexpressed or mutated in a variety of solid tumors and has, therefore, been identified as a good candidate for molecularly targeted therapy.  Activation of the Met tyrosine kinase by the TPR gene was originally described in vitro through carcinogen-induced rearrangement.  The TPR-MET fusion protein contains constitutively elevated Met tyrosine kinase activity and constitutes an ideal model to study the transforming activity of the Met kinase.  We found, when introduced into an interleukin 3-dependent cell line, TPR-MET induces factor independence and constitutive tyrosine phosphorylation of several cellular proteins.  One major tyrosine phosphorylated protein was identified as the TPR-MET oncoprotein itself.  Inhibition of the Met kinase activity by the novel small mol. drug SU11274 [(3Z)-N-(3-chlorophenyl)-3-({3,5-dimethyl-4-[(4-methylpiperazin-1-yl)carbonyl]-1H-pyrrol-2-yl}methylene)-N-methyl-2-oxo-2,3-dihydro-1H-indole-5-sulfonamide] led to time- and dose-dependent reduced cell growth.  The inhibitor did not affect other tyrosine kinase oncoproteins, including BCR-ABL, TEL-JAK2, TEL-PDGFβR, or TEL-ABL.  The Met inhibitor induced G1 cell cycle arrest and apoptosis with increased Annexin V staining and caspase 3 activity.  The autophosphorylation of the Met kinase was reduced on sites that have been shown previously to be important for activation of pathways involved in cell growth and survival, esp. the phosphatidylinositol-3'-kinase and the Ras pathway.  In particular, we found that the inhibitor blocked phosphorylation of AKT, GSK-3β, and the pro-apoptotic transcription factor FKHR.  The characterization of SU11274 as an effective inhibitor of Met tyrosine kinase activity illustrates the potential of targeting for Met therapeutic use in cancers assocd. with activated forms of this kinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGvIwRT4z1IbVg90H21EOLACvtfcHk0lhYBM71nMgpng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXntleku7s%253D&md5=3223841b665e6b95f3dab0f18ce64dbe</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSattler%26aufirst%3DM.%26aulast%3DPride%26aufirst%3DY.%2BB.%26aulast%3DMa%26aufirst%3DP.%26aulast%3DGramlich%26aufirst%3DJ.%2BL.%26aulast%3DChu%26aufirst%3DS.%2BC.%26aulast%3DQuinnan%26aufirst%3DL.%2BA.%26aulast%3DShirazian%26aufirst%3DS.%26aulast%3DLiang%26aufirst%3DC.%26aulast%3DPodar%26aufirst%3DK.%26aulast%3DChristensen%26aufirst%3DJ.%2BG.%26aulast%3DSalgia%26aufirst%3DR.%26atitle%3DA%2520novel%2520small%2520molecule%2520met%2520inhibitor%2520induces%2520apoptosis%2520in%2520cells%2520transformed%2520by%2520the%2520oncogenic%2520TPR-MET%2520tyrosine%2520kinase%26jtitle%3DCancer%2520Res.%26date%3D2003%26volume%3D63%26spage%3D5462%26epage%3D5469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Corso, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comoglio, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giordano, S.</span><span> </span><span class="NLM_article-title">Cancer therapy: can the challenge be MET?</span> <span class="citation_source-journal">Trends Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">284</span><span class="NLM_x">–</span> <span class="NLM_lpage">292</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=284-292&author=S.+Corsoauthor=P.+M.+Comoglioauthor=S.+Giordano&title=Cancer+therapy%3A+can+the+challenge+be+MET%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCorso%26aufirst%3DS.%26aulast%3DComoglio%26aufirst%3DP.%2BM.%26aulast%3DGiordano%26aufirst%3DS.%26atitle%3DCancer%2520therapy%253A%2520can%2520the%2520challenge%2520be%2520MET%253F%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2005%26volume%3D11%26spage%3D284%26epage%3D292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Eder, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vande Woude, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boerner, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LoRusso, P. M.</span><span> </span><span class="NLM_article-title">Novel therapeutic inhibitors of the c-Met signaling pathway in cancer</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2207</span><span class="NLM_x">–</span> <span class="NLM_lpage">2214</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm900803q&amp;key=10.1158%2F1078-0432.CCR-08-1306" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm900803q&amp;key=19318488" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm900803q&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjvVWltrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=2207-2214&author=J.+P.+Ederauthor=G.+F.+Vande+Woudeauthor=S.+A.+Boernerauthor=P.+M.+LoRusso&title=Novel+therapeutic+inhibitors+of+the+c-Met+signaling+pathway+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Therapeutic Inhibitors of the c-Met Signaling Pathway in Cancer</span></div><div class="casAuthors">Eder, Joseph Paul; Vande Woude, George F.; Boerner, Scott A.; Lo Russo, Patricia M.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2207-2214</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  A wide variety of human malignancies exhibit sustained c-Met stimulation, overexpression, or mutation, including carcinomas of the breast, liver, lung, ovary, kidney, and thyroid.  Notably, activating mutations in c-Met have been pos. identified in patients with a particular hereditary form of papillary renal cancer, directly implicating c-Met in human tumorigenesis.  Aberrant signaling of the c-Met signaling pathway due to dysregulation of the c-Met receptor or overexpression of its ligand, hepatocyte growth factor (HGF), has been assocd. with an aggressive phenotype.  Extensive evidence that c-Met signaling is involved in the progression and spread of several cancers and an enhanced understanding of its role in disease have generated considerable interest in c-Met and HGF as major targets in cancer drug development.  This has led to the development of a variety of c-Met pathway antagonists with potential clin. applications.  The three main approaches of pathway-selective anticancer drug development have included antagonism of ligand/receptor interaction, inhibition of the tyrosine kinase catalytic activity, and blockade of the receptor/effector interaction.  Several c-Met antagonists are now under clin. investigation.  Preliminary clin. results of several of these agents, including both monoclonal antibodies and small-mol. tyrosine kinase inhibitors, have been encouraging.  Several multitargeted therapies have also been under investigation in the clinic and have demonstrated promise, particularly with regard to tyrosine kinase inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9QBC0vQz8BrVg90H21EOLACvtfcHk0lhYBM71nMgpng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjvVWltrY%253D&md5=48b4fc788b2b2cab1ce523047e33721d</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-08-1306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-08-1306%26sid%3Dliteratum%253Aachs%26aulast%3DEder%26aufirst%3DJ.%2BP.%26aulast%3DVande%2BWoude%26aufirst%3DG.%2BF.%26aulast%3DBoerner%26aufirst%3DS.%2BA.%26aulast%3DLoRusso%26aufirst%3DP.%2BM.%26atitle%3DNovel%2520therapeutic%2520inhibitors%2520of%2520the%2520c-Met%2520signaling%2520pathway%2520in%2520cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2009%26volume%3D15%26spage%3D2207%26epage%3D2214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Knudsen, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vande Woude, G.</span><span> </span><span class="NLM_article-title">Showering c-MET-dependent cancers with drugs</span> <span class="citation_source-journal">Curr. Opin. Genet. Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">87</span><span class="NLM_x">–</span> <span class="NLM_lpage">96</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm900803q&amp;key=10.1016%2Fj.gde.2008.02.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm900803q&amp;key=18406132" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm900803q&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmsVarur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=87-96&author=B.+S.+Knudsenauthor=G.+Vande+Woude&title=Showering+c-MET-dependent+cancers+with+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Showering c-MET-dependent cancers with drugs</span></div><div class="casAuthors">Knudsen, Beatrice S.; Vande Woude, George</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Genetics & Development</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">87-96</span>CODEN:
                <span class="NLM_cas:coden">COGDET</span>;
        ISSN:<span class="NLM_cas:issn">0959-437X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The receptor tyrosine kinase, c-MET and its ligand hepatocyte growth factor/scatter factor (HGF/SF) have become leading candidates for targeted cancer therapies.  Inappropriate c-MET signaling through autocrine, paracrine, amplification, and mutational activation occurs in virtually all types of solid tumors (http://www.vai.org/met), contributing to one or a combination of proliferative, invasive, survival, or angiogenic cancer phenotypes. c-MET and HGF/SF participate in all stages of malignant progression and represent promising drug targets in a variety of cancer types, including carcinomas, sarcomas, and brain tumors.  While many are in pre-clin. testing, a few inhibitors have entered clin. trials.  With hundreds of thousands of potential responding cancers that express c-MET, the interest in this mol. as a drug target is not surprising.  However, the cognate c-MET diagnostic tests lag behind.  In addn., despite the great enthusiasm based on response rates in phase I trials, there is a need for caution.  It is almost without question that combination therapies with c-MET-HGF/SF inhibitors will be required for most cancers to achieve a cytotoxic tumor response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonjBq7fWvKhrVg90H21EOLACvtfcHk0lg1Jm59GxAiXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmsVarur8%253D&md5=d0744275be94658bab067f20644c98d6</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.gde.2008.02.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.gde.2008.02.001%26sid%3Dliteratum%253Aachs%26aulast%3DKnudsen%26aufirst%3DB.%2BS.%26aulast%3DVande%2BWoude%26aufirst%3DG.%26atitle%3DShowering%2520c-MET-dependent%2520cancers%2520with%2520drugs%26jtitle%3DCurr.%2520Opin.%2520Genet.%2520Dev.%26date%3D2008%26volume%3D18%26spage%3D87%26epage%3D96" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Ma, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tretiakova, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nallasura, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jagadeeswaran, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Husain, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salgia, R.</span><span> </span><span class="NLM_article-title">Downstream signalling and specific inhibition of c-MET/HGF pathway in small cell lung cancer: implications for tumour invasion</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">368</span><span class="NLM_x">–</span> <span class="NLM_lpage">377</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm900803q&amp;key=10.1038%2Fsj.bjc.6603884" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm900803q&amp;key=17667909" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm900803q&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotlSgt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2007&pages=368-377&author=P.+C.+Maauthor=M.+S.+Tretiakovaauthor=V.+Nallasuraauthor=R.+Jagadeeswaranauthor=A.+N.+Husainauthor=R.+Salgia&title=Downstream+signalling+and+specific+inhibition+of+c-MET%2FHGF+pathway+in+small+cell+lung+cancer%3A+implications+for+tumour+invasion"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Downstream signalling and specific inhibition of c-MET/HGF pathway in small cell lung cancer: implications for tumor invasion</span></div><div class="casAuthors">Ma, P. C.; Tretiakova, M. S.; Nallasura, V.; Jagadeeswaran, R.; Husain, A. N.; Salgia, R.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">368-377</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The c-MET receptor can be overexpressed, amplified, or mutated in solid tumors including small cell lung cancer (SCLC).  In c-MET-overexpressing SCLC cell line NCI-H69, hepatocyte growth factor (HGF) dramatically induced c-MET phosphorylation at phosphoepitopes pY1230/1234/1235 (catalytic tyrosine kinase), pY1003 (juxtamembrane), and also of paxillin at pY31 (CRKL-binding site).  We utilized a global proteomics phosphoantibody array approach to identify further c-MET/HGF signal transduction intermediates in SCLC.  Strong HGF induction of specific phosphorylation sites in phosphoproteins involved in c-MET/HGF signal transduction was detected, namely adducin-α [S724], adducin-γ [S662], CREB [S133], ERK1 [T185/Y187], ERK1/2 [T202/Y204], ERK2 [T185/Y187], MAPKK (MEK) 1/2 [S221/S225], MAPKK (MEK) 3/6 [S189/S207], RB [S612], RB1 [S780], JNK [T183/Y185], STAT3 [S727], focal adhesion kinase (FAK) [Y576/S722/S910], p38α-MAPK [T180/Y182], and AKT1[S473] and [T308].  Conversely, inhibition of phosphorylation by HGF in protein kinase C (PKC), protein kinase R (PKR), and also CDK1 was identified.  Phosphoantibody-based immunohistochem. anal. of SCLC tumor tissue and microarray established the role of c-MET in SCLC biol.  This supports a role of c-MET activation in tumor invasive front in the tumor progression and invasion involving FAK and AKT downstream.  The c-MET serves as an attractive therapeutic target in SCLC, as shown through small interfering RNA (siRNA) and selective prototype c-MET inhibitor SU11274, inhibiting the phosphorylation of c-MET itself and its downstream mols. such as AKT, S6 kinase, and ERK1/2.  Investigation of mechanisms of invasion and, ultimately, metastasis in SCLC would be very useful with these signal transduction mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxZfi_VG1B5rVg90H21EOLACvtfcHk0lg1Jm59GxAiXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotlSgt74%253D&md5=f7e7e198122e3071fe1025e737beb0e9</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6603884&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6603884%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DP.%2BC.%26aulast%3DTretiakova%26aufirst%3DM.%2BS.%26aulast%3DNallasura%26aufirst%3DV.%26aulast%3DJagadeeswaran%26aufirst%3DR.%26aulast%3DHusain%26aufirst%3DA.%2BN.%26aulast%3DSalgia%26aufirst%3DR.%26atitle%3DDownstream%2520signalling%2520and%2520specific%2520inhibition%2520of%2520c-MET%252FHGF%2520pathway%2520in%2520small%2520cell%2520lung%2520cancer%253A%2520implications%2520for%2520tumour%2520invasion%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2007%26volume%3D97%26spage%3D368%26epage%3D377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Ma, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jagadeeswaran, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jagadeesh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tretiakova, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nallasura, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaefer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naoki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lader, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richards, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugarbaker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Husain, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salgia, R.</span><span> </span><span class="NLM_article-title">Functional expression and mutations of c-Met and its therapeutic inhibition with SU11274 and small interfering RNA in non-small cell lung cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">1479</span><span class="NLM_x">–</span> <span class="NLM_lpage">1488</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2005&pages=1479-1488&author=P.+C.+Maauthor=R.+Jagadeeswaranauthor=S.+Jagadeeshauthor=M.+S.+Tretiakovaauthor=V.+Nallasuraauthor=E.+A.+Foxauthor=M.+Hansenauthor=E.+Schaeferauthor=K.+Naokiauthor=A.+Laderauthor=W.+Richardsauthor=D.+Sugarbakerauthor=A.+N.+Husainauthor=J.+G.+Christensenauthor=R.+Salgia&title=Functional+expression+and+mutations+of+c-Met+and+its+therapeutic+inhibition+with+SU11274+and+small+interfering+RNA+in+non-small+cell+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DP.%2BC.%26aulast%3DJagadeeswaran%26aufirst%3DR.%26aulast%3DJagadeesh%26aufirst%3DS.%26aulast%3DTretiakova%26aufirst%3DM.%2BS.%26aulast%3DNallasura%26aufirst%3DV.%26aulast%3DFox%26aufirst%3DE.%2BA.%26aulast%3DHansen%26aufirst%3DM.%26aulast%3DSchaefer%26aufirst%3DE.%26aulast%3DNaoki%26aufirst%3DK.%26aulast%3DLader%26aufirst%3DA.%26aulast%3DRichards%26aufirst%3DW.%26aulast%3DSugarbaker%26aufirst%3DD.%26aulast%3DHusain%26aufirst%3DA.%2BN.%26aulast%3DChristensen%26aufirst%3DJ.%2BG.%26aulast%3DSalgia%26aufirst%3DR.%26atitle%3DFunctional%2520expression%2520and%2520mutations%2520of%2520c-Met%2520and%2520its%2520therapeutic%2520inhibition%2520with%2520SU11274%2520and%2520small%2520interfering%2520RNA%2520in%2520non-small%2520cell%2520lung%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2005%26volume%3D65%26spage%3D1479%26epage%3D1488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Ma, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaefer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salgia, R.</span><span> </span><span class="NLM_article-title">A selective small molecule c-MET inhibitor, PHA665752, cooperates with rapamycin</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">2312</span><span class="NLM_x">–</span> <span class="NLM_lpage">2319</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm900803q&amp;key=10.1158%2F1078-0432.CCR-04-1708" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm900803q&amp;key=15788682" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm900803q&amp;key=1%3ACAS%3A528%3ADC%252BD2MXisFaju7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=2312-2319&author=P.+C.+Maauthor=E.+Schaeferauthor=J.+G.+Christensenauthor=R.+Salgia&title=A+selective+small+molecule+c-MET+inhibitor%2C+PHA665752%2C+cooperates+with+rapamycin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">A selective small molecule c-MET inhibitor, PHA665752, cooperates with rapamycin</span></div><div class="casAuthors">Ma, Patrick C.; Schaefer, Erik; Christensen, James G.; Salgia, Ravi</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2312-2319</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">c-MET is believed to be an attractive receptor target for mol. therapeutic inhibition.  TPR-MET, a constitutively active oncogenic variant of MET, serves as excellent model for testing c-MET inhibitors.  Here, we characterized a small mol. c-MET inhibitor, PHA665752, and tested its cooperation with the mammalian target of rapamycin inhibitor as potential targeted therapy.  The effect of PHA665752 treatment was detd. on cell growth, motility and migration, apoptosis, and cell-cycle arrest of TPR-MET-transformed cells.  Moreover, the effect of PHA665752 on the phosphorylation on MET, as well as its downstream effectors, p-AKT and p-S6K, was also detd.  Finally, growth of TPR-MET-transformed cells was tested in the presence of PHA665752 and rapamycin.  H441 non-small cell lung cancer (NSCLC) cells (with activated c-Met) were also tested against both PHA665752 and rapamycin.  PHA665752 specifically inhibited cell growth in BaF3.  TPR-MET cells (IC50 < 0.06 μmol/L), induced apoptosis and cell cycle arrest.  Constitutive cell motility and migration of the BaF3.  TPR-MET cells was also inhibited.  PHA665752 inhibited specific phosphorylation of TPR-MET as well as phosphorylation of downstream targets of the mammalian target of rapamycin pathway.  When combined with PHA665752, rapamycin showed cooperative inhibition to reduce growth of BaF3.  TPR-MET- and c-MET-expressing H441 NSCLC cells.  PHA665752 is a potent small mol.-selective c-MET inhibitor and is highly active against TPR-MET-transformed cells both biol. and biochem.  PHA665752 is also active against H441 NSCLC cells.  The c-MET inhibitor can cooperate with rapamycin in therapeutic inhibition of NSCLC, and in vivo studies of this combination against c-MET expressing cancers would be merited.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQ6fVYSbU8ibVg90H21EOLACvtfcHk0lg1Jm59GxAiXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXisFaju7c%253D&md5=9e69f0253f675f4a1aeb96c115e2e420</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-04-1708&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-04-1708%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DP.%2BC.%26aulast%3DSchaefer%26aufirst%3DE.%26aulast%3DChristensen%26aufirst%3DJ.%2BG.%26aulast%3DSalgia%26aufirst%3DR.%26atitle%3DA%2520selective%2520small%2520molecule%2520c-MET%2520inhibitor%252C%2520PHA665752%252C%2520cooperates%2520with%2520rapamycin%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2005%26volume%3D11%26spage%3D2312%26epage%3D2319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Shaharabany, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abramovitch, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kushnir, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsarfaty, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravid-Megido, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horev, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ron, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itzchak, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsarfaty, I.</span><span> </span><span class="NLM_article-title">In vivo molecular imaging of met tyrosine kinase growth factor receptor activity in normal organs and breast tumors</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">4873</span><span class="NLM_x">–</span> <span class="NLM_lpage">4878</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2001&pages=4873-4878&author=M.+Shaharabanyauthor=R.+Abramovitchauthor=T.+Kushnirauthor=G.+Tsarfatyauthor=M.+Ravid-Megidoauthor=J.+Horevauthor=R.+Ronauthor=Y.+Itzchakauthor=I.+Tsarfaty&title=In+vivo+molecular+imaging+of+met+tyrosine+kinase+growth+factor+receptor+activity+in+normal+organs+and+breast+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShaharabany%26aufirst%3DM.%26aulast%3DAbramovitch%26aufirst%3DR.%26aulast%3DKushnir%26aufirst%3DT.%26aulast%3DTsarfaty%26aufirst%3DG.%26aulast%3DRavid-Megido%26aufirst%3DM.%26aulast%3DHorev%26aufirst%3DJ.%26aulast%3DRon%26aufirst%3DR.%26aulast%3DItzchak%26aufirst%3DY.%26aulast%3DTsarfaty%26aufirst%3DI.%26atitle%3DIn%2520vivo%2520molecular%2520imaging%2520of%2520met%2520tyrosine%2520kinase%2520growth%2520factor%2520receptor%2520activity%2520in%2520normal%2520organs%2520and%2520breast%2520tumors%26jtitle%3DCancer%2520Res.%26date%3D2001%26volume%3D61%26spage%3D4873%26epage%3D4878" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Tsarfaty, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stein, G. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moshitch-Moshkovitz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufman, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Resau, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vande Woude, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsarfaty, I.</span><span> </span><span class="NLM_article-title">HGF/SF increases tumor blood volume: a novel tool for the in vivo functional molecular imaging of Met</span> <span class="citation_source-journal">Neoplasia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">344</span><span class="NLM_x">–</span> <span class="NLM_lpage">352</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2006&pages=344-352&author=G.+Tsarfatyauthor=G.+Y.+Steinauthor=S.+Moshitch-Moshkovitzauthor=D.+W.+Kaufmanauthor=B.+Caoauthor=J.+H.+Resauauthor=G.+F.+Vande+Woudeauthor=I.+Tsarfaty&title=HGF%2FSF+increases+tumor+blood+volume%3A+a+novel+tool+for+the+in+vivo+functional+molecular+imaging+of+Met"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTsarfaty%26aufirst%3DG.%26aulast%3DStein%26aufirst%3DG.%2BY.%26aulast%3DMoshitch-Moshkovitz%26aufirst%3DS.%26aulast%3DKaufman%26aufirst%3DD.%2BW.%26aulast%3DCao%26aufirst%3DB.%26aulast%3DResau%26aufirst%3DJ.%2BH.%26aulast%3DVande%2BWoude%26aufirst%3DG.%2BF.%26aulast%3DTsarfaty%26aufirst%3DI.%26atitle%3DHGF%252FSF%2520increases%2520tumor%2520blood%2520volume%253A%2520a%2520novel%2520tool%2520for%2520the%2520in%2520vivo%2520functional%2520molecular%2520imaging%2520of%2520Met%26jtitle%3DNeoplasia%26date%3D2006%26volume%3D8%26spage%3D344%26epage%3D352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Towner, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tesiram, Y. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbott, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saunders, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blindauer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herlea, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silasi-Mansat, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lupu, F.</span><span> </span><span class="NLM_article-title">In vivo detection of c-MET expression in a rat hepatocarcinogenesis model using molecularly targeted magnetic resonance imaging</span> <span class="citation_source-journal">Mol. Imaging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">18</span><span class="NLM_x">–</span> <span class="NLM_lpage">29</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm900803q&amp;key=17311762" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm900803q&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVKhtrjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=18-29&author=R.+A.+Townerauthor=N.+Smithauthor=Y.+A.+Tesiramauthor=A.+Abbottauthor=D.+Saundersauthor=R.+Blindauerauthor=O.+Herleaauthor=R.+Silasi-Mansatauthor=F.+Lupu&title=In+vivo+detection+of+c-MET+expression+in+a+rat+hepatocarcinogenesis+model+using+molecularly+targeted+magnetic+resonance+imaging"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo detection of c-MET expression in a rat hepatocarcinogenesis model using molecularly targeted magnetic resonance imaging</span></div><div class="casAuthors">Towner, Rheal A.; Smith, Nataliya; Tesiram, Yasvir A.; Abbott, Andrew; Saunders, Debbie; Blindauer, Rebecca; Herlea, Oana; Silasi-Mansat, Robert; Lupu, Florea</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Imaging</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">18-29</span>CODEN:
                <span class="NLM_cas:coden">MIOMBP</span>;
        ISSN:<span class="NLM_cas:issn">1535-3508</span>.
    
            (<span class="NLM_cas:orgname">BC Decker Inc.</span>)
        </div><div class="casAbstract">The multifunctional growth factor scatter factor/hepatocyte growth factor and its tyrosine kinase receptor, c-MET, have been implicated in the genesis and malignant progression of numerous human malignancies, including hepatocellular carcinomas.  The incidence of hepatocellular carcinomas in the United States has increased noticeably over the past two decades and is listed as the fifth major cancer in men worldwide.  In this study, we used a choline-deficient L-amino acid (CDAA)-defined rat hepatocarcinogenesis model to visualize increased in vivo expression of the c-MET antigen in neoplastic lesion formation with the use of a super paramagnetic iron oxide (SPIO)-anti-c-MET molecularly targeted magnetic resonance imaging (MRI) contrast agent.  SPIO-anti-c-MET was used for the first time to detect overexpression of c-MET in neoplastic nodules and tumors within the livers of CDAA-treated rats, as detd. by a decrease in MRI signal intensity and a decrease in regional T2 values.  Specificity for the binding of the molecularly targeted anti-c-MET contrast agent was detd. using rat hepatoma (H4-II-E-C3) cell cultures and immunofluorescence microscopic imaging of the targeting agents within neoplastic liver tissue 1 to 2 h following i.v. administration of SPIO-anti-c-MET and MRI investigation.  This method has the ability to visualize in vivo the overexpression of c-MET at early developmental stages of tumor formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHVxUOgOP2JbVg90H21EOLACvtfcHk0liYa1RgjfMt2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVKhtrjJ&md5=0ef525b274957f80bc363f3771c430e5</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTowner%26aufirst%3DR.%2BA.%26aulast%3DSmith%26aufirst%3DN.%26aulast%3DTesiram%26aufirst%3DY.%2BA.%26aulast%3DAbbott%26aufirst%3DA.%26aulast%3DSaunders%26aufirst%3DD.%26aulast%3DBlindauer%26aufirst%3DR.%26aulast%3DHerlea%26aufirst%3DO.%26aulast%3DSilasi-Mansat%26aufirst%3DR.%26aulast%3DLupu%26aufirst%3DF.%26atitle%3DIn%2520vivo%2520detection%2520of%2520c-MET%2520expression%2520in%2520a%2520rat%2520hepatocarcinogenesis%2520model%2520using%2520molecularly%2520targeted%2520magnetic%2520resonance%2520imaging%26jtitle%3DMol.%2520Imaging%26date%3D2007%26volume%3D6%26spage%3D18%26epage%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Perk, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stigter-van Walsum, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Visser, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kloet, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vosjan, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leemans, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giaccone, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albano, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comoglio, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Dongen, G. A.</span><span> </span><span class="NLM_article-title">Quantitative PET imaging of Met-expressing human cancer xenografts with <sup>89</sup>Zr-labelled monoclonal antibody DN30</span> <span class="citation_source-journal">Eur. J. Nucl. Med. Mol. Imaging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">1857</span><span class="NLM_x">–</span> <span class="NLM_lpage">1867</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm900803q&amp;key=10.1007%2Fs00259-008-0774-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm900803q&amp;key=18491091" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm900803q&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFCjtbzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2008&pages=1857-1867&author=L.+R.+Perkauthor=M.+Stigter-van+Walsumauthor=G.+W.+Visserauthor=R.+W.+Kloetauthor=M.+J.+Vosjanauthor=C.+R.+Leemansauthor=G.+Giacconeauthor=R.+Albanoauthor=P.+M.+Comoglioauthor=G.+A.+van+Dongen&title=Quantitative+PET+imaging+of+Met-expressing+human+cancer+xenografts+with+89Zr-labelled+monoclonal+antibody+DN30"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative PET imaging of Met-expressing human cancer xenografts with 89Zr-labelled monoclonal antibody DN30</span></div><div class="casAuthors">Perk, Lars R.; Stigter-van Walsum, Marijke; Visser, Gerard W. M.; Kloet, Reina W.; Vosjan, Maria J. W. D.; Leemans, C. Rene; Giaccone, Giuseppe; Albano, Raffaella; Comoglio, Paolo M.; van Dongen, Guus A. M. S.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nuclear Medicine and Molecular Imaging</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1857-1867</span>CODEN:
                <span class="NLM_cas:coden">EJNMA6</span>;
        ISSN:<span class="NLM_cas:issn">1619-7070</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Targeting the c-Met receptor with monoclonal antibodies (MAbs) is an appealing approach for cancer diagnosis and treatment because this receptor plays a prominent role in tumor invasion and metastasis.  Positron emission tomog. (PET) might be a powerful tool for guidance of therapy with anti-Met MAbs like the recently described MAb DN30 because it allows accurate quant. imaging of tumor targeting (immuno-PET).  We considered the potential of PET with either 89Zr-labeled (residualising radionuclide) or 124I-labeled (non-residualising radionuclide) DN30 for imaging of Met-expressing tumors.  The biodistribution of co-injected 89Zr-DN30 and iodine-labeled DN30 was compared in nude mice bearing either the human gastric cancer line GLT-16 (high Met expression) or the head-and-neck cancer line FaDu (low Met expression).  PET images were acquired in both xenograft models up to 4 days post-injection (p.i.) and used for quantification of tumor uptake.  Biodistribution studies in GTL-16-tumor-bearing mice revealed that 89Zr-DN30 achieved much higher tumor uptake levels than iodine-labeled DN30 (e.g. 19.6%ID/g vs 5.3%ID/g, 5 days p.i.), while blood levels were similar, indicating internalization of DN30.  Therefore, 89Zr-DN30 was selected for PET imaging of GLT-16-bearing mice.  Tumors as small as 11 mg were readily visualized with immuno-PET.  A distinctive lower 89Zr uptake was obsd. in FaDu compared to GTL-16 xenografts (e.g. 7.8%ID/g vs 18.1%ID/g, 3 days p.i.).  Nevertheless, FaDu xenografts were also clearly visualized with 89Zr-DN30 immuno-PET.  An excellent correlation was found between PET-image-derived 89Zr tumor uptake and ex-vivo-assessed 89Zr tumor uptake (R 2 = 0.98).  The long-lived positron emitter 89Zr seems attractive for PET-guided development of therapeutic anti-c-Met MAbs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8SV9_lqoBWLVg90H21EOLACvtfcHk0liYa1RgjfMt2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFCjtbzI&md5=e566f34c1ac2e47cc990662d199819f3</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1007%2Fs00259-008-0774-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-008-0774-5%26sid%3Dliteratum%253Aachs%26aulast%3DPerk%26aufirst%3DL.%2BR.%26aulast%3DStigter-van%2BWalsum%26aufirst%3DM.%26aulast%3DVisser%26aufirst%3DG.%2BW.%26aulast%3DKloet%26aufirst%3DR.%2BW.%26aulast%3DVosjan%26aufirst%3DM.%2BJ.%26aulast%3DLeemans%26aufirst%3DC.%2BR.%26aulast%3DGiaccone%26aufirst%3DG.%26aulast%3DAlbano%26aufirst%3DR.%26aulast%3DComoglio%26aufirst%3DP.%2BM.%26aulast%3Dvan%2BDongen%26aufirst%3DG.%2BA.%26atitle%3DQuantitative%2520PET%2520imaging%2520of%2520Met-expressing%2520human%2520cancer%2520xenografts%2520with%252089Zr-labelled%2520monoclonal%2520antibody%2520DN30%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2008%26volume%3D35%26spage%3D1857%26epage%3D1867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Hay, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skinner, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustafson, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teh, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knudsen, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Resau, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waters, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vande Woude, G. F.</span><span> </span><span class="NLM_article-title">Nuclear imaging of Met-expressing human and canine cancer xenografts with radiolabeled monoclonal antibodies (MetSeek)</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">7064s</span><span class="NLM_x">–</span> <span class="NLM_lpage">7069s</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=7064s-7069s&author=R.+V.+Hayauthor=B.+Caoauthor=R.+S.+Skinnerauthor=Y.+Suauthor=P.+Zhaoauthor=M.+F.+Gustafsonauthor=C.+N.+Qianauthor=B.+T.+Tehauthor=B.+S.+Knudsenauthor=J.+H.+Resauauthor=S.+Shenauthor=D.+J.+Watersauthor=M.+D.+Grossauthor=G.+F.+Vande+Woude&title=Nuclear+imaging+of+Met-expressing+human+and+canine+cancer+xenografts+with+radiolabeled+monoclonal+antibodies+%28MetSeek%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHay%26aufirst%3DR.%2BV.%26aulast%3DCao%26aufirst%3DB.%26aulast%3DSkinner%26aufirst%3DR.%2BS.%26aulast%3DSu%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DP.%26aulast%3DGustafson%26aufirst%3DM.%2BF.%26aulast%3DQian%26aufirst%3DC.%2BN.%26aulast%3DTeh%26aufirst%3DB.%2BT.%26aulast%3DKnudsen%26aufirst%3DB.%2BS.%26aulast%3DResau%26aufirst%3DJ.%2BH.%26aulast%3DShen%26aufirst%3DS.%26aulast%3DWaters%26aufirst%3DD.%2BJ.%26aulast%3DGross%26aufirst%3DM.%2BD.%26aulast%3DVande%2BWoude%26aufirst%3DG.%2BF.%26atitle%3DNuclear%2520imaging%2520of%2520Met-expressing%2520human%2520and%2520canine%2520cancer%2520xenografts%2520with%2520radiolabeled%2520monoclonal%2520antibodies%2520%2528MetSeek%2529%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2005%26volume%3D11%26spage%3D7064s%26epage%3D7069s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Schroeder, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">An, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, Z. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cornelius, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gullo-Brown, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henley, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeyaseelan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamath, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manne, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oppenheimer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sack, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefanski, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tokarski, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trainor, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wautlet, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fargnoli, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borzilleri, R. M.</span><span> </span><span class="NLM_article-title">Discovery of <i>N</i>-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide (BMS-777607), a selective and orally efficacious inhibitor of the Met kinase superfamily</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1251</span><span class="NLM_x">–</span> <span class="NLM_lpage">1254</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm801586s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=1251-1254&author=G.+M.+Schroederauthor=Y.+Anauthor=Z.+W.+Caiauthor=X.+T.+Chenauthor=C.+Clarkauthor=L.+A.+Corneliusauthor=J.+Daiauthor=J.+Gullo-Brownauthor=A.+Guptaauthor=B.+Henleyauthor=J.+T.+Huntauthor=R.+Jeyaseelanauthor=A.+Kamathauthor=K.+Kimauthor=J.+Lippyauthor=L.+J.+Lombardoauthor=V.+Manneauthor=S.+Oppenheimerauthor=J.+S.+Sackauthor=R.+J.+Schmidtauthor=G.+Shenauthor=K.+Stefanskiauthor=J.+S.+Tokarskiauthor=G.+L.+Trainorauthor=B.+S.+Wautletauthor=D.+Weiauthor=D.+K.+Williamsauthor=Y.+Zhangauthor=J.+Fargnoliauthor=R.+M.+Borzilleri&title=Discovery+of+N-%284-%282-amino-3-chloropyridin-4-yloxy%29-3-fluorophenyl%29-4-ethoxy-1-%284-fluorophenyl%29-2-oxo-1%2C2-dihydropyridine-3-carboxamide+%28BMS-777607%29%2C+a+selective+and+orally+efficacious+inhibitor+of+the+Met+kinase+superfamily"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm801586s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801586s%26sid%3Dliteratum%253Aachs%26aulast%3DSchroeder%26aufirst%3DG.%2BM.%26aulast%3DAn%26aufirst%3DY.%26aulast%3DCai%26aufirst%3DZ.%2BW.%26aulast%3DChen%26aufirst%3DX.%2BT.%26aulast%3DClark%26aufirst%3DC.%26aulast%3DCornelius%26aufirst%3DL.%2BA.%26aulast%3DDai%26aufirst%3DJ.%26aulast%3DGullo-Brown%26aufirst%3DJ.%26aulast%3DGupta%26aufirst%3DA.%26aulast%3DHenley%26aufirst%3DB.%26aulast%3DHunt%26aufirst%3DJ.%2BT.%26aulast%3DJeyaseelan%26aufirst%3DR.%26aulast%3DKamath%26aufirst%3DA.%26aulast%3DKim%26aufirst%3DK.%26aulast%3DLippy%26aufirst%3DJ.%26aulast%3DLombardo%26aufirst%3DL.%2BJ.%26aulast%3DManne%26aufirst%3DV.%26aulast%3DOppenheimer%26aufirst%3DS.%26aulast%3DSack%26aufirst%3DJ.%2BS.%26aulast%3DSchmidt%26aufirst%3DR.%2BJ.%26aulast%3DShen%26aufirst%3DG.%26aulast%3DStefanski%26aufirst%3DK.%26aulast%3DTokarski%26aufirst%3DJ.%2BS.%26aulast%3DTrainor%26aufirst%3DG.%2BL.%26aulast%3DWautlet%26aufirst%3DB.%2BS.%26aulast%3DWei%26aufirst%3DD.%26aulast%3DWilliams%26aufirst%3DD.%2BK.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DFargnoli%26aufirst%3DJ.%26aulast%3DBorzilleri%26aufirst%3DR.%2BM.%26atitle%3DDiscovery%2520of%2520N-%25284-%25282-amino-3-chloropyridin-4-yloxy%2529-3-fluorophenyl%2529-4-ethoxy-1-%25284-fluorophenyl%2529-2-oxo-1%252C2-dihydropyridine-3-carboxamide%2520%2528BMS-777607%2529%252C%2520a%2520selective%2520and%2520orally%2520efficacious%2520inhibitor%2520of%2520the%2520Met%2520kinase%2520superfamily%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D1251%26epage%3D1254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan-Lefko, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rex, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriguchi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osgood, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coxon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reese, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgess, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dussault, I.</span><span> </span><span class="NLM_article-title">Identification of a novel recepteur d'origine nantais/c-met small-molecule kinase inhibitor with antitumor activity in vivo</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">6680</span><span class="NLM_x">–</span> <span class="NLM_lpage">6687</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=6680-6687&author=Y.+Zhangauthor=P.+J.+Kaplan-Lefkoauthor=K.+Rexauthor=Y.+Yangauthor=J.+Moriguchiauthor=T.+Osgoodauthor=B.+Mattsonauthor=A.+Coxonauthor=M.+Reeseauthor=T.+S.+Kimauthor=J.+Linauthor=A.+Chenauthor=T.+L.+Burgessauthor=I.+Dussault&title=Identification+of+a+novel+recepteur+d%27origine+nantais%2Fc-met+small-molecule+kinase+inhibitor+with+antitumor+activity+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DKaplan-Lefko%26aufirst%3DP.%2BJ.%26aulast%3DRex%26aufirst%3DK.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DMoriguchi%26aufirst%3DJ.%26aulast%3DOsgood%26aufirst%3DT.%26aulast%3DMattson%26aufirst%3DB.%26aulast%3DCoxon%26aufirst%3DA.%26aulast%3DReese%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DT.%2BS.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DA.%26aulast%3DBurgess%26aufirst%3DT.%2BL.%26aulast%3DDussault%26aufirst%3DI.%26atitle%3DIdentification%2520of%2520a%2520novel%2520recepteur%2520d%2527origine%2520nantais%252Fc-met%2520small-molecule%2520kinase%2520inhibitor%2520with%2520antitumor%2520activity%2520in%2520vivo%26jtitle%3DCancer%2520Res.%26date%3D2008%26volume%3D68%26spage%3D6680%26epage%3D6687" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegmund, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan-Lefko, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rex, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriguchi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berry, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teffera, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellon, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimanovich, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominguez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norman, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harmange, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dussault, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, T. S.</span><span> </span><span class="NLM_article-title">Discovery of a potent, selective, and orally bioavailable c-Met inhibitor: 1-(2-hydroxy-2-methylpropyl)-<i>N</i>-(5-(7-methoxyquinolin-4-yloxy)pyridin-2-yl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide (AMG 458)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">3688</span><span class="NLM_x">–</span> <span class="NLM_lpage">3691</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800401t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=3688-3691&author=L.+Liuauthor=A.+Siegmundauthor=N.+Xiauthor=P.+Kaplan-Lefkoauthor=K.+Rexauthor=A.+Chenauthor=J.+Linauthor=J.+Moriguchiauthor=L.+Berryauthor=L.+Huangauthor=Y.+Tefferaauthor=Y.+Yangauthor=Y.+Zhangauthor=S.+F.+Bellonauthor=M.+Leeauthor=R.+Shimanovichauthor=A.+Bakauthor=C.+Dominguezauthor=M.+H.+Normanauthor=J.+C.+Harmangeauthor=I.+Dussaultauthor=T.+S.+Kim&title=Discovery+of+a+potent%2C+selective%2C+and+orally+bioavailable+c-Met+inhibitor%3A+1-%282-hydroxy-2-methylpropyl%29-N-%285-%287-methoxyquinolin-4-yloxy%29pyridin-2-yl%29-5-methyl-3-oxo-2-phenyl-2%2C3-dihydro-1H-pyrazole-4-carboxamide+%28AMG+458%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm800401t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800401t%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DSiegmund%26aufirst%3DA.%26aulast%3DXi%26aufirst%3DN.%26aulast%3DKaplan-Lefko%26aufirst%3DP.%26aulast%3DRex%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DA.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DMoriguchi%26aufirst%3DJ.%26aulast%3DBerry%26aufirst%3DL.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DTeffera%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DBellon%26aufirst%3DS.%2BF.%26aulast%3DLee%26aufirst%3DM.%26aulast%3DShimanovich%26aufirst%3DR.%26aulast%3DBak%26aufirst%3DA.%26aulast%3DDominguez%26aufirst%3DC.%26aulast%3DNorman%26aufirst%3DM.%2BH.%26aulast%3DHarmange%26aufirst%3DJ.%2BC.%26aulast%3DDussault%26aufirst%3DI.%26aulast%3DKim%26aufirst%3DT.%2BS.%26atitle%3DDiscovery%2520of%2520a%2520potent%252C%2520selective%252C%2520and%2520orally%2520bioavailable%2520c-Met%2520inhibitor%253A%25201-%25282-hydroxy-2-methylpropyl%2529-N-%25285-%25287-methoxyquinolin-4-yloxy%2529pyridin-2-yl%2529-5-methyl-3-oxo-2-phenyl-2%252C3-dihydro-1H-pyrazole-4-carboxamide%2520%2528AMG%2520458%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D3688%26epage%3D3691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wislez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujimoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prudkin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Izzo, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uno, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanna, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langley, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wistuba, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurie, J. M.</span><span> </span><span class="NLM_article-title">A selective small molecule inhibitor of c-Met, PHA-665752, reverses lung premalignancy induced by mutant K-ras</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">952</span><span class="NLM_x">–</span> <span class="NLM_lpage">960</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm900803q&amp;key=10.1158%2F1535-7163.MCT-07-2045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm900803q&amp;key=18413809" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm900803q&amp;key=1%3ACAS%3A528%3ADC%252BD1cXks1Gmsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=952-960&author=Y.+Yangauthor=M.+Wislezauthor=N.+Fujimotoauthor=L.+Prudkinauthor=J.+G.+Izzoauthor=F.+Unoauthor=L.+Jiauthor=A.+E.+Hannaauthor=R.+R.+Langleyauthor=D.+Liuauthor=F.+M.+Johnsonauthor=I.+Wistubaauthor=J.+M.+Kurie&title=A+selective+small+molecule+inhibitor+of+c-Met%2C+PHA-665752%2C+reverses+lung+premalignancy+induced+by+mutant+K-ras"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">A selective small molecule inhibitor of c-Met, PHA-665752, reverses lung premalignancy induced by mutant K-ras</span></div><div class="casAuthors">Yang, Yanan; Wislez, Marie; Fujimoto, Nobukazu; Prudkin, Ludmila; Izzo, Julie G.; Uno, Futoshi; Ji, Lin; Hanna, Amy E.; Langley, Robert R.; Liu, Diane; Johnson, Faye M.; Wistuba, Ignacio; Kurie, Jonathan M.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">952-960</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The c-Met receptor tyrosine kinase has been implicated in cellular transformation induced by mutant Ras, a commonly activated proto-oncogene in non-small cell lung cancer (NSCLC).  However, the role of c-Met has not been defined in K-ras-mutant NSCLC, a disease for which no effective targeted therapeutic options currently exist.  To acquire a greater understanding of its role, we used genetic and pharmacol. approaches to inhibit c-Met in mice and cultured cells.  In KrasLA1 mice, which develop premalignant lung lesions that progress to multifocal lung adenocarcinomas owing to somatic mutations in K-ras, c-Met was expressed in multiple cell types within premalignant lung lesions, and high concns. of HGF were detected in bronchoalveolar lavage samples.  Short-term treatment with PHA-665752, a c-Met inhibitor, decreased the nos. of premalignant lung lesions and induced apoptosis in tumor cells and vascular endothelial cells within lesions.  In cell culture, PHA-665752 induced apoptosis of a lung adenocarcinoma cell line derived from KrasLA1 mice (LKR-13) and a murine lung endothelial cell line (MEC).  C-Met depletion by siRNA transfection induced apoptosis of MECs but not LKR-13 cells.  Collectively, these findings suggest that apoptosis was an on-target effect of PHA-665752 in MECs but not in LKR-13 cells.  We conclude that PHA-665752 inhibited lung tumorigenesis in KrasLA1 mice and may provide a novel therapeutic approach to the prevention of K-ras-mutant NSCLC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4lgtND1nnfbVg90H21EOLACvtfcHk0lhfVMMkNTuoyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXks1Gmsb0%253D&md5=0d2ee01079be38dc194598c659bde3b5</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-07-2045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-07-2045%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DY.%26aulast%3DWislez%26aufirst%3DM.%26aulast%3DFujimoto%26aufirst%3DN.%26aulast%3DPrudkin%26aufirst%3DL.%26aulast%3DIzzo%26aufirst%3DJ.%2BG.%26aulast%3DUno%26aufirst%3DF.%26aulast%3DJi%26aufirst%3DL.%26aulast%3DHanna%26aufirst%3DA.%2BE.%26aulast%3DLangley%26aufirst%3DR.%2BR.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DJohnson%26aufirst%3DF.%2BM.%26aulast%3DWistuba%26aufirst%3DI.%26aulast%3DKurie%26aufirst%3DJ.%2BM.%26atitle%3DA%2520selective%2520small%2520molecule%2520inhibitor%2520of%2520c-Met%252C%2520PHA-665752%252C%2520reverses%2520lung%2520premalignancy%2520induced%2520by%2520mutant%2520K-ras%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2008%26volume%3D7%26spage%3D952%26epage%3D960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Chattopadhyay, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Naggar, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clayman, G. L.</span><span> </span><span class="NLM_article-title">Small molecule c-MET inhibitor PHA665752: effect on cell growth and motility in papillary thyroid carcinoma</span> <span class="citation_source-journal">Head Neck</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">991</span><span class="NLM_x">–</span> <span class="NLM_lpage">1000</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm900803q&amp;key=10.1002%2Fhed.20816" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm900803q&amp;key=18327775" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm900803q&amp;key=1%3ACAS%3A280%3ADC%252BD1cvptFemug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2008&pages=991-1000&author=C.+Chattopadhyayauthor=A.+K.+El-Naggarauthor=M.+D.+Williamsauthor=G.+L.+Clayman&title=Small+molecule+c-MET+inhibitor+PHA665752%3A+effect+on+cell+growth+and+motility+in+papillary+thyroid+carcinoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule c-MET inhibitor PHA665752: effect on cell growth and motility in papillary thyroid carcinoma</span></div><div class="casAuthors">Chattopadhyay Chandrani; El-Naggar Adel K; Williams Michelle D; Clayman Gary L</div><div class="citationInfo"><span class="NLM_cas:title">Head & neck</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">991-1000</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  c-Met is upregulated in papillary thyroid carcinoma (PTC) and can be an attractive therapeutic target.  We tested the effects of the small molecule c-met inhibitor PHA665752 in blocking c-met-dependent phenotypic effects in PTC cell lines.  METHODS:  PTC patient tissues and cell lines were evaluated for c-met expression.  The effect of PHA665752 on c-met phosphorylation, downstream signaling, hepatocyte growth factor (HGF)-dependent cell growth, and induction of apoptosis was studied.  The IC(50) of PHA665752 in c-met-expressing PTC cells was determined, and growth curves at 0.1x, 1x, and 10x IC(50) concentrations were obtained.  Poly(ADP-ribose) polymerase (PARP) and caspase-9-processing post-PHA665752 treatment were studied as markers of apoptosis, and assays analyzing HGF-dependent cell invasion and migration in the presence and absence of PHA665752 were done.  RESULTS:  c-Met was upregulated in most of the patient tissues with PTC and in many PTC cell lines.  PHA665752 specifically inhibited c-met phosphorylation, c-met-dependent cell growth, signal transduction, cell survival, cell invasion, and migration in PTC cells with high c-met.  CONCLUSIONS:  PHA665752 is an effective and specific inhibitor of c-met in PTC cells with high levels of c-met expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQGY_jMmnUJzEkUaC_kzhvyfW6udTcc2eZUollNNanezrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1cvptFemug%253D%253D&md5=788a9e87b01dc3d07343501fbcc89e50</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1002%2Fhed.20816&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhed.20816%26sid%3Dliteratum%253Aachs%26aulast%3DChattopadhyay%26aufirst%3DC.%26aulast%3DEl-Naggar%26aufirst%3DA.%2BK.%26aulast%3DWilliams%26aufirst%3DM.%2BD.%26aulast%3DClayman%26aufirst%3DG.%2BL.%26atitle%3DSmall%2520molecule%2520c-MET%2520inhibitor%2520PHA665752%253A%2520effect%2520on%2520cell%2520growth%2520and%2520motility%2520in%2520papillary%2520thyroid%2520carcinoma%26jtitle%3DHead%2520Neck%26date%3D2008%26volume%3D30%26spage%3D991%26epage%3D1000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Tseng, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dandekar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yaghoubi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muir, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vincent, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michaud, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gambhir, S. S.</span><span> </span><span class="NLM_article-title">Preclinical efficacy of the c-Met inhibitor CE-355621 in a U87 MG mouse xenograft model evaluated by 18F-FDG small-animal PET</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">129</span><span class="NLM_x">–</span> <span class="NLM_lpage">134</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2008&pages=129-134&author=J.+R.+Tsengauthor=K.+W.+Kangauthor=M.+Dandekarauthor=S.+Yaghoubiauthor=J.+H.+Leeauthor=J.+G.+Christensenauthor=S.+Muirauthor=P.+W.+Vincentauthor=N.+R.+Michaudauthor=S.+S.+Gambhir&title=Preclinical+efficacy+of+the+c-Met+inhibitor+CE-355621+in+a+U87+MG+mouse+xenograft+model+evaluated+by+18F-FDG+small-animal+PET"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTseng%26aufirst%3DJ.%2BR.%26aulast%3DKang%26aufirst%3DK.%2BW.%26aulast%3DDandekar%26aufirst%3DM.%26aulast%3DYaghoubi%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DChristensen%26aufirst%3DJ.%2BG.%26aulast%3DMuir%26aufirst%3DS.%26aulast%3DVincent%26aufirst%3DP.%2BW.%26aulast%3DMichaud%26aufirst%3DN.%2BR.%26aulast%3DGambhir%26aufirst%3DS.%2BS.%26atitle%3DPreclinical%2520efficacy%2520of%2520the%2520c-Met%2520inhibitor%2520CE-355621%2520in%2520a%2520U87%2520MG%2520mouse%2520xenograft%2520model%2520evaluated%2520by%252018F-FDG%2520small-animal%2520PET%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2008%26volume%3D49%26spage%3D129%26epage%3D134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Koon, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salgia, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welch, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berkowitz, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mok, S. C.</span><span> </span><span class="NLM_article-title">Effect of a c-Met-specific, ATP-competitive small-molecule inhibitor SU11274 on human ovarian carcinoma cell growth, motility, and invasion</span> <span class="citation_source-journal">Int. J. Gynecol. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">976</span><span class="NLM_x">–</span> <span class="NLM_lpage">984</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm900803q&amp;key=10.1111%2Fj.1525-1438.2007.01135.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm900803q&amp;key=18021219" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm900803q&amp;key=1%3ACAS%3A280%3ADC%252BD1cnjsVWlug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=976-984&author=E.+C.+Koonauthor=P.+C.+Maauthor=R.+Salgiaauthor=W.+R.+Welchauthor=J.+G.+Christensenauthor=R.+S.+Berkowitzauthor=S.+C.+Mok&title=Effect+of+a+c-Met-specific%2C+ATP-competitive+small-molecule+inhibitor+SU11274+on+human+ovarian+carcinoma+cell+growth%2C+motility%2C+and+invasion"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of a c-Met-specific, ATP-competitive small-molecule inhibitor SU11274 on human ovarian carcinoma cell growth, motility, and invasion</span></div><div class="casAuthors">Koon E C; Ma P C; Salgia R; Welch W R; Christensen J G; Berkowitz R S; Mok S C</div><div class="citationInfo"><span class="NLM_cas:title">International journal of gynecological cancer : official journal of the International Gynecological Cancer Society</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">976-84</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Increased expression of the receptor tyrosine kinase c-Met has been shown to correlate with enhanced cell proliferation, motility, and invasion.  The objectives of this study were to characterize total and activated c-Met expression in both normal and malignant human ovarian epithelial cells and to determine the effects of inhibiting the activation of c-Met on ovarian epithelial cell growth, motility, and invasion.  Total c-Met was overexpressed in 82 (68%) of 119 ovarian carcinomas, as shown by immunohistochemistry.  Quantitative reverse transcription-polymerase chain reaction and Western blot analyses revealed that ovarian carcinoma cell lines had higher levels of c-Met messenger RNA, total protein, and activated protein expression compared to normal ovarian epithelial cell cultures.  Using a specific adenosine triphosphate-competitive small-molecule inhibitor, SU11274, activated c-Met was decreased in normal and ovarian carcinoma cell lines. 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assays showed that cell growth inhibition directly correlated to the level of activated c-Met detected in each cell line (r =-0.87, P = 0.012).  Using modified Boyden chamber assays, ovarian carcinoma cells treated with SU11274 demonstrated significantly decreased cell motility and invasion compared to untreated cells (P = 0.003 and P < 0.001, respectively).  These data indicate that c-Met is overexpressed in the majority of malignant ovarian epithelial cells both in vivo and in vitro and that decreasing activated c-Met in vitro can significantly decrease ovarian carcinoma cell growth, motility, and invasion.  Developing therapies that specifically inhibit the activation of c-Met may represent a novel therapeutic modality for patients with ovarian carcinomas expressing high levels of c-Met.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR8AvUJS8-dyEHdcurJClFcfW6udTcc2eZOc88g6EfsJLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1cnjsVWlug%253D%253D&md5=9e2ffd432d52d0ac324816c8505633a0</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1111%2Fj.1525-1438.2007.01135.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1525-1438.2007.01135.x%26sid%3Dliteratum%253Aachs%26aulast%3DKoon%26aufirst%3DE.%2BC.%26aulast%3DMa%26aufirst%3DP.%2BC.%26aulast%3DSalgia%26aufirst%3DR.%26aulast%3DWelch%26aufirst%3DW.%2BR.%26aulast%3DChristensen%26aufirst%3DJ.%2BG.%26aulast%3DBerkowitz%26aufirst%3DR.%2BS.%26aulast%3DMok%26aufirst%3DS.%2BC.%26atitle%3DEffect%2520of%2520a%2520c-Met-specific%252C%2520ATP-competitive%2520small-molecule%2520inhibitor%2520SU11274%2520on%2520human%2520ovarian%2520carcinoma%2520cell%2520growth%252C%2520motility%252C%2520and%2520invasion%26jtitle%3DInt.%2520J.%2520Gynecol.%2520Cancer%26date%3D2008%26volume%3D18%26spage%3D976%26epage%3D984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Zou, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arango, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonnell, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamazaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koudriakova, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alton, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nambu, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Los, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bender, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mroczkowski, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, J. G.</span><span> </span><span class="NLM_article-title">An orally available small-molecule inhibitor of c-Met, PF-2341066, exhibits cytoreductive antitumor efficacy through antiproliferative and antiangiogenic mechanisms</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">4408</span><span class="NLM_x">–</span> <span class="NLM_lpage">4417</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm900803q&amp;key=10.1158%2F0008-5472.CAN-06-4443" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm900803q&amp;key=17483355" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm900803q&amp;key=1%3ACAS%3A528%3ADC%252BD2sXltVyrsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=4408-4417&author=H.+Y.+Zouauthor=Q.+Liauthor=J.+H.+Leeauthor=M.+E.+Arangoauthor=S.+R.+McDonnellauthor=S.+Yamazakiauthor=T.+B.+Koudriakovaauthor=G.+Altonauthor=J.+J.+Cuiauthor=P.+P.+Kungauthor=M.+D.+Nambuauthor=G.+Losauthor=S.+L.+Benderauthor=B.+Mroczkowskiauthor=J.+G.+Christensen&title=An+orally+available+small-molecule+inhibitor+of+c-Met%2C+PF-2341066%2C+exhibits+cytoreductive+antitumor+efficacy+through+antiproliferative+and+antiangiogenic+mechanisms"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">An Orally Available Small-Molecule Inhibitor of c-Met, PF-2341066, Exhibits Cytoreductive Antitumor Efficacy through Antiproliferative and Antiangiogenic Mechanisms</span></div><div class="casAuthors">Zou, Helen Y.; Li, Qiuhua; Lee, Joseph H.; Arango, Maria E.; McDonnell, Scott R.; Yamazaki, Shinji; Koudriakova, Tatiana B.; Alton, Gordon; Cui, Jingrong J.; Kung, Pei-Pei; Nambu, Mitchell D.; Los, Gerrit; Bender, Steven L.; Mroczkowski, Barbara; Christensen, James G.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4408-4417</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The c-Met receptor tyrosine kinase and its ligand, hepatocyte growth factor (HGF), have been implicated in the progression of several human cancers and are attractive therapeutic targets.  PF-2341066 was identified as a potent, orally bioavailable, ATP-competitive small-mol. inhibitor of the catalytic activity of c-Met kinase.  PF-2341066 was selective for c-Met (and anaplastic lymphoma kinase) compared with a panel of >120 diverse tyrosine and serine-threonine kinases.  PF-2341066 potently inhibited c-Met phosphorylation and c-Met-dependent proliferation, migration, or invasion of human tumor cells in vitro (IC50 values, 5-20 nmol/L).  In addn., PF-2341066 potently inhibited HGF-stimulated endothelial cell survival or invasion and serum-stimulated tubulogenesis in vitro, suggesting that this agent also exhibits antiangiogenic properties.  PF-2341066 showed efficacy at well-tolerated doses, including marked cytoreductive antitumor activity, in several tumor models that expressed activated c-Met.  The antitumor efficacy of PF-2341066 was dose dependent and showed a strong correlation to inhibition of c-Met phosphorylation in vivo.  Near-maximal inhibition of c-Met activity for the full dosing interval was necessary to maximize the efficacy of PF-2341066.  Addnl. mechanism-of-action studies showed dose-dependent inhibition of c-Met-dependent signal transduction, tumor cell proliferation (Ki67), induction of apoptosis (caspase-3), and redn. of microvessel d. (CD31).  These results indicated that the antitumor activity of PF-2341066 may be mediated by direct effects on tumor cell growth or survival as well as antiangiogenic mechanisms.  Collectively, these results show the therapeutic potential of targeting c-Met with selective small-mol. inhibitors for the treatment of human cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEAWtGPOBHC7Vg90H21EOLACvtfcHk0ljjuArxjhmtVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXltVyrsbg%253D&md5=798bf93e6cf8d5e9897e27485cba9002</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-06-4443&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-06-4443%26sid%3Dliteratum%253Aachs%26aulast%3DZou%26aufirst%3DH.%2BY.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DArango%26aufirst%3DM.%2BE.%26aulast%3DMcDonnell%26aufirst%3DS.%2BR.%26aulast%3DYamazaki%26aufirst%3DS.%26aulast%3DKoudriakova%26aufirst%3DT.%2BB.%26aulast%3DAlton%26aufirst%3DG.%26aulast%3DCui%26aufirst%3DJ.%2BJ.%26aulast%3DKung%26aufirst%3DP.%2BP.%26aulast%3DNambu%26aufirst%3DM.%2BD.%26aulast%3DLos%26aufirst%3DG.%26aulast%3DBender%26aufirst%3DS.%2BL.%26aulast%3DMroczkowski%26aufirst%3DB.%26aulast%3DChristensen%26aufirst%3DJ.%2BG.%26atitle%3DAn%2520orally%2520available%2520small-molecule%2520inhibitor%2520of%2520c-Met%252C%2520PF-2341066%252C%2520exhibits%2520cytoreductive%2520antitumor%2520efficacy%2520through%2520antiproliferative%2520and%2520antiangiogenic%2520mechanisms%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26spage%3D4408%26epage%3D4417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Puri, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khramtsov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmed, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nallasura, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hetzel, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jagadeeswaran, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karczmar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salgia, R.</span><span> </span><span class="NLM_article-title">A selective small molecule inhibitor of c-Met, PHA665752, inhibits tumorigenicity and angiogenesis in mouse lung cancer xenografts</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">3529</span><span class="NLM_x">–</span> <span class="NLM_lpage">3534</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=3529-3534&author=N.+Puriauthor=A.+Khramtsovauthor=S.+Ahmedauthor=V.+Nallasuraauthor=J.+T.+Hetzelauthor=R.+Jagadeeswaranauthor=G.+Karczmarauthor=R.+Salgia&title=A+selective+small+molecule+inhibitor+of+c-Met%2C+PHA665752%2C+inhibits+tumorigenicity+and+angiogenesis+in+mouse+lung+cancer+xenografts"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPuri%26aufirst%3DN.%26aulast%3DKhramtsov%26aufirst%3DA.%26aulast%3DAhmed%26aufirst%3DS.%26aulast%3DNallasura%26aufirst%3DV.%26aulast%3DHetzel%26aufirst%3DJ.%2BT.%26aulast%3DJagadeeswaran%26aufirst%3DR.%26aulast%3DKarczmar%26aufirst%3DG.%26aulast%3DSalgia%26aufirst%3DR.%26atitle%3DA%2520selective%2520small%2520molecule%2520inhibitor%2520of%2520c-Met%252C%2520PHA665752%252C%2520inhibits%2520tumorigenicity%2520and%2520angiogenesis%2520in%2520mouse%2520lung%2520cancer%2520xenografts%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26spage%3D3529%26epage%3D3534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Smolen, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sordella, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muir, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohapatra, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barmettler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Archibald, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okimoto, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sgroi, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Settleman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haber, D. A.</span><span> </span><span class="NLM_article-title">Amplification of MET may identify a subset of cancers with extreme sensitivity to the selective tyrosine kinase inhibitor PHA-665752</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">2316</span><span class="NLM_x">–</span> <span class="NLM_lpage">2321</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=2316-2321&author=G.+A.+Smolenauthor=R.+Sordellaauthor=B.+Muirauthor=G.+Mohapatraauthor=A.+Barmettlerauthor=H.+Archibaldauthor=W.+J.+Kimauthor=R.+A.+Okimotoauthor=D.+W.+Bellauthor=D.+C.+Sgroiauthor=J.+G.+Christensenauthor=J.+Settlemanauthor=D.+A.+Haber&title=Amplification+of+MET+may+identify+a+subset+of+cancers+with+extreme+sensitivity+to+the+selective+tyrosine+kinase+inhibitor+PHA-665752"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSmolen%26aufirst%3DG.%2BA.%26aulast%3DSordella%26aufirst%3DR.%26aulast%3DMuir%26aufirst%3DB.%26aulast%3DMohapatra%26aufirst%3DG.%26aulast%3DBarmettler%26aufirst%3DA.%26aulast%3DArchibald%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DW.%2BJ.%26aulast%3DOkimoto%26aufirst%3DR.%2BA.%26aulast%3DBell%26aufirst%3DD.%2BW.%26aulast%3DSgroi%26aufirst%3DD.%2BC.%26aulast%3DChristensen%26aufirst%3DJ.%2BG.%26aulast%3DSettleman%26aufirst%3DJ.%26aulast%3DHaber%26aufirst%3DD.%2BA.%26atitle%3DAmplification%2520of%2520MET%2520may%2520identify%2520a%2520subset%2520of%2520cancers%2520with%2520extreme%2520sensitivity%2520to%2520the%2520selective%2520tyrosine%2520kinase%2520inhibitor%2520PHA-665752%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2006%26volume%3D103%26spage%3D2316%26epage%3D2321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Wang, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhan, Y. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, W. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yue, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsen, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, X.</span><span> </span><span class="NLM_article-title">SU5416 is a potent inhibitor of hepatocyte growth factor receptor (c-Met) and blocks HGF-induced invasiveness of human HepG2 hepatoma cells</span> <span class="citation_source-journal">J. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">267</span><span class="NLM_x">–</span> <span class="NLM_lpage">273</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm900803q&amp;key=10.1016%2Fj.jhep.2004.04.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm900803q&amp;key=15288476" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm900803q&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmt1KjsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2004&pages=267-273&author=S.+Y.+Wangauthor=B.+Chenauthor=Y.+Q.+Zhanauthor=W.+X.+Xuauthor=C.+Y.+Liauthor=R.+F.+Yangauthor=H.+Zhengauthor=P.+B.+Yueauthor=S.+H.+Larsenauthor=H.+B.+Sunauthor=X.+Yang&title=SU5416+is+a+potent+inhibitor+of+hepatocyte+growth+factor+receptor+%28c-Met%29+and+blocks+HGF-induced+invasiveness+of+human+HepG2+hepatoma+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">SU5416 is a potent inhibitor of hepatocyte growth factor receptor (c-Met) and blocks HGF-induced invasiveness of human HepG2 hepatoma cells</span></div><div class="casAuthors">Wang, Si Y.; Chen, Bing; Zhan, Yi Q.; Xu, Wang X.; Li, Chang Y.; Yang, Ri F.; Zheng, Hong; Yue, Pei B.; Larsen, Steven H.; Sun, Hui B.; Yang, Xiaoming</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hepatology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">267-273</span>CODEN:
                <span class="NLM_cas:coden">JOHEEC</span>;
        ISSN:<span class="NLM_cas:issn">0168-8278</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">SU5416 is a potent inhibitor of receptor tyrosine kinases, including those of the vascular endothelial growth factor receptor, stem cell factor receptor, and platelet-derived growth factor receptor.  Because of the overwhelming evidence favoring the role of aberrant hepatocyte growth factor (HGF)/Met signaling in the pathogenesis of various human cancers, various inhibitor strategies have been employed to therapeutically target this receptor.  Cell proliferation was detd. by incorporation of [3H] thymidine.  Invasiveness was assayed in Boyden Chambers with 8 μm Matrigel coated filters.  Phosphorylation of ERK1/2, Akt by HGF stimulation was detected by Western blotting.  We found that SU5416 inhibited motility scattering and the invasive activity of a hepatocellular carcinoma cell line HepG2 in vitro and growth in primary cultured hepatocytes induced by HGF.  Consequently, tyrosine autophosphorylation of the c-met induced by HGF was inhibited in these cells by SU5416 in a dose-dependent manner.  Furthermore, ERK1/2 and Akt phosphorylation, the signaling events down-stream of c-met activation were reduced.  Moreover, SU5416 caused reversion in NIH3T3 fibroblasts transformed by the oncogenic form of the receptor, Tpr-Met.  Inhibition of various solid tumors growth and metastasis by SU5416 may be partially attributed to blocking activation of the hepatocyte growth factor receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAnCngzAredrVg90H21EOLACvtfcHk0liCojDT1cEayA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmt1KjsLo%253D&md5=257971973a1e53bd95a2b1d4ced918dd</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.jhep.2004.04.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jhep.2004.04.013%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DS.%2BY.%26aulast%3DChen%26aufirst%3DB.%26aulast%3DZhan%26aufirst%3DY.%2BQ.%26aulast%3DXu%26aufirst%3DW.%2BX.%26aulast%3DLi%26aufirst%3DC.%2BY.%26aulast%3DYang%26aufirst%3DR.%2BF.%26aulast%3DZheng%26aufirst%3DH.%26aulast%3DYue%26aufirst%3DP.%2BB.%26aulast%3DLarsen%26aufirst%3DS.%2BH.%26aulast%3DSun%26aufirst%3DH.%2BB.%26aulast%3DYang%26aufirst%3DX.%26atitle%3DSU5416%2520is%2520a%2520potent%2520inhibitor%2520of%2520hepatocyte%2520growth%2520factor%2520receptor%2520%2528c-Met%2529%2520and%2520blocks%2520HGF-induced%2520invasiveness%2520of%2520human%2520HepG2%2520hepatoma%2520cells%26jtitle%3DJ.%2520Hepatol.%26date%3D2004%26volume%3D41%26spage%3D267%26epage%3D273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Christensen, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreck, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuruganti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruslim, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blake, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipson, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramphal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Do, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherrington, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendel, D. B.</span><span> </span><span class="NLM_article-title">A selective small molecule inhibitor of c-Met kinase inhibits c-Met-dependent phenotypes in vitro and exhibits cytoreductive antitumor activity in vivo</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">7345</span><span class="NLM_x">–</span> <span class="NLM_lpage">7355</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=7345-7355&author=J.+G.+Christensenauthor=R.+Schreckauthor=J.+Burrowsauthor=P.+Kurugantiauthor=E.+Chanauthor=P.+Leauthor=J.+Chenauthor=X.+Wangauthor=L.+Ruslimauthor=R.+Blakeauthor=K.+E.+Lipsonauthor=J.+Ramphalauthor=S.+Doauthor=J.+J.+Cuiauthor=J.+M.+Cherringtonauthor=D.+B.+Mendel&title=A+selective+small+molecule+inhibitor+of+c-Met+kinase+inhibits+c-Met-dependent+phenotypes+in+vitro+and+exhibits+cytoreductive+antitumor+activity+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChristensen%26aufirst%3DJ.%2BG.%26aulast%3DSchreck%26aufirst%3DR.%26aulast%3DBurrows%26aufirst%3DJ.%26aulast%3DKuruganti%26aufirst%3DP.%26aulast%3DChan%26aufirst%3DE.%26aulast%3DLe%26aufirst%3DP.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DRuslim%26aufirst%3DL.%26aulast%3DBlake%26aufirst%3DR.%26aulast%3DLipson%26aufirst%3DK.%2BE.%26aulast%3DRamphal%26aufirst%3DJ.%26aulast%3DDo%26aufirst%3DS.%26aulast%3DCui%26aufirst%3DJ.%2BJ.%26aulast%3DCherrington%26aufirst%3DJ.%2BM.%26aulast%3DMendel%26aufirst%3DD.%2BB.%26atitle%3DA%2520selective%2520small%2520molecule%2520inhibitor%2520of%2520c-Met%2520kinase%2520inhibits%2520c-Met-dependent%2520phenotypes%2520in%2520vitro%2520and%2520exhibits%2520cytoreductive%2520antitumor%2520activity%2520in%2520vivo%26jtitle%3DCancer%2520Res.%26date%3D2003%26volume%3D63%26spage%3D7345%26epage%3D7355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Christensen, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salgia, R.</span><span> </span><span class="NLM_article-title">c-Met as a target for human cancer and characterization of inhibitors for therapeutic intervention</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">225</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm900803q&amp;key=10.1016%2Fj.canlet.2004.09.044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm900803q&amp;key=15922853" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm900803q&amp;key=1%3ACAS%3A528%3ADC%252BD2MXks1Ggs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=225&publication_year=2005&pages=1-26&author=J.+G.+Christensenauthor=J.+Burrowsauthor=R.+Salgia&title=c-Met+as+a+target+for+human+cancer+and+characterization+of+inhibitors+for+therapeutic+intervention"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">c-Met as a target for human cancer and characterization of inhibitors for therapeutic intervention</span></div><div class="casAuthors">Christensen, James G.; Burrows, Jon; Salgia, Ravi</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">225</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-26</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Receptor tyrosine kinase (RTK) targeted agents such as trastuzumab, Imatinib, bevacizumab, and gefitinib inhibitors have illustrated the utility of targeting this protein class for treatment of selected cancers.  A unique member of the RTK family, c-Met, also represents an intriguing target for cancer therapy that is yet to be explored in a clin. setting.  The proto-oncogene, c-Met, encodes the high-affinity receptor for hepatocyte growth factor (HGF) or scatter factor (SF).  C-Met and HGF are each required for normal mammalian development and have been shown to be particularly important in cell migration, morphogenic differentiation, and organization of three-dimensional tubular structures (e.g. renal tubular cells, gland formation, etc.) as well as cell growth and angiogenesis.  Both c-Met and HGF have been shown to be deregulated in and to correlate with poor prognosis in a no. of major human cancers.  New data describing the constitutive phosphorylation of c-Met in a no. of human tumors is presented here along with a variety of mechanisms by which c-Met can become activated, including mutation and gene amplification.  In support of the clin. data implicating c-Met activation in the pathogenesis of human cancers, introduction of c-Met and HGF (or mutant c-Met) into cells conferred the properties of motility, invasiveness, and tumorigenicity to the transformed cells.  Conversely, the inhibition of c-Met with a variety of receptor antagonists inhibited the motility, invasiveness, and tumorigenicity of human tumor cell lines.  Consistent with this observation, small-mol. inhibitors of c-Met were developed that antagonized c-Met/HGF-dependent phenotypes and tumor growth in mouse models.  This review will address the potential for development of c-Met inhibitors for treatment of human cancers with particular emphasis on recent findings with small-mol. inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojTbSn0ouMILVg90H21EOLACvtfcHk0liCojDT1cEayA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXks1Ggs7c%253D&md5=106b145cbf442e9fec9667817697658d</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2004.09.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2004.09.044%26sid%3Dliteratum%253Aachs%26aulast%3DChristensen%26aufirst%3DJ.%2BG.%26aulast%3DBurrows%26aufirst%3DJ.%26aulast%3DSalgia%26aufirst%3DR.%26atitle%3Dc-Met%2520as%2520a%2520target%2520for%2520human%2520cancer%2520and%2520characterization%2520of%2520inhibitors%2520for%2520therapeutic%2520intervention%26jtitle%3DCancer%2520Lett.%26date%3D2005%26volume%3D225%26spage%3D1%26epage%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Kopka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faust, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keul, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breyholz, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holtke, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schober, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schafers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levkau, B.</span><span> </span><span class="NLM_article-title">5-Pyrrolidinylsulfonyl isatins as a potential tool for the molecular imaging of caspases in apoptosis</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6704</span><span class="NLM_x">–</span> <span class="NLM_lpage">6715</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm051217c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6704-6715&author=K.+Kopkaauthor=A.+Faustauthor=P.+Keulauthor=S.+Wagnerauthor=H.+J.+Breyholzauthor=C.+Holtkeauthor=O.+Schoberauthor=M.+Schafersauthor=B.+Levkau&title=5-Pyrrolidinylsulfonyl+isatins+as+a+potential+tool+for+the+molecular+imaging+of+caspases+in+apoptosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm051217c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm051217c%26sid%3Dliteratum%253Aachs%26aulast%3DKopka%26aufirst%3DK.%26aulast%3DFaust%26aufirst%3DA.%26aulast%3DKeul%26aufirst%3DP.%26aulast%3DWagner%26aufirst%3DS.%26aulast%3DBreyholz%26aufirst%3DH.%2BJ.%26aulast%3DHoltke%26aufirst%3DC.%26aulast%3DSchober%26aufirst%3DO.%26aulast%3DSchafers%26aufirst%3DM.%26aulast%3DLevkau%26aufirst%3DB.%26atitle%3D5-Pyrrolidinylsulfonyl%2520isatins%2520as%2520a%2520potential%2520tool%2520for%2520the%2520molecular%2520imaging%2520of%2520caspases%2520in%2520apoptosis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6704%26epage%3D6715" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Li, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, X. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, X. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, H. L.</span><span> </span><span class="NLM_article-title">Design, synthesis, antitumor evaluations and molecular modeling studies of novel 3,5-substituted indolin-2-one derivatives</span> <span class="citation_source-journal">Acta Pharmacol. Sin.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">140</span><span class="NLM_x">–</span> <span class="NLM_lpage">152</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm900803q&amp;key=10.1111%2Fj.1745-7254.2007.00473.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm900803q&amp;key=17184594" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm900803q&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnvVylug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2007&pages=140-152&author=H.+H.+Liauthor=X.+H.+Zhengauthor=J.+Z.+Tanauthor=L.+L.+Chenauthor=H.+Liuauthor=X.+M.+Luoauthor=X.+Shenauthor=L.+P.+Linauthor=K.+X.+Chenauthor=J.+Dingauthor=H.+L.+Jiang&title=Design%2C+synthesis%2C+antitumor+evaluations+and+molecular+modeling+studies+of+novel+3%2C5-substituted+indolin-2-one+derivatives"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis, antitumor evaluations and molecular modeling studies of novel 3,5-substituted indolin-2-one derivatives</span></div><div class="casAuthors">Li, Hai-hong; Zhang, Xiu-hua; Tan, Jin-zhi; Chen, Li-li; Liu, Hong; Luo, Xiao-min; Shen, Xu; Lin, Li-ping; Chen, Kai-xian; Ding, Jian; Jiang, Hua-liang</div><div class="citationInfo"><span class="NLM_cas:title">Acta Pharmacologica Sinica</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">140-152</span>CODEN:
                <span class="NLM_cas:coden">APSCG5</span>;
        ISSN:<span class="NLM_cas:issn">1671-4083</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Asia Pty Ltd.</span>)
        </div><div class="casAbstract">To design and synthesize a novel class of antitumor agents, featuring the 3,5-substituted indolin-2-one framework.  Based on enzyme binding features of (Z)-SU5402, introducing a β-pyrrole group at the 3-position of the indolin-2-one core, a series of novel 3,5-substituted indolin-2-ones were designed and synthesized.  Four human carcinoma cell lines of A-431, A-549, MDA-MB-468, and Autosomal Dominant Polycystic Kidney disease were chosen for the cell proliferation assay.  Twenty new compds. (1a-t) with E configuration have been designed, synthesized and bioassayed.  Their structural features were detd. by NMR spectra, low- and high-resoln. mass spectra, and confirmed by x-ray crystallog.  Although the enzyme assay showed a weak inhibition effect against the epidermal growth factor receptor, vascular endothelial growth factor receptor, fibroblast growth factor receptor and platelet-derived growth factor receptor tyrosine kinases, the cell-based antitumor activity was promising.  Compds. 1h (I) and its NO2 deriv. 1g showed higher inhibitory activity toward the A-549 and MDA-MB-468 cell lines with IC50 of 0.065-9.4 μmol/L.  This study provides a new template for further development of potent antitumor drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEOip0mRUA1LVg90H21EOLACvtfcHk0lgTDTsj6Uf3gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnvVylug%253D%253D&md5=839cf37d1f58fb5c042a03ea4af5cdfc</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1111%2Fj.1745-7254.2007.00473.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1745-7254.2007.00473.x%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DH.%2BH.%26aulast%3DZheng%26aufirst%3DX.%2BH.%26aulast%3DTan%26aufirst%3DJ.%2BZ.%26aulast%3DChen%26aufirst%3DL.%2BL.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DLuo%26aufirst%3DX.%2BM.%26aulast%3DShen%26aufirst%3DX.%26aulast%3DLin%26aufirst%3DL.%2BP.%26aulast%3DChen%26aufirst%3DK.%2BX.%26aulast%3DDing%26aufirst%3DJ.%26aulast%3DJiang%26aufirst%3DH.%2BL.%26atitle%3DDesign%252C%2520synthesis%252C%2520antitumor%2520evaluations%2520and%2520molecular%2520modeling%2520studies%2520of%2520novel%25203%252C5-substituted%2520indolin-2-one%2520derivatives%26jtitle%3DActa%2520Pharmacol.%2520Sin.%26date%3D2007%26volume%3D28%26spage%3D140%26epage%3D152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Sun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shirazian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukuda, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nematalla, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sistla, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luu, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, C.</span><span> </span><span class="NLM_article-title">Discovery of 5-[5-fluoro-2-oxo-1,2- dihydroindol-(3<i>Z</i>)-ylidenemethyl]-2,4- dimethyl-1<i>H</i>-pyrrole-3-carboxylic acid (2-diethylaminoethyl)amide, a novel tyrosine kinase inhibitor targeting vascular endothelial and platelet-derived growth factor receptor tyrosine kinase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">1116</span><span class="NLM_x">–</span> <span class="NLM_lpage">1119</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0204183" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm900803q&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhslSlsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=1116-1119&author=L.+Sunauthor=C.+Liangauthor=S.+Shirazianauthor=Y.+Zhouauthor=T.+Millerauthor=J.+Cuiauthor=J.+Y.+Fukudaauthor=J.+Y.+Chuauthor=A.+Nematallaauthor=X.+Wangauthor=H.+Chenauthor=A.+Sistlaauthor=T.+C.+Luuauthor=F.+Tangauthor=J.+Weiauthor=C.+Tang&title=Discovery+of+5-%5B5-fluoro-2-oxo-1%2C2-+dihydroindol-%283Z%29-ylidenemethyl%5D-2%2C4-+dimethyl-1H-pyrrole-3-carboxylic+acid+%282-diethylaminoethyl%29amide%2C+a+novel+tyrosine+kinase+inhibitor+targeting+vascular+endothelial+and+platelet-derived+growth+factor+receptor+tyrosine+kinase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 5-[5-Fluoro-2-oxo-1,2- dihydroindol-(3Z)-ylidenemethyl]-2,4- dimethyl-1H-pyrrole-3-carboxylic Acid (2-Diethylaminoethyl)amide, a Novel Tyrosine Kinase Inhibitor Targeting Vascular Endothelial and Platelet-Derived Growth Factor Receptor Tyrosine Kinase</span></div><div class="casAuthors">Sun, Li; Liang, Chris; Shirazian, Sheri; Zhou, Yong; Miller, Todd; Cui, Jean; Fukuda, Juri Y.; Chu, Ji-Yu; Nematalla, Asaad; Wang, Xueyan; Chen, Hui; Sistla, Anand; Luu, Tony C.; Tang, Flora; Wei, James; Tang, Cho</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1116-1119</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">To improve the antitumor properties and optimize the pharmaceutical properties including soly. and protein binding of indolin-2-ones, a series of different basic and weakly basic pyrrolylmethylidene indolinones I [R1 = H, F, Cl, Br; R2 = Et2NCH2CH2, pyridin-4-ylmethyl, 2-(1,2,3-triazol-1-yl)ethyl, etc.] were designed and synthesized.  Indolinone I [R1 = F, R2 = Et2NCH2CH2 (II)] showed the best overall profile in terms of potency for the VEGF-R2 and PDGF-Rβ tyrosine kinase at biochem. and cellular levels, soly., protein binding, and bioavailability.  II is currently in phase I clin. trials for the treatment of cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptdQJ1VSPq8bVg90H21EOLACvtfcHk0lgTDTsj6Uf3gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhslSlsbg%253D&md5=f6570cfa1ae4e31703c741d90fe65382</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjm0204183&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0204183%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DL.%26aulast%3DLiang%26aufirst%3DC.%26aulast%3DShirazian%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DMiller%26aufirst%3DT.%26aulast%3DCui%26aufirst%3DJ.%26aulast%3DFukuda%26aufirst%3DJ.%2BY.%26aulast%3DChu%26aufirst%3DJ.%2BY.%26aulast%3DNematalla%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DSistla%26aufirst%3DA.%26aulast%3DLuu%26aufirst%3DT.%2BC.%26aulast%3DTang%26aufirst%3DF.%26aulast%3DWei%26aufirst%3DJ.%26aulast%3DTang%26aufirst%3DC.%26atitle%3DDiscovery%2520of%25205-%255B5-fluoro-2-oxo-1%252C2-%2520dihydroindol-%25283Z%2529-ylidenemethyl%255D-2%252C4-%2520dimethyl-1H-pyrrole-3-carboxylic%2520acid%2520%25282-diethylaminoethyl%2529amide%252C%2520a%2520novel%2520tyrosine%2520kinase%2520inhibitor%2520targeting%2520vascular%2520endothelial%2520and%2520platelet-derived%2520growth%2520factor%2520receptor%2520tyrosine%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D1116%26epage%3D1119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Bell, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stirdivant, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahern, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Culberson, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darke, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinsmore, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drakas, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallicchio, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heimbrook, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hua, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kett, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kornienko, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munshi, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quigley, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reid, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trotter, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waxman, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zartman, C. B.</span><span> </span><span class="NLM_article-title">Biochemical and structural characterization of a novel class of inhibitors of the type 1 insulin-like growth factor and insulin receptor kinases</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">9430</span><span class="NLM_x">–</span> <span class="NLM_lpage">9440</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi0500628" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2005&pages=9430-9440&author=I.+M.+Bellauthor=S.+M.+Stirdivantauthor=J.+Ahernauthor=J.+C.+Culbersonauthor=P.+L.+Darkeauthor=C.+J.+Dinsmoreauthor=R.+A.+Drakasauthor=S.+N.+Gallicchioauthor=S.+L.+Grahamauthor=D.+C.+Heimbrookauthor=D.+L.+Hallauthor=J.+Huaauthor=N.+R.+Kettauthor=A.+S.+Kimauthor=M.+Kornienkoauthor=L.+C.+Kuoauthor=S.+K.+Munshiauthor=A.+G.+Quigleyauthor=J.+C.+Reidauthor=B.+W.+Trotterauthor=L.+H.+Waxmanauthor=T.+M.+Williamsauthor=C.+B.+Zartman&title=Biochemical+and+structural+characterization+of+a+novel+class+of+inhibitors+of+the+type+1+insulin-like+growth+factor+and+insulin+receptor+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fbi0500628&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi0500628%26sid%3Dliteratum%253Aachs%26aulast%3DBell%26aufirst%3DI.%2BM.%26aulast%3DStirdivant%26aufirst%3DS.%2BM.%26aulast%3DAhern%26aufirst%3DJ.%26aulast%3DCulberson%26aufirst%3DJ.%2BC.%26aulast%3DDarke%26aufirst%3DP.%2BL.%26aulast%3DDinsmore%26aufirst%3DC.%2BJ.%26aulast%3DDrakas%26aufirst%3DR.%2BA.%26aulast%3DGallicchio%26aufirst%3DS.%2BN.%26aulast%3DGraham%26aufirst%3DS.%2BL.%26aulast%3DHeimbrook%26aufirst%3DD.%2BC.%26aulast%3DHall%26aufirst%3DD.%2BL.%26aulast%3DHua%26aufirst%3DJ.%26aulast%3DKett%26aufirst%3DN.%2BR.%26aulast%3DKim%26aufirst%3DA.%2BS.%26aulast%3DKornienko%26aufirst%3DM.%26aulast%3DKuo%26aufirst%3DL.%2BC.%26aulast%3DMunshi%26aufirst%3DS.%2BK.%26aulast%3DQuigley%26aufirst%3DA.%2BG.%26aulast%3DReid%26aufirst%3DJ.%2BC.%26aulast%3DTrotter%26aufirst%3DB.%2BW.%26aulast%3DWaxman%26aufirst%3DL.%2BH.%26aulast%3DWilliams%26aufirst%3DT.%2BM.%26aulast%3DZartman%26aufirst%3DC.%2BB.%26atitle%3DBiochemical%2520and%2520structural%2520characterization%2520of%2520a%2520novel%2520class%2520of%2520inhibitors%2520of%2520the%2520type%25201%2520insulin-like%2520growth%2520factor%2520and%2520insulin%2520receptor%2520kinases%26jtitle%3DBiochemistry%26date%3D2005%26volume%3D44%26spage%3D9430%26epage%3D9440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Manley, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalman, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conway, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ball, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Havens, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaidyanathan, R.</span><span> </span><span class="NLM_article-title">Early amidation approach to 3-[(4-amido)pyrrol-2-yl]-2-indolinones</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">6447</span><span class="NLM_x">–</span> <span class="NLM_lpage">6450</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo034304q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2003&pages=6447-6450&author=J.+M.+Manleyauthor=M.+J.+Kalmanauthor=B.+G.+Conwayauthor=C.+C.+Ballauthor=J.+L.+Havensauthor=R.+Vaidyanathan&title=Early+amidation+approach+to+3-%5B%284-amido%29pyrrol-2-yl%5D-2-indolinones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjo034304q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo034304q%26sid%3Dliteratum%253Aachs%26aulast%3DManley%26aufirst%3DJ.%2BM.%26aulast%3DKalman%26aufirst%3DM.%2BJ.%26aulast%3DConway%26aufirst%3DB.%2BG.%26aulast%3DBall%26aufirst%3DC.%2BC.%26aulast%3DHavens%26aufirst%3DJ.%2BL.%26aulast%3DVaidyanathan%26aufirst%3DR.%26atitle%3DEarly%2520amidation%2520approach%2520to%25203-%255B%25284-amido%2529pyrrol-2-yl%255D-2-indolinones%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2003%26volume%3D68%26spage%3D6447%26epage%3D6450" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Sun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nematalla, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, J.</span><span> </span><span class="NLM_article-title">Rational design of 4,5-disubstituted-5,7-dihydro-pyrrolo[2,3-<i>d</i>]pyrimidin-6-ones as a novel class of inhibitors of epidermal growth factor receptor (EGF-R) and Her2(p185(erbB)) tyrosine kinases</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">2153</span><span class="NLM_x">–</span> <span class="NLM_lpage">2157</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=2153-2157&author=L.+Sunauthor=J.+Cuiauthor=C.+Liangauthor=Y.+Zhouauthor=A.+Nematallaauthor=X.+Wangauthor=H.+Chenauthor=C.+Tangauthor=J.+Wei&title=Rational+design+of+4%2C5-disubstituted-5%2C7-dihydro-pyrrolo%5B2%2C3-d%5Dpyrimidin-6-ones+as+a+novel+class+of+inhibitors+of+epidermal+growth+factor+receptor+%28EGF-R%29+and+Her2%28p185%28erbB%29%29+tyrosine+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DL.%26aulast%3DCui%26aufirst%3DJ.%26aulast%3DLiang%26aufirst%3DC.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DNematalla%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DTang%26aufirst%3DC.%26aulast%3DWei%26aufirst%3DJ.%26atitle%3DRational%2520design%2520of%25204%252C5-disubstituted-5%252C7-dihydro-pyrrolo%255B2%252C3-d%255Dpyrimidin-6-ones%2520as%2520a%2520novel%2520class%2520of%2520inhibitors%2520of%2520epidermal%2520growth%2520factor%2520receptor%2520%2528EGF-R%2529%2520and%2520Her2%2528p185%2528erbB%2529%2529%2520tyrosine%2520kinases%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D2153%26epage%3D2157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Tang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barkauskas, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molter, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flask, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dowlati, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halmos, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kern, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, P. C.</span><span> </span><span class="NLM_article-title">Dual MET-EGFR combinatorial inhibition against T790M-EGFR-mediated erlotinib-resistant lung cancer</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">911</span><span class="NLM_x">–</span> <span class="NLM_lpage">922</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm900803q&amp;key=10.1038%2Fsj.bjc.6604559" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm900803q&amp;key=19238632" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm900803q&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtV2jurrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2008&pages=911-922&author=Z.+Tangauthor=R.+Duauthor=S.+Jiangauthor=C.+Wuauthor=D.+S.+Barkauskasauthor=J.+Richeyauthor=J.+Molterauthor=M.+Lamauthor=C.+Flaskauthor=S.+Gersonauthor=A.+Dowlatiauthor=L.+Liuauthor=Z.+Leeauthor=B.+Halmosauthor=Y.+Wangauthor=J.+A.+Kernauthor=P.+C.+Ma&title=Dual+MET-EGFR+combinatorial+inhibition+against+T790M-EGFR-mediated+erlotinib-resistant+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Dual MET-EGFR combinatorial inhibition against T790M-EGFR-mediated erlotinib-resistant lung cancer</span></div><div class="casAuthors">Tang, Z.; Du, R.; Jiang, S.; Wu, C.; Barkauskas, D. S.; Richey, J.; Molter, J.; Lam, M.; Flask, C.; Gerson, S.; Dowlati, A.; Liu, L.; Lee, Z.; Halmos, B.; Wang, Y.; Kern, J. A.; Ma, P. C.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">911-922</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Despite clin. approval of erlotinib, most advanced lung cancer patients are primary non-responders.  Initial responders invariably develop secondary resistance, which can be accounted for by T790M-EGFR mutation in half of the relapses.  We show that MET is highly expressed in lung cancer, often concomitantly with epidermal growth factor receptor (EGFR), including H1975 cell line.  The erlotinib-resistant lung cancer cell line H1975, which expresses L858R/T790M-EGFR in-cis, was used to test for the effect of MET inhibition using the small mol. inhibitor SU11274.  H1975 cells express wild-type MET, without genomic amplification (CNV=1.1).  At 2 μ, SU11274 had significant in vitro pro-apoptotic effect in H1975 cells, 3.9-fold (P=0.0015) higher than erlotinib, but had no effect on the MET and EGFR-neg. H520 cells.  In vivo, SU11274 also induced significant tumor cytoredn. in H1975 murine xenografts in our bioluminescence mol. imaging assay.  Using small-animal microPET/MRI, SU11274 treatment was found to induce an early tumor metabolic response in H1975 tumor xenografts.  MET and EGFR pathways were found to exhibit collaborative signalling with receptor cross-activation, which had different patterns between wild type (A549) and L858R/T790M-EGFR (H1975).  SU11274 plus erlotinib/CL-387,785 potentiated MET inhibition of downstream cell proliferative survival signalling.  Knockdown studies in H1975 cells using siRNA against MET alone, EGFR alone, or both, confirmed the enhanced downstream inhibition with dual MET-EGFR signal path inhibition.  Finally, in our time-lapse video-microscopy and in vivo multimodal mol. imaging studies, dual SU11274-erlotinib concurrent treatment effectively inhibited H1975 cells with enhanced abrogation of cytoskeletal functions and complete regression of the xenograft growth.  Together, our results suggest that MET-based targeted inhibition using small-mol. MET inhibitor can be a potential treatment strategy for T790M-EGFR-mediated erlotinib-resistant non-small-cell lung cancer.  Furthermore, optimized inhibition may be further achieved with MET inhibition in combination with erlotinib or an irreversible EGFR-TKI.  British Journal of Cancer (2008) 99, 911-922. doi:10.1038/sj.bjc.6604559 www.bjcancer.com Published online 26 August 2008.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDTEFxM4PPcrVg90H21EOLACvtfcHk0lhzrKzaaQ0meA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtV2jurrI&md5=c7f20d0e22b5358c6196d57f466d8ea1</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6604559&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6604559%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DZ.%26aulast%3DDu%26aufirst%3DR.%26aulast%3DJiang%26aufirst%3DS.%26aulast%3DWu%26aufirst%3DC.%26aulast%3DBarkauskas%26aufirst%3DD.%2BS.%26aulast%3DRichey%26aufirst%3DJ.%26aulast%3DMolter%26aufirst%3DJ.%26aulast%3DLam%26aufirst%3DM.%26aulast%3DFlask%26aufirst%3DC.%26aulast%3DGerson%26aufirst%3DS.%26aulast%3DDowlati%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DLee%26aufirst%3DZ.%26aulast%3DHalmos%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DKern%26aufirst%3DJ.%2BA.%26aulast%3DMa%26aufirst%3DP.%2BC.%26atitle%3DDual%2520MET-EGFR%2520combinatorial%2520inhibition%2520against%2520T790M-EGFR-mediated%2520erlotinib-resistant%2520lung%2520cancer%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2008%26volume%3D99%26spage%3D911%26epage%3D922" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Langstrom, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundqvist, H.</span><span> </span><span class="NLM_article-title">The preparation of <sup>11</sup>C-methyl iodide and its use in the synthesis of <sup>11</sup>C-methyl-<span class="smallcaps smallerCapital">l</span>-methionine</span> <span class="citation_source-journal">Int. J. Appl. Radiat. Isot.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1976</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">357</span><span class="NLM_x">–</span> <span class="NLM_lpage">363</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Fjm900803q&amp;key=10.1016%2F0020-708X%2876%2990088-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Fjm900803q&amp;key=955739" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm900803q&amp;key=1%3ACAS%3A528%3ADyaE28XlvVylsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1976&pages=357-363&author=B.+Langstromauthor=H.+Lundqvist&title=The+preparation+of+11C-methyl+iodide+and+its+use+in+the+synthesis+of+11C-methyl-l-methionine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">The preparation of carbon-11-labeled methyl iodide and its use in the synthesis of carbon-11-labeled methyl-L-methionine</span></div><div class="casAuthors">Langstrom, B.; Lundqvist, H.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Applied Radiation and Isotopes</span>
        (<span class="NLM_cas:date">1976</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">357-63</span>CODEN:
                <span class="NLM_cas:coden">IJARAY</span>;
        ISSN:<span class="NLM_cas:issn">0020-708X</span>.
    </div><div class="casAbstract">Irradn. with protons of B2O3 (10-20 MeV) or H2O (70 MeV) produced 11CO2 in hot chem. reactions.  The CO2 was used as the starting material for the synthesis of H311CI which is useful for labeling biochem. mols. with 11C-Me.  An example is the methylation of the Na salt of homocysteine which gives L-methionine specifically labeled in the Me group.  The process was completed in <80 min, i.e. 4 half-lives of 11C.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7HFYJkLDhVbVg90H21EOLACvtfcHk0lj_aZWmxWa9eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE28XlvVylsLY%253D&md5=2270e5e03e98a7b54e173337e2478f47</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2F0020-708X%2876%2990088-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0020-708X%252876%252990088-0%26sid%3Dliteratum%253Aachs%26aulast%3DLangstrom%26aufirst%3DB.%26aulast%3DLundqvist%26aufirst%3DH.%26atitle%3DThe%2520preparation%2520of%252011C-methyl%2520iodide%2520and%2520its%2520use%2520in%2520the%2520synthesis%2520of%252011C-methyl-l-methionine%26jtitle%3DInt.%2520J.%2520Appl.%2520Radiat.%2520Isot.%26date%3D1976%26volume%3D27%26spage%3D357%26epage%3D363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Ma, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tretiakova, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacKinnon, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramnath, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dietrich, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seiwert, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jagadeeswaran, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krausz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vokes, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Husain, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salgia, R.</span><span> </span><span class="NLM_article-title">Expression and mutational analysis of MET in human solid cancers</span> <span class="citation_source-journal">Genes, Chromosomes Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1025</span><span class="NLM_x">–</span> <span class="NLM_lpage">1037</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm900803q&amp;key=10.1002%2Fgcc.20604" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm900803q&amp;key=18709663" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm900803q&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlWns7vE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=1025-1037&author=P.+C.+Maauthor=M.+S.+Tretiakovaauthor=A.+C.+MacKinnonauthor=N.+Ramnathauthor=C.+Johnsonauthor=S.+Dietrichauthor=T.+Seiwertauthor=J.+G.+Christensenauthor=R.+Jagadeeswaranauthor=T.+Krauszauthor=E.+E.+Vokesauthor=A.+N.+Husainauthor=R.+Salgia&title=Expression+and+mutational+analysis+of+MET+in+human+solid+cancers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Expression and mutational analysis of MET in human solid cancers</span></div><div class="casAuthors">Ma, Patrick C.; Tretiakova, Maria S.; MacKinnon, Alexander C.; Ramnath, Nithya; Johnson, Candace; Dietrich, Sascha; Seiwert, Tanguy; Christensen, James G.; Jagadeeswaran, Ramasamy; Krausz, Thomas; Vokes, Everett E.; Husain, Aliya N.; Salgia, Ravi</div><div class="citationInfo"><span class="NLM_cas:title">Genes, Chromosomes & Cancer</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1025-1037</span>CODEN:
                <span class="NLM_cas:coden">GCCAES</span>;
        ISSN:<span class="NLM_cas:issn">1045-2257</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">MET receptor tyrosine kinase and its ligand hepatocyte growth factor (HGF) regulate a variety of cellular functions, many of which can be dysregulated in human cancers.  Activated MET signaling can lead to cell motility and scattering, angiogenesis, proliferation, branching morphogenesis, invasion, and eventual metastasis.  We performed systematic anal. of the expression of the MET receptor and its ligand HGF in tumor tissue microarrays (TMA) from human solid cancers.  Std. immunohistochem. (IHC) and a computerized automated scoring system were used.  DNA sequencing for MET mutations in both nonkinase and kinase domains was also performed.  MET was differentially overexpressed in human solid cancers.  The ligand HGF was widely expressed in both tumors, primarily intratumoral, and nonmalignant tissues.  The MET/HGF likely is functional and may be activated in autocrine fashion in vivo.  MET and stem cell factor (SCF) were found to be pos. stained in the bronchioalevolar junctions of lung tumors.  A no. of novel mutations of MET were identified, particularly in the extracellular semaphorin domain and the juxtamembrane domain.  MET-HGF pathway can be assayed in TMAs and is often overexpressed in a wide variety of human solid cancers.  MET can be activated through overexpression, mutation, or autocrine signaling in malignant cells.  Mutations in the nonkinase regions of MET might play an important role in tumorigenesis and tumor progression.  MET would be an important therapeutic antitumor target to be inhibited, and in lung cancer, MET may represent a cancer early progenitor cell marker.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjnenTNgIcAbVg90H21EOLACvtfcHk0lj_aZWmxWa9eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlWns7vE&md5=cf53884177f20939300673fb034ac91f</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1002%2Fgcc.20604&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fgcc.20604%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DP.%2BC.%26aulast%3DTretiakova%26aufirst%3DM.%2BS.%26aulast%3DMacKinnon%26aufirst%3DA.%2BC.%26aulast%3DRamnath%26aufirst%3DN.%26aulast%3DJohnson%26aufirst%3DC.%26aulast%3DDietrich%26aufirst%3DS.%26aulast%3DSeiwert%26aufirst%3DT.%26aulast%3DChristensen%26aufirst%3DJ.%2BG.%26aulast%3DJagadeeswaran%26aufirst%3DR.%26aulast%3DKrausz%26aufirst%3DT.%26aulast%3DVokes%26aufirst%3DE.%2BE.%26aulast%3DHusain%26aufirst%3DA.%2BN.%26aulast%3DSalgia%26aufirst%3DR.%26atitle%3DExpression%2520and%2520mutational%2520analysis%2520of%2520MET%2520in%2520human%2520solid%2520cancers%26jtitle%3DGenes%252C%2520Chromosomes%2520Cancer%26date%3D2008%26volume%3D47%26spage%3D1025%26epage%3D1037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 17 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yongjia  Tang</span>, <span class="hlFld-ContribAuthor ">Haoran  Xu</span>, <span class="hlFld-ContribAuthor ">Yaxue  Dai</span>, <span class="hlFld-ContribAuthor ">Fang  Wang</span>, <span class="hlFld-ContribAuthor ">Wenjing  Huang</span>, <span class="hlFld-ContribAuthor ">Peifei  Liu</span>, <span class="hlFld-ContribAuthor ">Yueqing  Gu</span>. </span><span class="cited-content_cbyCitation_article-title">A novel peptide targeting c-Met for hepatocellular carcinoma diagnosis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Materials Chemistry B</span><span> <strong>2021,</strong> <em>9 </em>
                                    (22)
                                     , 4577-4586. <a href="https://doi.org/10.1039/D1TB00408E" title="DOI URL">https://doi.org/10.1039/D1TB00408E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1TB00408E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1TB00408E%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Materials%2520Chemistry%2520B%26atitle%3DA%252Bnovel%252Bpeptide%252Btargeting%252Bc-Met%252Bfor%252Bhepatocellular%252Bcarcinoma%252Bdiagnosis%26aulast%3DTang%26aufirst%3DYongjia%26date%3D2021%26date%3D2021%26volume%3D9%26issue%3D22%26spage%3D4577%26epage%3D4586" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vegard Torp  Lien</span>, <span class="hlFld-ContribAuthor ">Sofie  Celen</span>, <span class="hlFld-ContribAuthor ">Syed  Nuruddin</span>, <span class="hlFld-ContribAuthor ">Bala  Attili</span>, <span class="hlFld-ContribAuthor ">Gilles  Doumont</span>, <span class="hlFld-ContribAuthor ">Gaetan  Van Simaeys</span>, <span class="hlFld-ContribAuthor ">Guy  Bormans</span>, <span class="hlFld-ContribAuthor ">Jo  Klaveness</span>, <span class="hlFld-ContribAuthor ">Dag Erlend  Olberg</span>. </span><span class="cited-content_cbyCitation_article-title">Preclinical evaluation of [18F]cabozantinib as a PET imaging agent in a prostate cancer mouse model. </span><span class="cited-content_cbyCitation_journal-name">Nuclear Medicine and Biology</span><span> <strong>2021,</strong> <em>93 </em>, 74-80. <a href="https://doi.org/10.1016/j.nucmedbio.2020.12.002" title="DOI URL">https://doi.org/10.1016/j.nucmedbio.2020.12.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.nucmedbio.2020.12.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.nucmedbio.2020.12.002%26sid%3Dliteratum%253Aachs%26jtitle%3DNuclear%2520Medicine%2520and%2520Biology%26atitle%3DPreclinical%252Bevaluation%252Bof%252B%25255B18F%25255Dcabozantinib%252Bas%252Ba%252BPET%252Bimaging%252Bagent%252Bin%252Ba%252Bprostate%252Bcancer%252Bmouse%252Bmodel%26aulast%3DLien%26aufirst%3DVegard%2BTorp%26date%3D2021%26volume%3D93%26spage%3D74%26epage%3D80" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qingyu  Lin</span>, <span class="hlFld-ContribAuthor ">Yingying  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhequan  Fu</span>, <span class="hlFld-ContribAuthor ">Bingxin  Hu</span>, <span class="hlFld-ContribAuthor ">Zhan  Si</span>, <span class="hlFld-ContribAuthor ">Yanzhao  Zhao</span>, <span class="hlFld-ContribAuthor ">Hongcheng  Shi</span>, <span class="hlFld-ContribAuthor ">Dengfeng  Cheng</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and evaluation of 18F labeled crizotinib derivative [18F]FPC as a novel PET probe for imaging c-MET-positive NSCLC tumor. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2020,</strong> <em>28 </em>
                                    (15)
                                     , 115577. <a href="https://doi.org/10.1016/j.bmc.2020.115577" title="DOI URL">https://doi.org/10.1016/j.bmc.2020.115577</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2020.115577&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2020.115577%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bevaluation%252Bof%252B18F%252Blabeled%252Bcrizotinib%252Bderivative%252B%25255B18F%25255DFPC%252Bas%252Ba%252Bnovel%252BPET%252Bprobe%252Bfor%252Bimaging%252Bc-MET-positive%252BNSCLC%252Btumor%26aulast%3DLin%26aufirst%3DQingyu%26date%3D2020%26volume%3D28%26issue%3D15%26spage%3D115577" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei-Na  Wu</span>, <span class="hlFld-ContribAuthor ">Hao  Wu</span>, <span class="hlFld-ContribAuthor ">Run-Bin  Zhong</span>, <span class="hlFld-ContribAuthor ">Yuan  Wang</span>, <span class="hlFld-ContribAuthor ">Zhi-Hong  Xu</span>, <span class="hlFld-ContribAuthor ">Xiao-Lei  Zhao</span>, <span class="hlFld-ContribAuthor ">Zhou-Qing  Xu</span>, <span class="hlFld-ContribAuthor ">Yun-Chang  Fan</span>. </span><span class="cited-content_cbyCitation_article-title">Ratiometric fluorescent probe based on pyrrole-modified rhodamine 6G hydrazone for the imaging of Cu2+ in lysosomes. </span><span class="cited-content_cbyCitation_journal-name">Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy</span><span> <strong>2019,</strong> <em>212 </em>, 121-127. <a href="https://doi.org/10.1016/j.saa.2018.12.041" title="DOI URL">https://doi.org/10.1016/j.saa.2018.12.041</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.saa.2018.12.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.saa.2018.12.041%26sid%3Dliteratum%253Aachs%26jtitle%3DSpectrochimica%2520Acta%2520Part%2520A%253A%2520Molecular%2520and%2520Biomolecular%2520Spectroscopy%26atitle%3DRatiometric%252Bfluorescent%252Bprobe%252Bbased%252Bon%252Bpyrrole-modified%252Brhodamine%252B6G%252Bhydrazone%252Bfor%252Bthe%252Bimaging%252Bof%252BCu2%25252B%252Bin%252Blysosomes%26aulast%3DWu%26aufirst%3DWei-Na%26date%3D2019%26volume%3D212%26spage%3D121%26epage%3D127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vegard Torp  Lien</span>, <span class="hlFld-ContribAuthor ">Jo  Klaveness</span>, <span class="hlFld-ContribAuthor ">Dag Erlend  Olberg</span>. </span><span class="cited-content_cbyCitation_article-title">One-step synthesis of [
              18
              F]cabozantinib for use in positron emission tomography imaging of c-Met. </span><span class="cited-content_cbyCitation_journal-name">Journal of Labelled Compounds and Radiopharmaceuticals</span><span> <strong>2018,</strong> <em>61 </em>
                                    (1)
                                     , 11-17. <a href="https://doi.org/10.1002/jlcr.3564" title="DOI URL">https://doi.org/10.1002/jlcr.3564</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jlcr.3564&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjlcr.3564%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Labelled%2520Compounds%2520and%2520Radiopharmaceuticals%26atitle%3DOne-step%252Bsynthesis%252Bof%252B%25255B%252B18%252BF%25255Dcabozantinib%252Bfor%252Buse%252Bin%252Bpositron%252Bemission%252Btomography%252Bimaging%252Bof%252Bc-Met%26aulast%3DLien%26aufirst%3DVegard%2BTorp%26date%3D2018%26date%3D2017%26volume%3D61%26issue%3D1%26spage%3D11%26epage%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhaoguo  Han</span>, <span class="hlFld-ContribAuthor ">Yongyi  Wu</span>, <span class="hlFld-ContribAuthor ">Kai  Wang</span>, <span class="hlFld-ContribAuthor ">Yadi  Xiao</span>, <span class="hlFld-ContribAuthor ">Zhen  Cheng</span>, <span class="hlFld-ContribAuthor ">Xilin  Sun</span>, <span class="hlFld-ContribAuthor ">Baozhong  Shen</span>. </span><span class="cited-content_cbyCitation_article-title">Analysis of progress and challenges for various patterns of c-MET-targeted molecular imaging: a systematic review. </span><span class="cited-content_cbyCitation_journal-name">EJNMMI Research</span><span> <strong>2017,</strong> <em>7 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13550-017-0286-z" title="DOI URL">https://doi.org/10.1186/s13550-017-0286-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13550-017-0286-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13550-017-0286-z%26sid%3Dliteratum%253Aachs%26jtitle%3DEJNMMI%2520Research%26atitle%3DAnalysis%252Bof%252Bprogress%252Band%252Bchallenges%252Bfor%252Bvarious%252Bpatterns%252Bof%252Bc-MET-targeted%252Bmolecular%252Bimaging%25253A%252Ba%252Bsystematic%252Breview%26aulast%3DHan%26aufirst%3DZhaoguo%26date%3D2017%26date%3D2017%26volume%3D7%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vadim  Bernard-Gauthier</span>, <span class="hlFld-ContribAuthor ">Justin  Bailey</span>, <span class="hlFld-ContribAuthor ">Sheldon  Berke</span>, <span class="hlFld-ContribAuthor ">Ralf  Schirrmacher</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Advances in the Development and Application of Radiolabeled Kinase Inhibitors for PET Imaging. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2015,</strong> <em>20 </em>
                                    (12)
                                     , 22000-22027. <a href="https://doi.org/10.3390/molecules201219816" title="DOI URL">https://doi.org/10.3390/molecules201219816</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules201219816&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules201219816%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DRecent%252BAdvances%252Bin%252Bthe%252BDevelopment%252Band%252BApplication%252Bof%252BRadiolabeled%252BKinase%252BInhibitors%252Bfor%252BPET%252BImaging%26aulast%3DBernard-Gauthier%26aufirst%3DVadim%26date%3D2015%26date%3D2015%26volume%3D20%26issue%3D12%26spage%3D22000%26epage%3D22027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hao  Hong</span>, <span class="hlFld-ContribAuthor ">Feng  Chen</span>, <span class="hlFld-ContribAuthor ">Yin  Zhang</span>, <span class="hlFld-ContribAuthor ">Weibo  Cai</span>. </span><span class="cited-content_cbyCitation_article-title">New radiotracers for imaging of vascular targets in angiogenesis-related diseases. </span><span class="cited-content_cbyCitation_journal-name">Advanced Drug Delivery Reviews</span><span> <strong>2014,</strong> <em>76 </em>, 2-20. <a href="https://doi.org/10.1016/j.addr.2014.07.011" title="DOI URL">https://doi.org/10.1016/j.addr.2014.07.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.addr.2014.07.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.addr.2014.07.011%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Drug%2520Delivery%2520Reviews%26atitle%3DNew%252Bradiotracers%252Bfor%252Bimaging%252Bof%252Bvascular%252Btargets%252Bin%252Bangiogenesis-related%252Bdiseases%26aulast%3DHong%26aufirst%3DHao%26date%3D2014%26volume%3D76%26spage%3D2%26epage%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hsiao-Chun  Wang</span>, <span class="hlFld-ContribAuthor ">Ajit Dhananjay  Jagtap</span>, <span class="hlFld-ContribAuthor ">Pei-Teh  Chang</span>, <span class="hlFld-ContribAuthor ">Jia-Rong  Liu</span>, <span class="hlFld-ContribAuthor ">Chih-Peng  Liu</span>, <span class="hlFld-ContribAuthor ">Hsiang-Wen  Tseng</span>, <span class="hlFld-ContribAuthor ">Grace Shiahuy  Chen</span>, <span class="hlFld-ContribAuthor ">Ji-Wang  Chern</span>. </span><span class="cited-content_cbyCitation_article-title">Bioisosteric replacement of an acylureido moiety attached to an indolin-2-one scaffold with a malonamido or a 2/4-pyridinoylamido moiety produces a selectively potent Aurora-B inhibitor. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>84 </em>, 312-334. <a href="https://doi.org/10.1016/j.ejmech.2014.07.033" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.07.033</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.07.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.07.033%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DBioisosteric%252Breplacement%252Bof%252Ban%252Bacylureido%252Bmoiety%252Battached%252Bto%252Ban%252Bindolin-2-one%252Bscaffold%252Bwith%252Ba%252Bmalonamido%252Bor%252Ba%252B2%25252F4-pyridinoylamido%252Bmoiety%252Bproduces%252Ba%252Bselectively%252Bpotent%252BAurora-B%252Binhibitor%26aulast%3DWang%26aufirst%3DHsiao-Chun%26date%3D2014%26volume%3D84%26spage%3D312%26epage%3D334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anugula  Nagaraju</span>, <span class="hlFld-ContribAuthor ">Gaurav  Shukla</span>, <span class="hlFld-ContribAuthor ">Abhijeet  Srivastava</span>, <span class="hlFld-ContribAuthor ">B. Janaki  Ramulu</span>, <span class="hlFld-ContribAuthor ">Girijesh Kumar  Verma</span>, <span class="hlFld-ContribAuthor ">Keshav  Raghuvanshi</span>, <span class="hlFld-ContribAuthor ">Maya Shankar  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">Easy access to α-hydroxyimino-β-oxodithioesters and application towards the synthesis of diverse 1,4-thiazine-3-ones via reduction/annulation cascade. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2014,</strong> <em>70 </em>
                                    (23)
                                     , 3740-3746. <a href="https://doi.org/10.1016/j.tet.2014.03.097" title="DOI URL">https://doi.org/10.1016/j.tet.2014.03.097</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2014.03.097&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2014.03.097%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DEasy%252Baccess%252Bto%252B%2525CE%2525B1-hydroxyimino-%2525CE%2525B2-oxodithioesters%252Band%252Bapplication%252Btowards%252Bthe%252Bsynthesis%252Bof%252Bdiverse%252B1%25252C4-thiazine-3-ones%252Bvia%252Breduction%25252Fannulation%252Bcascade%26aulast%3DNagaraju%26aufirst%3DAnugula%26date%3D2014%26volume%3D70%26issue%3D23%26spage%3D3740%26epage%3D3746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Neeta K.  Venepalli</span>, <span class="hlFld-ContribAuthor ">Laura  Goff</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting the HGF-cMET Axis in Hepatocellular Carcinoma. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Hepatology</span><span> <strong>2013,</strong> <em>2013 </em>, 1-11. <a href="https://doi.org/10.1155/2013/341636" title="DOI URL">https://doi.org/10.1155/2013/341636</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1155/2013/341636&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1155%2F2013%2F341636%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Hepatology%26atitle%3DTargeting%252Bthe%252BHGF-cMET%252BAxis%252Bin%252BHepatocellular%252BCarcinoma%26aulast%3DVenepalli%26aufirst%3DNeeta%2BK.%26date%3D2013%26volume%3D2013%26spage%3D1%26epage%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fabiola  Cecchi</span>, <span class="hlFld-ContribAuthor ">Daniel C  Rabe</span>, <span class="hlFld-ContribAuthor ">Donald P  Bottaro</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting the HGF/Met signaling pathway in cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Targets</span><span> <strong>2012,</strong> <em>16 </em>
                                    (6)
                                     , 553-572. <a href="https://doi.org/10.1517/14728222.2012.680957" title="DOI URL">https://doi.org/10.1517/14728222.2012.680957</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/14728222.2012.680957&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F14728222.2012.680957%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Targets%26atitle%3DTargeting%252Bthe%252BHGF%25252FMet%252Bsignaling%252Bpathway%252Bin%252Bcancer%252Btherapy%26aulast%3DCecchi%26aufirst%3DFabiola%26date%3D2012%26date%3D2012%26volume%3D16%26issue%3D6%26spage%3D553%26epage%3D572" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yan  Feng</span>, <span class="hlFld-ContribAuthor ">Praveena S.  Thiagarajan</span>, <span class="hlFld-ContribAuthor ">Patrick C.  Ma</span>. </span><span class="cited-content_cbyCitation_article-title">MET Signaling: Novel Targeted Inhibition and Its Clinical Development in Lung Cancer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Thoracic Oncology</span><span> <strong>2012,</strong> <em>7 </em>
                                    (2)
                                     , 459-467. <a href="https://doi.org/10.1097/JTO.0b013e3182417e44" title="DOI URL">https://doi.org/10.1097/JTO.0b013e3182417e44</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1097/JTO.0b013e3182417e44&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1097%2FJTO.0b013e3182417e44%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Thoracic%2520Oncology%26atitle%3DMET%252BSignaling%25253A%252BNovel%252BTargeted%252BInhibition%252Band%252BIts%252BClinical%252BDevelopment%252Bin%252BLung%252BCancer%26aulast%3DFeng%26aufirst%3DYan%26date%3D2012%26volume%3D7%26issue%3D2%26spage%3D459%26epage%3D467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yanni  Hu</span>, <span class="hlFld-ContribAuthor ">Mei  Tian</span>, <span class="hlFld-ContribAuthor ">Hong  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular Imaging in Therapeutic Efficacy Assessment of Targeted Therapy for Nonsmall Cell Lung Cancer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomedicine and Biotechnology</span><span> <strong>2012,</strong> <em>2012 </em>, 1-10. <a href="https://doi.org/10.1155/2012/419402" title="DOI URL">https://doi.org/10.1155/2012/419402</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1155/2012/419402&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1155%2F2012%2F419402%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomedicine%2520and%2520Biotechnology%26atitle%3DMolecular%252BImaging%252Bin%252BTherapeutic%252BEfficacy%252BAssessment%252Bof%252BTargeted%252BTherapy%252Bfor%252BNonsmall%252BCell%252BLung%252BCancer%26aulast%3DHu%26aufirst%3DYanni%26date%3D2012%26volume%3D2012%26spage%3D1%26epage%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yan  Feng</span>, <span class="hlFld-ContribAuthor ">Patrick C.  Ma</span>. </span><span class="cited-content_cbyCitation_article-title">Anti-MET Targeted Therapy Has Come of Age: The First Durable Complete Response with MetMAb in Metastatic Gastric Cancer: Figure 1.. </span><span class="cited-content_cbyCitation_journal-name">Cancer Discovery</span><span> <strong>2011,</strong> <em>1 </em>
                                    (7)
                                     , 550-554. <a href="https://doi.org/10.1158/2159-8290.CD-11-0289" title="DOI URL">https://doi.org/10.1158/2159-8290.CD-11-0289</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/2159-8290.CD-11-0289&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F2159-8290.CD-11-0289%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Discovery%26atitle%3DAnti-MET%252BTargeted%252BTherapy%252BHas%252BCome%252Bof%252BAge%25253A%252BThe%252BFirst%252BDurable%252BComplete%252BResponse%252Bwith%252BMetMAb%252Bin%252BMetastatic%252BGastric%252BCancer%25253A%252BFigure%252B1.%26aulast%3DFeng%26aufirst%3DYan%26date%3D2011%26date%3D2011%26volume%3D1%26issue%3D7%26spage%3D550%26epage%3D554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ran  Yang</span>, <span class="hlFld-ContribAuthor ">Qingwen  Wang</span>, <span class="hlFld-ContribAuthor ">Huajin  Zeng</span>, <span class="hlFld-ContribAuthor ">Zao  Qin</span>, <span class="hlFld-ContribAuthor ">Jianjun  Li</span>, <span class="hlFld-ContribAuthor ">Lingbo  Qu</span>. </span><span class="cited-content_cbyCitation_article-title">Determination of puerarin in biological samples and its application to a pharmacokinetic study by flow-injection chemiluminescence. </span><span class="cited-content_cbyCitation_journal-name">Luminescence</span><span> <strong>2011,</strong> <em>26 </em>
                                    (5)
                                     , 368-373. <a href="https://doi.org/10.1002/bio.1281" title="DOI URL">https://doi.org/10.1002/bio.1281</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/bio.1281&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fbio.1281%26sid%3Dliteratum%253Aachs%26jtitle%3DLuminescence%26atitle%3DDetermination%252Bof%252Bpuerarin%252Bin%252Bbiological%252Bsamples%252Band%252Bits%252Bapplication%252Bto%252Ba%252Bpharmacokinetic%252Bstudy%252Bby%252Bflow-injection%252Bchemiluminescence%26aulast%3DYang%26aufirst%3DRan%26date%3D2011%26date%3D2011%26volume%3D26%26issue%3D5%26spage%3D368%26epage%3D373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Justin W.  Hicks</span>, <span class="hlFld-ContribAuthor ">Henry F.  VanBrocklin</span>, <span class="hlFld-ContribAuthor ">Alan A.  Wilson</span>, <span class="hlFld-ContribAuthor ">Sylvain  Houle</span>, <span class="hlFld-ContribAuthor ">Neil  Vasdev</span>. </span><span class="cited-content_cbyCitation_article-title">Radiolabeled Small Molecule Protein Kinase Inhibitors for Imaging with PET or SPECT. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2010,</strong> <em>15 </em>
                                    (11)
                                     , 8260-8278. <a href="https://doi.org/10.3390/molecules15118260" title="DOI URL">https://doi.org/10.3390/molecules15118260</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules15118260&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules15118260%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DRadiolabeled%252BSmall%252BMolecule%252BProtein%252BKinase%252BInhibitors%252Bfor%252BImaging%252Bwith%252BPET%252Bor%252BSPECT%26aulast%3DHicks%26aufirst%3DJustin%2BW.%26date%3D2010%26date%3D2010%26volume%3D15%26issue%3D11%26spage%3D8260%26epage%3D8278" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm900803q/production/images/medium/jm-2009-00803q_0005.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm900803q/production/images/large/jm-2009-00803q_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900803q&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm900803q/production/images/medium/jm-2009-00803q_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm900803q/production/images/large/jm-2009-00803q_0001.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. [<sup>11</sup>C]<b>14</b>-PET imaging of lung cancer xenografts. Coronal micro-PET images of nude mouse pair xenografted with NCI-H520 (animal on the left) and NCI-H1975 (animal on the right). Mice were injected with 18.5 MBq of [<sup>11</sup>C]<b>14</b> via the tail vein, and dynamic scanning was performed for 90 min thereafter as detailed in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. Image planes have been chosen for illustration where both the left and right tumors are visible. The locations of the lung cancer tumor xenografts are highlighted by yellow arrows.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm900803q/production/images/large/jm-2009-00803q_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900803q&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm900803q/production/images/medium/jm-2009-00803q_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm900803q/production/images/large/jm-2009-00803q_0006.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of the <sup>11</sup>C Radiolabeling Precursor <b>13</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm900803q/production/images/large/jm-2009-00803q_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900803q&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm900803q/production/images/medium/jm-2009-00803q_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm900803q/production/images/large/jm-2009-00803q_0007.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Radiosynthesis of [<sup>11</sup>C]<b>14</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm900803q/production/images/large/jm-2009-00803q_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900803q&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm900803q/production/images/medium/jm-2009-00803q_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm900803q/production/images/large/jm-2009-00803q_0002.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Pharmacokinetic profile of [<sup><b>11</b></sup>C]<b>14</b>-PET imaging of lung cancer xenografts. The average radioactivity−time curve in terms of SUV during the time period of [<sup>11</sup>C]<b>14</b>-PET imaging of each of the lung cancer xenografts was plotted as illustrated. The radiotracer uptake level in NCI-H1975 xenograft is higher than that in the control xenograft NCI-H520 (<i>p</i> = 0.000 19). Regions of interest were manually drawn by creating a volume of interest in the tumor region based on MR images. <i>p</i> < 0.05 indicates statistical significance.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm900803q/production/images/large/jm-2009-00803q_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900803q&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm900803q/production/images/medium/jm-2009-00803q_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm900803q/production/images/large/jm-2009-00803q_0003.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Murine xenograft models of human NCI-H1975 and NCI-H520 lung cancer cell lines. Expression of MET and EGFR in the NCI-H1975 and NCI-H520 human lung cancer cell lines is shown here. The two lung cancer cell lines were cultured in regular growth media in cell culture, with the cell lysates collected for SDS−PAGE and immunoblotting using phospho-MET and total MET antibodies as described in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. Immunoblotting using antiphospho-EGFR and anti-EGFR antibodies was also performed for comparison. Actin antibody was used as a protein loading control. H&E staining of the xenografts is also shown here (40X).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm900803q/production/images/large/jm-2009-00803q_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900803q&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm900803q/production/images/medium/jm-2009-00803q_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm900803q/production/images/large/jm-2009-00803q_0004.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Immunohistochemical analysis of MET receptor expression in tumor xenograft of human lung cancer (NCI-H1975 and H520) in vivo. The expression of MET receptor in the lung cancer xenografts established was evaluated using immunohistochemistry of the xenograft formalin-fixed paraffin-embedded sections using anti-MET primary antibody as described in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-1/jm900803q/production/images/large/jm-2009-00803q_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900803q&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i29">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40853" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40853" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 44 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Sun, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiller, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spinola, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minna, J. D.</span><span> </span><span class="NLM_article-title">New molecularly targeted therapies for lung cancer</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">2740</span><span class="NLM_x">–</span> <span class="NLM_lpage">2750</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2007&pages=2740-2750&author=S.+Sunauthor=J.+H.+Schillerauthor=M.+Spinolaauthor=J.+D.+Minna&title=New+molecularly+targeted+therapies+for+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DS.%26aulast%3DSchiller%26aufirst%3DJ.%2BH.%26aulast%3DSpinola%26aufirst%3DM.%26aulast%3DMinna%26aufirst%3DJ.%2BD.%26atitle%3DNew%2520molecularly%2520targeted%2520therapies%2520for%2520lung%2520cancer%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2007%26volume%3D117%26spage%3D2740%26epage%3D2750" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Savage, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antman, K. H.</span><span> </span><span class="NLM_article-title">Imatinib mesylate—a new oral targeted therapy</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">346</span><span class="NLM_x">, </span> <span class="NLM_fpage">683</span><span class="NLM_x">–</span> <span class="NLM_lpage">693</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm900803q&amp;key=10.1056%2FNEJMra013339" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm900803q&amp;key=11870247" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm900803q&amp;key=1%3ACAS%3A528%3ADC%252BD38XhsFOjsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=346&publication_year=2002&pages=683-693&author=D.+G.+Savageauthor=K.+H.+Antman&title=Imatinib+mesylate%E2%80%94a+new+oral+targeted+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Imatinib mesylate - a new oral targeted therapy</span></div><div class="casAuthors">Savage, David G.; Antman, Karen H.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">346</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">683-693</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review.  Imatinib mesylate is an inhibitor of specific protein Tyr kinases that was targeted to the platelet-derived growth factor receptor.  It is highly active and has an acceptable level of toxicity when given alone for the treatment of chronic-phase chronic myelogenous leukemia (CML) and gastrointestinal stromal tumors.  Imatinib has also limited activity against blast-phase CML and relapsed Philadelphia-chromosome-pos. acute lymphoblastic leukemia, conditions resistant to std. chemotherapy and even to allogeneic stem cell transplantation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXP-6mujVB5LVg90H21EOLACvtfcHk0ljEmctY6quiwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhsFOjsro%253D&md5=2274455b28cbb1642b4f1282acc1c42c</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1056%2FNEJMra013339&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra013339%26sid%3Dliteratum%253Aachs%26aulast%3DSavage%26aufirst%3DD.%2BG.%26aulast%3DAntman%26aufirst%3DK.%2BH.%26atitle%3DImatinib%2520mesylate%25E2%2580%2594a%2520new%2520oral%2520targeted%2520therapy%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2002%26volume%3D346%26spage%3D683%26epage%3D693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Ryan, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ibrahim, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ko, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sridhara, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Justice, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pazdur, R.</span><span> </span><span class="NLM_article-title">FDA drug approval summary: lapatinib in combination with capecitabine for previously treated metastatic breast cancer that overexpresses HER-2</span> <span class="citation_source-journal">Oncologist</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1114</span><span class="NLM_x">–</span> <span class="NLM_lpage">1119</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=1114-1119&author=Q.+Ryanauthor=A.+Ibrahimauthor=M.+H.+Cohenauthor=J.+Johnsonauthor=C.+W.+Koauthor=R.+Sridharaauthor=R.+Justiceauthor=R.+Pazdur&title=FDA+drug+approval+summary%3A+lapatinib+in+combination+with+capecitabine+for+previously+treated+metastatic+breast+cancer+that+overexpresses+HER-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRyan%26aufirst%3DQ.%26aulast%3DIbrahim%26aufirst%3DA.%26aulast%3DCohen%26aufirst%3DM.%2BH.%26aulast%3DJohnson%26aufirst%3DJ.%26aulast%3DKo%26aufirst%3DC.%2BW.%26aulast%3DSridhara%26aufirst%3DR.%26aulast%3DJustice%26aufirst%3DR.%26aulast%3DPazdur%26aufirst%3DR.%26atitle%3DFDA%2520drug%2520approval%2520summary%253A%2520lapatinib%2520in%2520combination%2520with%2520capecitabine%2520for%2520previously%2520treated%2520metastatic%2520breast%2520cancer%2520that%2520overexpresses%2520HER-2%26jtitle%3DOncologist%26date%3D2008%26volume%3D13%26spage%3D1114%26epage%3D1119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Goodman, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rock, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dagher, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramchandani, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobburu, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Booth, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verbois, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morse, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chidambaram, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, J. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahjoob, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Justice, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pazdur, R.</span><span> </span><span class="NLM_article-title">Approval summary: sunitinib for the treatment of imatinib refractory or intolerant gastrointestinal stromal tumors and advanced renal cell carcinoma</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1367</span><span class="NLM_x">–</span> <span class="NLM_lpage">1373</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm900803q&amp;key=10.1158%2F1078-0432.CCR-06-2328" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm900803q&amp;key=17332278" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm900803q&amp;key=1%3ACAS%3A528%3ADC%252BD2sXitlSjsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=1367-1373&author=V.+L.+Goodmanauthor=E.+P.+Rockauthor=R.+Dagherauthor=R.+P.+Ramchandaniauthor=S.+Abrahamauthor=J.+V.+Gobburuauthor=B.+P.+Boothauthor=S.+L.+Verboisauthor=D.+E.+Morseauthor=C.+Y.+Liangauthor=N.+Chidambaramauthor=J.+X.+Jiangauthor=S.+Tangauthor=K.+Mahjoobauthor=R.+Justiceauthor=R.+Pazdur&title=Approval+summary%3A+sunitinib+for+the+treatment+of+imatinib+refractory+or+intolerant+gastrointestinal+stromal+tumors+and+advanced+renal+cell+carcinoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Approval Summary: Sunitinib for the Treatment of Imatinib Refractory or Intolerant Gastrointestinal Stromal Tumors and Advanced Renal Cell Carcinoma</span></div><div class="casAuthors">Goodman, Vicki L.; Rock, Edwin P.; Dagher, Ramzi; Ramchandani, Roshni P.; Abraham, Sophia; Gobburu, Jogarao V. S.; Booth, Brian P.; Verbois, S. Leigh; Morse, David E.; Liang, Cheng Yi; Chidambaram, Nallaperumal; Jiang, Janet X.; Tang, Shenghui; Mahjoob, Kooros; Justice, Robert; Pazdur, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1367-1373</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Purpose: To describe the Food and Drug Administration (FDA) review and approval of sunitinib malate (Sutent).  Sunitinib received regular approval for the treatment of gastrointestinal stromal tumor (GIST) after disease progression or intolerance to imatinib mesylate (Gleevec).  Addnl., sunitinib received accelerated approval for the treatment of advanced renal cell carcinoma.  Exptl. Design: For the GIST indication, FDA reviewed data from a randomized, placebo-controlled trial with supportive evidence from a single-arm study.  For the advanced renal cell carcinoma indication, FDA reviewed data from two single-arm studies of patients with cytokine-refractory metastatic renal cell carcinoma.  Results: In patients with imatinib refractory or intolerant GIST, time-to-tumor progression of sunitinib-treated patients was superior to that of placebo-treated patients.  Median time-to-tumor progression of sunitinib-treated patients was 27.3 wk, compared with 6.4 wk for placebo-treated patients (P < 0.0001).  Partial responses were obsd. in 6.8% of sunitinib-treated patients.  In patients with metastatic renal cell carcinoma, partial responses were obsd. in 25.5% (95% confidence interval, 17.5, 34.9) and 36.5% (95% confidence interval, 24.7, 49.6) of patients treated with sunitinib. Median response durations were 27.1 and 54 wk.  The most common adverse events attributed to sunitinib included diarrhea, mucositis, skin abnormalities, and altered taste.  Redns. in left ventricular ejection fraction and severe hypertension were also more common in sunitinib-treated patients.  Conclusions: On Jan. 26, 2006, the FDA approved sunitinib for the treatment of patients with imatinib refractory or intolerant GIST.  Accelerated approval was granted for the treatment of advanced renal cell carcinoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphXuKPm_-9xrVg90H21EOLACvtfcHk0ljEmctY6quiwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXitlSjsbc%253D&md5=baa2be61674d19588b831222672f13f5</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-06-2328&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-06-2328%26sid%3Dliteratum%253Aachs%26aulast%3DGoodman%26aufirst%3DV.%2BL.%26aulast%3DRock%26aufirst%3DE.%2BP.%26aulast%3DDagher%26aufirst%3DR.%26aulast%3DRamchandani%26aufirst%3DR.%2BP.%26aulast%3DAbraham%26aufirst%3DS.%26aulast%3DGobburu%26aufirst%3DJ.%2BV.%26aulast%3DBooth%26aufirst%3DB.%2BP.%26aulast%3DVerbois%26aufirst%3DS.%2BL.%26aulast%3DMorse%26aufirst%3DD.%2BE.%26aulast%3DLiang%26aufirst%3DC.%2BY.%26aulast%3DChidambaram%26aufirst%3DN.%26aulast%3DJiang%26aufirst%3DJ.%2BX.%26aulast%3DTang%26aufirst%3DS.%26aulast%3DMahjoob%26aufirst%3DK.%26aulast%3DJustice%26aufirst%3DR.%26aulast%3DPazdur%26aufirst%3DR.%26atitle%3DApproval%2520summary%253A%2520sunitinib%2520for%2520the%2520treatment%2520of%2520imatinib%2520refractory%2520or%2520intolerant%2520gastrointestinal%2520stromal%2520tumors%2520and%2520advanced%2520renal%2520cell%2520carcinoma%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2007%26volume%3D13%26spage%3D1367%26epage%3D1373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Wilhelm, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowinger, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simantov, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelley, S.</span><span> </span><span class="NLM_article-title">Discovery and development of sorafenib: a multikinase inhibitor for treating cancer</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">835</span><span class="NLM_x">–</span> <span class="NLM_lpage">844</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm900803q&amp;key=10.1038%2Fnrd2130" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm900803q&amp;key=17016424" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm900803q&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVajsbbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=835-844&author=S.+Wilhelmauthor=C.+Carterauthor=M.+Lynchauthor=T.+Lowingerauthor=J.+Dumasauthor=R.+A.+Smithauthor=B.+Schwartzauthor=R.+Simantovauthor=S.+Kelley&title=Discovery+and+development+of+sorafenib%3A+a+multikinase+inhibitor+for+treating+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and development of sorafenib: a multikinase inhibitor for treating cancer</span></div><div class="casAuthors">Wilhelm, Scott; Carter, Christopher; Lynch, Mark; Lowinger, Timothy; Dumas, Jacques; Smith, Roger A.; Schwartz, Brian; Simantov, Ronit; Kelley, Susan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">835-844</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Since the mol. revolution of the 1980s, knowledge of the etiol. of cancer has increased considerably, which has led to the discovery and development of targeted therapies tailored to inhibit cancer-specific pathways.  The introduction and refinement of rapid, high-throughput screening technologies over the past decade has greatly facilitated this targeted discovery and development process.  Here, the authors describe the discovery and continuing development of sorafenib (previously known as BAY 43-9006), the first oral multikinase inhibitor that targets Raf and affects tumor signaling and the tumor vasculature.  The discovery cycle of sorafenib (Nexavar; Bayer Pharmaceuticals) - from initial screening for a lead compd. to FDA approval for the treatment of advanced renal cell carcinoma in Dec. 2005 - was completed in just 11 years, with approval being received ∼5 years after the initiation of the first Phase I trial.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6WjjfgNSCtbVg90H21EOLACvtfcHk0ljXM6tz3dxP9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVajsbbM&md5=490d4995170f3a7270ae9bbdd24b12e5</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnrd2130&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2130%26sid%3Dliteratum%253Aachs%26aulast%3DWilhelm%26aufirst%3DS.%26aulast%3DCarter%26aufirst%3DC.%26aulast%3DLynch%26aufirst%3DM.%26aulast%3DLowinger%26aufirst%3DT.%26aulast%3DDumas%26aufirst%3DJ.%26aulast%3DSmith%26aufirst%3DR.%2BA.%26aulast%3DSchwartz%26aufirst%3DB.%26aulast%3DSimantov%26aufirst%3DR.%26aulast%3DKelley%26aufirst%3DS.%26atitle%3DDiscovery%2520and%2520development%2520of%2520sorafenib%253A%2520a%2520multikinase%2520inhibitor%2520for%2520treating%2520cancer%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2006%26volume%3D5%26spage%3D835%26epage%3D844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Birchmeier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birchmeier, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gherardi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vande Woude, G. F.</span><span> </span><span class="NLM_article-title">Met, metastasis, motility and more</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">915</span><span class="NLM_x">–</span> <span class="NLM_lpage">925</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm900803q&amp;key=10.1038%2Fnrm1261" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm900803q&amp;key=14685170" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm900803q&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpvFeju7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2003&pages=915-925&author=C.+Birchmeierauthor=W.+Birchmeierauthor=E.+Gherardiauthor=G.+F.+Vande+Woude&title=Met%2C+metastasis%2C+motility+and+more"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Met, metastasis, motility and more</span></div><div class="casAuthors">Birchmeier, Carmen; Birhcmeier, Walter; Gherardi, Ermanno; Vande Woude, George F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">915-925</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Hepatocyte growth factor. scatter factor and its receptor, the tyrosine kinase Met, arose late in evolution and are unique to vertebrates.  In spite of this, Met uses mols. such as Gab1 - homologues of which are present in Caenorhabditis elegans and Drosophila melanogaster - for downstream signalling. Pivotal roles for Met in development and cancer have been established: Met controls cell migration and growth in embryogenesis; it also controls growth, invasion and metastasis in cancer cells; and activating Met mutations predispose to human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoG_-6XRpZ-sLVg90H21EOLACvtfcHk0ljXM6tz3dxP9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpvFeju7s%253D&md5=ff5a02c73415784480c628fe65299a81</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnrm1261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm1261%26sid%3Dliteratum%253Aachs%26aulast%3DBirchmeier%26aufirst%3DC.%26aulast%3DBirchmeier%26aufirst%3DW.%26aulast%3DGherardi%26aufirst%3DE.%26aulast%3DVande%2BWoude%26aufirst%3DG.%2BF.%26atitle%3DMet%252C%2520metastasis%252C%2520motility%2520and%2520more%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2003%26volume%3D4%26spage%3D915%26epage%3D925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Ma, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maulik, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salgia, R.</span><span> </span><span class="NLM_article-title">c-Met: structure, functions and potential for therapeutic inhibition</span> <span class="citation_source-journal">Cancer Metastasis Rev</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">309</span><span class="NLM_x">–</span> <span class="NLM_lpage">325</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm900803q&amp;key=10.1023%2FA%3A1023768811842" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm900803q&amp;key=12884908" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm900803q&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjslyiurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=309-325&author=P.+C.+Maauthor=G.+Maulikauthor=J.+Christensenauthor=R.+Salgia&title=c-Met%3A+structure%2C+functions+and+potential+for+therapeutic+inhibition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">c-Met: Structure, functions and potential for therapeutic inhibition</span></div><div class="casAuthors">Ma, Patrick C.; Maulik, Gautam; Christensen, James; Salgia, Ravi</div><div class="citationInfo"><span class="NLM_cas:title">Cancer and Metastasis Reviews</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">309-325</span>CODEN:
                <span class="NLM_cas:coden">CMRED4</span>;
        ISSN:<span class="NLM_cas:issn">0167-7659</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic Publishers</span>)
        </div><div class="casAbstract">A review.  Studies on signal transduction pathways have generated various promising mol. targets for therapeutic inhibition in cancer therapy.  Receptor tyrosine kinases represent an important class of such therapeutic targets.  C-Met is a receptor tyrosine kinase that has been shown to be overexpressed and/or mutated in a variety of malignancies.  A no. of c-Met activating mutations, many of which are located in the tyrosine kinase domain, have been detected in various solid tumors and have been implicated in invasion and metastasis of tumor cells.  It is known that stimulation of c-Met via its natural ligand, hepatocyte growth factor (also known as scatter factor, HGF/SF) results in a plethora of biol. and biochem. effects in the cell.  Activation of c-Met signaling can lead to scattering, angiogenesis, proliferation, enhanced cell motility, invasion, and eventual metastasis.  In this review, the role of c-Met dysregulation in tumor progression and metastasis is discussed in detail with particular emphasis on c-Met mutations.  Moreover, we summarize current knowledge on various pathways of c-Met signal transduction, highlighting the central role in the cytoskeletal functions.  In this summary is included recent data in our lab. indicating that phosphorylation of focal adhesion proteins, such as paxillin, p125FAK, and PYK2, occurs in response to c-Met stimulation in lung cancer cells.  Most importantly, current data on c-Met suggest that when mutated or overexpressed in malignant cells, c-Met would serve as an important therapeutic target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9rIdb5Ao4a7Vg90H21EOLACvtfcHk0lixSKYgXodJpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjslyiurY%253D&md5=7b7bf60da872071a39ce313efd32fd1f</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1023%2FA%3A1023768811842&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1023768811842%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DP.%2BC.%26aulast%3DMaulik%26aufirst%3DG.%26aulast%3DChristensen%26aufirst%3DJ.%26aulast%3DSalgia%26aufirst%3DR.%26atitle%3Dc-Met%253A%2520structure%252C%2520functions%2520and%2520potential%2520for%2520therapeutic%2520inhibition%26jtitle%3DCancer%2520Metastasis%2520Rev%26date%3D2003%26volume%3D22%26spage%3D309%26epage%3D325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Birchmeier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gherardi, E.</span><span> </span><span class="NLM_article-title">Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase</span> <span class="citation_source-journal">Trends Cell Biol</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">404</span><span class="NLM_x">–</span> <span class="NLM_lpage">410</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm900803q&amp;key=10.1016%2FS0962-8924%2898%2901359-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm900803q&amp;key=9789329" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm900803q&amp;key=1%3ACAS%3A528%3ADyaK1cXmvFWjur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1998&pages=404-410&author=C.+Birchmeierauthor=E.+Gherardi&title=Developmental+roles+of+HGF%2FSF+and+its+receptor%2C+the+c-Met+tyrosine+kinase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase</span></div><div class="casAuthors">Birchmeier, Carmen; Gherardi, Ermanno</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Cell Biology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">404-410</span>CODEN:
                <span class="NLM_cas:coden">TCBIEK</span>;
        ISSN:<span class="NLM_cas:issn">0962-8924</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review with 60 refs., discussing the main features of HGF/SF and its receptor, the product of the c-met protooncogene, and their role in embryogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4W8ZYocgc4bVg90H21EOLACvtfcHk0lixSKYgXodJpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmvFWjur8%253D&md5=5e0560f3eae9ddd2931cbe3d3a84d555</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2FS0962-8924%2898%2901359-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0962-8924%252898%252901359-2%26sid%3Dliteratum%253Aachs%26aulast%3DBirchmeier%26aufirst%3DC.%26aulast%3DGherardi%26aufirst%3DE.%26atitle%3DDevelopmental%2520roles%2520of%2520HGF%252FSF%2520and%2520its%2520receptor%252C%2520the%2520c-Met%2520tyrosine%2520kinase%26jtitle%3DTrends%2520Cell%2520Biol%26date%3D1998%26volume%3D8%26spage%3D404%26epage%3D410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Rosario, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birchmeier, W.</span><span> </span><span class="NLM_article-title">How to make tubes: signaling by the Met receptor tyrosine kinase</span> <span class="citation_source-journal">Trends Cell Biol</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">328</span><span class="NLM_x">–</span> <span class="NLM_lpage">335</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm900803q&amp;key=10.1016%2FS0962-8924%2803%2900104-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm900803q&amp;key=12791299" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm900803q&amp;key=1%3ACAS%3A528%3ADC%252BD3sXkt1aqsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=328-335&author=M.+Rosarioauthor=W.+Birchmeier&title=How+to+make+tubes%3A+signaling+by+the+Met+receptor+tyrosine+kinase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">How to make tubes: signaling by the Met receptor tyrosine kinase</span></div><div class="casAuthors">Rosario, Marta; Birchmeier, Walter</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Cell Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">328-335</span>CODEN:
                <span class="NLM_cas:coden">TCBIEK</span>;
        ISSN:<span class="NLM_cas:issn">0962-8924</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Hepatocyte growth factor/scatter factor (HGF/SF), acting through the receptor tyrosine kinase Met, stimulates cells derived from a variety of different organs to form elongated hollow tubules when grown in 3-dimensional gels.  In vivo data also indicate a role for HGF/SF and Met in tubule formation during liver and kidney regeneration and mammary gland formation.  Activation of Met results in the recruitment of a myriad of signal transducers that regulate dissocn. of adherens junctions and the stimulation of cellular motility, survival, proliferation, and morphogenesis during tubule formation.  Among these many signal transducers, the Gab1 adaptor protein and its effector, the SHP2 tyrosine phosphatase, have been found to be crucial for tubulogenesis and for the sustained stimulation of the ERK/MAP kinase pathway.  Here, we discuss the contribution of these and other signaling pathways and the role of HGF/SF and Met in the formation of epithelial cell tubules both in vitro in branching-morphogenesis assays and in vivo during organogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGommZXQu8RmWLVg90H21EOLACvtfcHk0lixSKYgXodJpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXkt1aqsrw%253D&md5=e08657de76e99d6c71ce3c4753ffd900</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2FS0962-8924%2803%2900104-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0962-8924%252803%252900104-1%26sid%3Dliteratum%253Aachs%26aulast%3DRosario%26aufirst%3DM.%26aulast%3DBirchmeier%26aufirst%3DW.%26atitle%3DHow%2520to%2520make%2520tubes%253A%2520signaling%2520by%2520the%2520Met%2520receptor%2520tyrosine%2520kinase%26jtitle%3DTrends%2520Cell%2520Biol%26date%3D2003%26volume%3D13%26spage%3D328%26epage%3D335" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Dietrich, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uppalapati, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seiwert, T. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, P. C.</span><span> </span><span class="NLM_article-title">Role of c-MET in upper aerodigestive malignancies—from biology to novel therapies</span> <span class="citation_source-journal">J. Environ. Pathol., Toxicol. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">149</span><span class="NLM_x">–</span> <span class="NLM_lpage">162</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2005&pages=149-162&author=S.+Dietrichauthor=R.+Uppalapatiauthor=T.+Y.+Seiwertauthor=P.+C.+Ma&title=Role+of+c-MET+in+upper+aerodigestive+malignancies%E2%80%94from+biology+to+novel+therapies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDietrich%26aufirst%3DS.%26aulast%3DUppalapati%26aufirst%3DR.%26aulast%3DSeiwert%26aufirst%3DT.%2BY.%26aulast%3DMa%26aufirst%3DP.%2BC.%26atitle%3DRole%2520of%2520c-MET%2520in%2520upper%2520aerodigestive%2520malignancies%25E2%2580%2594from%2520biology%2520to%2520novel%2520therapies%26jtitle%3DJ.%2520Environ.%2520Pathol.%252C%2520Toxicol.%2520Oncol.%26date%3D2005%26volume%3D24%26spage%3D149%26epage%3D162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Sattler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pride, Y. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gramlich, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinnan, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shirazian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podar, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salgia, R.</span><span> </span><span class="NLM_article-title">A novel small molecule met inhibitor induces apoptosis in cells transformed by the oncogenic TPR-MET tyrosine kinase</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">5462</span><span class="NLM_x">–</span> <span class="NLM_lpage">5469</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm900803q&amp;key=14500382" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm900803q&amp;key=1%3ACAS%3A528%3ADC%252BD3sXntleku7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=5462-5469&author=M.+Sattlerauthor=Y.+B.+Prideauthor=P.+Maauthor=J.+L.+Gramlichauthor=S.+C.+Chuauthor=L.+A.+Quinnanauthor=S.+Shirazianauthor=C.+Liangauthor=K.+Podarauthor=J.+G.+Christensenauthor=R.+Salgia&title=A+novel+small+molecule+met+inhibitor+induces+apoptosis+in+cells+transformed+by+the+oncogenic+TPR-MET+tyrosine+kinase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">A Novel Small Molecule Met Inhibitor Induces Apoptosis in Cells Transformed by the Oncogenic TPR-MET Tyrosine Kinase</span></div><div class="casAuthors">Sattler, Martin; Pride, Yuri B.; Ma, Patrick; Gramlich, Jessica L.; Chu, Stephanie C.; Quinnan, Laura A.; Shirazian, Sheri; Liang, Congxin; Podar, Klaus; Christensen, James G.; Salgia, Ravi</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5462-5469</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The Met receptor tyrosine kinase has been shown to be overexpressed or mutated in a variety of solid tumors and has, therefore, been identified as a good candidate for molecularly targeted therapy.  Activation of the Met tyrosine kinase by the TPR gene was originally described in vitro through carcinogen-induced rearrangement.  The TPR-MET fusion protein contains constitutively elevated Met tyrosine kinase activity and constitutes an ideal model to study the transforming activity of the Met kinase.  We found, when introduced into an interleukin 3-dependent cell line, TPR-MET induces factor independence and constitutive tyrosine phosphorylation of several cellular proteins.  One major tyrosine phosphorylated protein was identified as the TPR-MET oncoprotein itself.  Inhibition of the Met kinase activity by the novel small mol. drug SU11274 [(3Z)-N-(3-chlorophenyl)-3-({3,5-dimethyl-4-[(4-methylpiperazin-1-yl)carbonyl]-1H-pyrrol-2-yl}methylene)-N-methyl-2-oxo-2,3-dihydro-1H-indole-5-sulfonamide] led to time- and dose-dependent reduced cell growth.  The inhibitor did not affect other tyrosine kinase oncoproteins, including BCR-ABL, TEL-JAK2, TEL-PDGFβR, or TEL-ABL.  The Met inhibitor induced G1 cell cycle arrest and apoptosis with increased Annexin V staining and caspase 3 activity.  The autophosphorylation of the Met kinase was reduced on sites that have been shown previously to be important for activation of pathways involved in cell growth and survival, esp. the phosphatidylinositol-3'-kinase and the Ras pathway.  In particular, we found that the inhibitor blocked phosphorylation of AKT, GSK-3β, and the pro-apoptotic transcription factor FKHR.  The characterization of SU11274 as an effective inhibitor of Met tyrosine kinase activity illustrates the potential of targeting for Met therapeutic use in cancers assocd. with activated forms of this kinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGvIwRT4z1IbVg90H21EOLACvtfcHk0lhGCrq3kg-U3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXntleku7s%253D&md5=3223841b665e6b95f3dab0f18ce64dbe</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSattler%26aufirst%3DM.%26aulast%3DPride%26aufirst%3DY.%2BB.%26aulast%3DMa%26aufirst%3DP.%26aulast%3DGramlich%26aufirst%3DJ.%2BL.%26aulast%3DChu%26aufirst%3DS.%2BC.%26aulast%3DQuinnan%26aufirst%3DL.%2BA.%26aulast%3DShirazian%26aufirst%3DS.%26aulast%3DLiang%26aufirst%3DC.%26aulast%3DPodar%26aufirst%3DK.%26aulast%3DChristensen%26aufirst%3DJ.%2BG.%26aulast%3DSalgia%26aufirst%3DR.%26atitle%3DA%2520novel%2520small%2520molecule%2520met%2520inhibitor%2520induces%2520apoptosis%2520in%2520cells%2520transformed%2520by%2520the%2520oncogenic%2520TPR-MET%2520tyrosine%2520kinase%26jtitle%3DCancer%2520Res.%26date%3D2003%26volume%3D63%26spage%3D5462%26epage%3D5469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Corso, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comoglio, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giordano, S.</span><span> </span><span class="NLM_article-title">Cancer therapy: can the challenge be MET?</span> <span class="citation_source-journal">Trends Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">284</span><span class="NLM_x">–</span> <span class="NLM_lpage">292</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=284-292&author=S.+Corsoauthor=P.+M.+Comoglioauthor=S.+Giordano&title=Cancer+therapy%3A+can+the+challenge+be+MET%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCorso%26aufirst%3DS.%26aulast%3DComoglio%26aufirst%3DP.%2BM.%26aulast%3DGiordano%26aufirst%3DS.%26atitle%3DCancer%2520therapy%253A%2520can%2520the%2520challenge%2520be%2520MET%253F%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2005%26volume%3D11%26spage%3D284%26epage%3D292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Eder, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vande Woude, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boerner, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LoRusso, P. M.</span><span> </span><span class="NLM_article-title">Novel therapeutic inhibitors of the c-Met signaling pathway in cancer</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2207</span><span class="NLM_x">–</span> <span class="NLM_lpage">2214</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm900803q&amp;key=10.1158%2F1078-0432.CCR-08-1306" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm900803q&amp;key=19318488" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm900803q&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjvVWltrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=2207-2214&author=J.+P.+Ederauthor=G.+F.+Vande+Woudeauthor=S.+A.+Boernerauthor=P.+M.+LoRusso&title=Novel+therapeutic+inhibitors+of+the+c-Met+signaling+pathway+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Therapeutic Inhibitors of the c-Met Signaling Pathway in Cancer</span></div><div class="casAuthors">Eder, Joseph Paul; Vande Woude, George F.; Boerner, Scott A.; Lo Russo, Patricia M.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2207-2214</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  A wide variety of human malignancies exhibit sustained c-Met stimulation, overexpression, or mutation, including carcinomas of the breast, liver, lung, ovary, kidney, and thyroid.  Notably, activating mutations in c-Met have been pos. identified in patients with a particular hereditary form of papillary renal cancer, directly implicating c-Met in human tumorigenesis.  Aberrant signaling of the c-Met signaling pathway due to dysregulation of the c-Met receptor or overexpression of its ligand, hepatocyte growth factor (HGF), has been assocd. with an aggressive phenotype.  Extensive evidence that c-Met signaling is involved in the progression and spread of several cancers and an enhanced understanding of its role in disease have generated considerable interest in c-Met and HGF as major targets in cancer drug development.  This has led to the development of a variety of c-Met pathway antagonists with potential clin. applications.  The three main approaches of pathway-selective anticancer drug development have included antagonism of ligand/receptor interaction, inhibition of the tyrosine kinase catalytic activity, and blockade of the receptor/effector interaction.  Several c-Met antagonists are now under clin. investigation.  Preliminary clin. results of several of these agents, including both monoclonal antibodies and small-mol. tyrosine kinase inhibitors, have been encouraging.  Several multitargeted therapies have also been under investigation in the clinic and have demonstrated promise, particularly with regard to tyrosine kinase inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9QBC0vQz8BrVg90H21EOLACvtfcHk0lhGCrq3kg-U3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjvVWltrY%253D&md5=48b4fc788b2b2cab1ce523047e33721d</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-08-1306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-08-1306%26sid%3Dliteratum%253Aachs%26aulast%3DEder%26aufirst%3DJ.%2BP.%26aulast%3DVande%2BWoude%26aufirst%3DG.%2BF.%26aulast%3DBoerner%26aufirst%3DS.%2BA.%26aulast%3DLoRusso%26aufirst%3DP.%2BM.%26atitle%3DNovel%2520therapeutic%2520inhibitors%2520of%2520the%2520c-Met%2520signaling%2520pathway%2520in%2520cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2009%26volume%3D15%26spage%3D2207%26epage%3D2214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Knudsen, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vande Woude, G.</span><span> </span><span class="NLM_article-title">Showering c-MET-dependent cancers with drugs</span> <span class="citation_source-journal">Curr. Opin. Genet. Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">87</span><span class="NLM_x">–</span> <span class="NLM_lpage">96</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm900803q&amp;key=10.1016%2Fj.gde.2008.02.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm900803q&amp;key=18406132" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm900803q&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmsVarur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=87-96&author=B.+S.+Knudsenauthor=G.+Vande+Woude&title=Showering+c-MET-dependent+cancers+with+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Showering c-MET-dependent cancers with drugs</span></div><div class="casAuthors">Knudsen, Beatrice S.; Vande Woude, George</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Genetics & Development</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">87-96</span>CODEN:
                <span class="NLM_cas:coden">COGDET</span>;
        ISSN:<span class="NLM_cas:issn">0959-437X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The receptor tyrosine kinase, c-MET and its ligand hepatocyte growth factor/scatter factor (HGF/SF) have become leading candidates for targeted cancer therapies.  Inappropriate c-MET signaling through autocrine, paracrine, amplification, and mutational activation occurs in virtually all types of solid tumors (http://www.vai.org/met), contributing to one or a combination of proliferative, invasive, survival, or angiogenic cancer phenotypes. c-MET and HGF/SF participate in all stages of malignant progression and represent promising drug targets in a variety of cancer types, including carcinomas, sarcomas, and brain tumors.  While many are in pre-clin. testing, a few inhibitors have entered clin. trials.  With hundreds of thousands of potential responding cancers that express c-MET, the interest in this mol. as a drug target is not surprising.  However, the cognate c-MET diagnostic tests lag behind.  In addn., despite the great enthusiasm based on response rates in phase I trials, there is a need for caution.  It is almost without question that combination therapies with c-MET-HGF/SF inhibitors will be required for most cancers to achieve a cytotoxic tumor response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonjBq7fWvKhrVg90H21EOLACvtfcHk0lhGCrq3kg-U3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmsVarur8%253D&md5=d0744275be94658bab067f20644c98d6</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.gde.2008.02.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.gde.2008.02.001%26sid%3Dliteratum%253Aachs%26aulast%3DKnudsen%26aufirst%3DB.%2BS.%26aulast%3DVande%2BWoude%26aufirst%3DG.%26atitle%3DShowering%2520c-MET-dependent%2520cancers%2520with%2520drugs%26jtitle%3DCurr.%2520Opin.%2520Genet.%2520Dev.%26date%3D2008%26volume%3D18%26spage%3D87%26epage%3D96" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Ma, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tretiakova, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nallasura, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jagadeeswaran, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Husain, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salgia, R.</span><span> </span><span class="NLM_article-title">Downstream signalling and specific inhibition of c-MET/HGF pathway in small cell lung cancer: implications for tumour invasion</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">368</span><span class="NLM_x">–</span> <span class="NLM_lpage">377</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm900803q&amp;key=10.1038%2Fsj.bjc.6603884" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm900803q&amp;key=17667909" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm900803q&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotlSgt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2007&pages=368-377&author=P.+C.+Maauthor=M.+S.+Tretiakovaauthor=V.+Nallasuraauthor=R.+Jagadeeswaranauthor=A.+N.+Husainauthor=R.+Salgia&title=Downstream+signalling+and+specific+inhibition+of+c-MET%2FHGF+pathway+in+small+cell+lung+cancer%3A+implications+for+tumour+invasion"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Downstream signalling and specific inhibition of c-MET/HGF pathway in small cell lung cancer: implications for tumor invasion</span></div><div class="casAuthors">Ma, P. C.; Tretiakova, M. S.; Nallasura, V.; Jagadeeswaran, R.; Husain, A. N.; Salgia, R.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">368-377</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The c-MET receptor can be overexpressed, amplified, or mutated in solid tumors including small cell lung cancer (SCLC).  In c-MET-overexpressing SCLC cell line NCI-H69, hepatocyte growth factor (HGF) dramatically induced c-MET phosphorylation at phosphoepitopes pY1230/1234/1235 (catalytic tyrosine kinase), pY1003 (juxtamembrane), and also of paxillin at pY31 (CRKL-binding site).  We utilized a global proteomics phosphoantibody array approach to identify further c-MET/HGF signal transduction intermediates in SCLC.  Strong HGF induction of specific phosphorylation sites in phosphoproteins involved in c-MET/HGF signal transduction was detected, namely adducin-α [S724], adducin-γ [S662], CREB [S133], ERK1 [T185/Y187], ERK1/2 [T202/Y204], ERK2 [T185/Y187], MAPKK (MEK) 1/2 [S221/S225], MAPKK (MEK) 3/6 [S189/S207], RB [S612], RB1 [S780], JNK [T183/Y185], STAT3 [S727], focal adhesion kinase (FAK) [Y576/S722/S910], p38α-MAPK [T180/Y182], and AKT1[S473] and [T308].  Conversely, inhibition of phosphorylation by HGF in protein kinase C (PKC), protein kinase R (PKR), and also CDK1 was identified.  Phosphoantibody-based immunohistochem. anal. of SCLC tumor tissue and microarray established the role of c-MET in SCLC biol.  This supports a role of c-MET activation in tumor invasive front in the tumor progression and invasion involving FAK and AKT downstream.  The c-MET serves as an attractive therapeutic target in SCLC, as shown through small interfering RNA (siRNA) and selective prototype c-MET inhibitor SU11274, inhibiting the phosphorylation of c-MET itself and its downstream mols. such as AKT, S6 kinase, and ERK1/2.  Investigation of mechanisms of invasion and, ultimately, metastasis in SCLC would be very useful with these signal transduction mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxZfi_VG1B5rVg90H21EOLACvtfcHk0lgpRcbt_XQLfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotlSgt74%253D&md5=f7e7e198122e3071fe1025e737beb0e9</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6603884&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6603884%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DP.%2BC.%26aulast%3DTretiakova%26aufirst%3DM.%2BS.%26aulast%3DNallasura%26aufirst%3DV.%26aulast%3DJagadeeswaran%26aufirst%3DR.%26aulast%3DHusain%26aufirst%3DA.%2BN.%26aulast%3DSalgia%26aufirst%3DR.%26atitle%3DDownstream%2520signalling%2520and%2520specific%2520inhibition%2520of%2520c-MET%252FHGF%2520pathway%2520in%2520small%2520cell%2520lung%2520cancer%253A%2520implications%2520for%2520tumour%2520invasion%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2007%26volume%3D97%26spage%3D368%26epage%3D377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Ma, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jagadeeswaran, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jagadeesh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tretiakova, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nallasura, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaefer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naoki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lader, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richards, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugarbaker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Husain, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salgia, R.</span><span> </span><span class="NLM_article-title">Functional expression and mutations of c-Met and its therapeutic inhibition with SU11274 and small interfering RNA in non-small cell lung cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">1479</span><span class="NLM_x">–</span> <span class="NLM_lpage">1488</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2005&pages=1479-1488&author=P.+C.+Maauthor=R.+Jagadeeswaranauthor=S.+Jagadeeshauthor=M.+S.+Tretiakovaauthor=V.+Nallasuraauthor=E.+A.+Foxauthor=M.+Hansenauthor=E.+Schaeferauthor=K.+Naokiauthor=A.+Laderauthor=W.+Richardsauthor=D.+Sugarbakerauthor=A.+N.+Husainauthor=J.+G.+Christensenauthor=R.+Salgia&title=Functional+expression+and+mutations+of+c-Met+and+its+therapeutic+inhibition+with+SU11274+and+small+interfering+RNA+in+non-small+cell+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DP.%2BC.%26aulast%3DJagadeeswaran%26aufirst%3DR.%26aulast%3DJagadeesh%26aufirst%3DS.%26aulast%3DTretiakova%26aufirst%3DM.%2BS.%26aulast%3DNallasura%26aufirst%3DV.%26aulast%3DFox%26aufirst%3DE.%2BA.%26aulast%3DHansen%26aufirst%3DM.%26aulast%3DSchaefer%26aufirst%3DE.%26aulast%3DNaoki%26aufirst%3DK.%26aulast%3DLader%26aufirst%3DA.%26aulast%3DRichards%26aufirst%3DW.%26aulast%3DSugarbaker%26aufirst%3DD.%26aulast%3DHusain%26aufirst%3DA.%2BN.%26aulast%3DChristensen%26aufirst%3DJ.%2BG.%26aulast%3DSalgia%26aufirst%3DR.%26atitle%3DFunctional%2520expression%2520and%2520mutations%2520of%2520c-Met%2520and%2520its%2520therapeutic%2520inhibition%2520with%2520SU11274%2520and%2520small%2520interfering%2520RNA%2520in%2520non-small%2520cell%2520lung%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2005%26volume%3D65%26spage%3D1479%26epage%3D1488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Ma, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaefer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salgia, R.</span><span> </span><span class="NLM_article-title">A selective small molecule c-MET inhibitor, PHA665752, cooperates with rapamycin</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">2312</span><span class="NLM_x">–</span> <span class="NLM_lpage">2319</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm900803q&amp;key=10.1158%2F1078-0432.CCR-04-1708" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm900803q&amp;key=15788682" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm900803q&amp;key=1%3ACAS%3A528%3ADC%252BD2MXisFaju7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=2312-2319&author=P.+C.+Maauthor=E.+Schaeferauthor=J.+G.+Christensenauthor=R.+Salgia&title=A+selective+small+molecule+c-MET+inhibitor%2C+PHA665752%2C+cooperates+with+rapamycin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">A selective small molecule c-MET inhibitor, PHA665752, cooperates with rapamycin</span></div><div class="casAuthors">Ma, Patrick C.; Schaefer, Erik; Christensen, James G.; Salgia, Ravi</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2312-2319</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">c-MET is believed to be an attractive receptor target for mol. therapeutic inhibition.  TPR-MET, a constitutively active oncogenic variant of MET, serves as excellent model for testing c-MET inhibitors.  Here, we characterized a small mol. c-MET inhibitor, PHA665752, and tested its cooperation with the mammalian target of rapamycin inhibitor as potential targeted therapy.  The effect of PHA665752 treatment was detd. on cell growth, motility and migration, apoptosis, and cell-cycle arrest of TPR-MET-transformed cells.  Moreover, the effect of PHA665752 on the phosphorylation on MET, as well as its downstream effectors, p-AKT and p-S6K, was also detd.  Finally, growth of TPR-MET-transformed cells was tested in the presence of PHA665752 and rapamycin.  H441 non-small cell lung cancer (NSCLC) cells (with activated c-Met) were also tested against both PHA665752 and rapamycin.  PHA665752 specifically inhibited cell growth in BaF3.  TPR-MET cells (IC50 < 0.06 μmol/L), induced apoptosis and cell cycle arrest.  Constitutive cell motility and migration of the BaF3.  TPR-MET cells was also inhibited.  PHA665752 inhibited specific phosphorylation of TPR-MET as well as phosphorylation of downstream targets of the mammalian target of rapamycin pathway.  When combined with PHA665752, rapamycin showed cooperative inhibition to reduce growth of BaF3.  TPR-MET- and c-MET-expressing H441 NSCLC cells.  PHA665752 is a potent small mol.-selective c-MET inhibitor and is highly active against TPR-MET-transformed cells both biol. and biochem.  PHA665752 is also active against H441 NSCLC cells.  The c-MET inhibitor can cooperate with rapamycin in therapeutic inhibition of NSCLC, and in vivo studies of this combination against c-MET expressing cancers would be merited.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQ6fVYSbU8ibVg90H21EOLACvtfcHk0lgpRcbt_XQLfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXisFaju7c%253D&md5=9e69f0253f675f4a1aeb96c115e2e420</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-04-1708&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-04-1708%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DP.%2BC.%26aulast%3DSchaefer%26aufirst%3DE.%26aulast%3DChristensen%26aufirst%3DJ.%2BG.%26aulast%3DSalgia%26aufirst%3DR.%26atitle%3DA%2520selective%2520small%2520molecule%2520c-MET%2520inhibitor%252C%2520PHA665752%252C%2520cooperates%2520with%2520rapamycin%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2005%26volume%3D11%26spage%3D2312%26epage%3D2319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Shaharabany, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abramovitch, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kushnir, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsarfaty, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravid-Megido, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horev, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ron, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itzchak, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsarfaty, I.</span><span> </span><span class="NLM_article-title">In vivo molecular imaging of met tyrosine kinase growth factor receptor activity in normal organs and breast tumors</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">4873</span><span class="NLM_x">–</span> <span class="NLM_lpage">4878</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2001&pages=4873-4878&author=M.+Shaharabanyauthor=R.+Abramovitchauthor=T.+Kushnirauthor=G.+Tsarfatyauthor=M.+Ravid-Megidoauthor=J.+Horevauthor=R.+Ronauthor=Y.+Itzchakauthor=I.+Tsarfaty&title=In+vivo+molecular+imaging+of+met+tyrosine+kinase+growth+factor+receptor+activity+in+normal+organs+and+breast+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShaharabany%26aufirst%3DM.%26aulast%3DAbramovitch%26aufirst%3DR.%26aulast%3DKushnir%26aufirst%3DT.%26aulast%3DTsarfaty%26aufirst%3DG.%26aulast%3DRavid-Megido%26aufirst%3DM.%26aulast%3DHorev%26aufirst%3DJ.%26aulast%3DRon%26aufirst%3DR.%26aulast%3DItzchak%26aufirst%3DY.%26aulast%3DTsarfaty%26aufirst%3DI.%26atitle%3DIn%2520vivo%2520molecular%2520imaging%2520of%2520met%2520tyrosine%2520kinase%2520growth%2520factor%2520receptor%2520activity%2520in%2520normal%2520organs%2520and%2520breast%2520tumors%26jtitle%3DCancer%2520Res.%26date%3D2001%26volume%3D61%26spage%3D4873%26epage%3D4878" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Tsarfaty, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stein, G. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moshitch-Moshkovitz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufman, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Resau, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vande Woude, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsarfaty, I.</span><span> </span><span class="NLM_article-title">HGF/SF increases tumor blood volume: a novel tool for the in vivo functional molecular imaging of Met</span> <span class="citation_source-journal">Neoplasia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">344</span><span class="NLM_x">–</span> <span class="NLM_lpage">352</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2006&pages=344-352&author=G.+Tsarfatyauthor=G.+Y.+Steinauthor=S.+Moshitch-Moshkovitzauthor=D.+W.+Kaufmanauthor=B.+Caoauthor=J.+H.+Resauauthor=G.+F.+Vande+Woudeauthor=I.+Tsarfaty&title=HGF%2FSF+increases+tumor+blood+volume%3A+a+novel+tool+for+the+in+vivo+functional+molecular+imaging+of+Met"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTsarfaty%26aufirst%3DG.%26aulast%3DStein%26aufirst%3DG.%2BY.%26aulast%3DMoshitch-Moshkovitz%26aufirst%3DS.%26aulast%3DKaufman%26aufirst%3DD.%2BW.%26aulast%3DCao%26aufirst%3DB.%26aulast%3DResau%26aufirst%3DJ.%2BH.%26aulast%3DVande%2BWoude%26aufirst%3DG.%2BF.%26aulast%3DTsarfaty%26aufirst%3DI.%26atitle%3DHGF%252FSF%2520increases%2520tumor%2520blood%2520volume%253A%2520a%2520novel%2520tool%2520for%2520the%2520in%2520vivo%2520functional%2520molecular%2520imaging%2520of%2520Met%26jtitle%3DNeoplasia%26date%3D2006%26volume%3D8%26spage%3D344%26epage%3D352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Towner, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tesiram, Y. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbott, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saunders, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blindauer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herlea, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silasi-Mansat, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lupu, F.</span><span> </span><span class="NLM_article-title">In vivo detection of c-MET expression in a rat hepatocarcinogenesis model using molecularly targeted magnetic resonance imaging</span> <span class="citation_source-journal">Mol. Imaging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">18</span><span class="NLM_x">–</span> <span class="NLM_lpage">29</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm900803q&amp;key=17311762" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm900803q&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVKhtrjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=18-29&author=R.+A.+Townerauthor=N.+Smithauthor=Y.+A.+Tesiramauthor=A.+Abbottauthor=D.+Saundersauthor=R.+Blindauerauthor=O.+Herleaauthor=R.+Silasi-Mansatauthor=F.+Lupu&title=In+vivo+detection+of+c-MET+expression+in+a+rat+hepatocarcinogenesis+model+using+molecularly+targeted+magnetic+resonance+imaging"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo detection of c-MET expression in a rat hepatocarcinogenesis model using molecularly targeted magnetic resonance imaging</span></div><div class="casAuthors">Towner, Rheal A.; Smith, Nataliya; Tesiram, Yasvir A.; Abbott, Andrew; Saunders, Debbie; Blindauer, Rebecca; Herlea, Oana; Silasi-Mansat, Robert; Lupu, Florea</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Imaging</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">18-29</span>CODEN:
                <span class="NLM_cas:coden">MIOMBP</span>;
        ISSN:<span class="NLM_cas:issn">1535-3508</span>.
    
            (<span class="NLM_cas:orgname">BC Decker Inc.</span>)
        </div><div class="casAbstract">The multifunctional growth factor scatter factor/hepatocyte growth factor and its tyrosine kinase receptor, c-MET, have been implicated in the genesis and malignant progression of numerous human malignancies, including hepatocellular carcinomas.  The incidence of hepatocellular carcinomas in the United States has increased noticeably over the past two decades and is listed as the fifth major cancer in men worldwide.  In this study, we used a choline-deficient L-amino acid (CDAA)-defined rat hepatocarcinogenesis model to visualize increased in vivo expression of the c-MET antigen in neoplastic lesion formation with the use of a super paramagnetic iron oxide (SPIO)-anti-c-MET molecularly targeted magnetic resonance imaging (MRI) contrast agent.  SPIO-anti-c-MET was used for the first time to detect overexpression of c-MET in neoplastic nodules and tumors within the livers of CDAA-treated rats, as detd. by a decrease in MRI signal intensity and a decrease in regional T2 values.  Specificity for the binding of the molecularly targeted anti-c-MET contrast agent was detd. using rat hepatoma (H4-II-E-C3) cell cultures and immunofluorescence microscopic imaging of the targeting agents within neoplastic liver tissue 1 to 2 h following i.v. administration of SPIO-anti-c-MET and MRI investigation.  This method has the ability to visualize in vivo the overexpression of c-MET at early developmental stages of tumor formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHVxUOgOP2JbVg90H21EOLACvtfcHk0ljZi9RDMT8FpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVKhtrjJ&md5=0ef525b274957f80bc363f3771c430e5</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTowner%26aufirst%3DR.%2BA.%26aulast%3DSmith%26aufirst%3DN.%26aulast%3DTesiram%26aufirst%3DY.%2BA.%26aulast%3DAbbott%26aufirst%3DA.%26aulast%3DSaunders%26aufirst%3DD.%26aulast%3DBlindauer%26aufirst%3DR.%26aulast%3DHerlea%26aufirst%3DO.%26aulast%3DSilasi-Mansat%26aufirst%3DR.%26aulast%3DLupu%26aufirst%3DF.%26atitle%3DIn%2520vivo%2520detection%2520of%2520c-MET%2520expression%2520in%2520a%2520rat%2520hepatocarcinogenesis%2520model%2520using%2520molecularly%2520targeted%2520magnetic%2520resonance%2520imaging%26jtitle%3DMol.%2520Imaging%26date%3D2007%26volume%3D6%26spage%3D18%26epage%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Perk, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stigter-van Walsum, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Visser, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kloet, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vosjan, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leemans, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giaccone, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albano, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comoglio, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Dongen, G. A.</span><span> </span><span class="NLM_article-title">Quantitative PET imaging of Met-expressing human cancer xenografts with <sup>89</sup>Zr-labelled monoclonal antibody DN30</span> <span class="citation_source-journal">Eur. J. Nucl. Med. Mol. Imaging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">1857</span><span class="NLM_x">–</span> <span class="NLM_lpage">1867</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm900803q&amp;key=10.1007%2Fs00259-008-0774-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm900803q&amp;key=18491091" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm900803q&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFCjtbzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2008&pages=1857-1867&author=L.+R.+Perkauthor=M.+Stigter-van+Walsumauthor=G.+W.+Visserauthor=R.+W.+Kloetauthor=M.+J.+Vosjanauthor=C.+R.+Leemansauthor=G.+Giacconeauthor=R.+Albanoauthor=P.+M.+Comoglioauthor=G.+A.+van+Dongen&title=Quantitative+PET+imaging+of+Met-expressing+human+cancer+xenografts+with+89Zr-labelled+monoclonal+antibody+DN30"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative PET imaging of Met-expressing human cancer xenografts with 89Zr-labelled monoclonal antibody DN30</span></div><div class="casAuthors">Perk, Lars R.; Stigter-van Walsum, Marijke; Visser, Gerard W. M.; Kloet, Reina W.; Vosjan, Maria J. W. D.; Leemans, C. Rene; Giaccone, Giuseppe; Albano, Raffaella; Comoglio, Paolo M.; van Dongen, Guus A. M. S.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nuclear Medicine and Molecular Imaging</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1857-1867</span>CODEN:
                <span class="NLM_cas:coden">EJNMA6</span>;
        ISSN:<span class="NLM_cas:issn">1619-7070</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Targeting the c-Met receptor with monoclonal antibodies (MAbs) is an appealing approach for cancer diagnosis and treatment because this receptor plays a prominent role in tumor invasion and metastasis.  Positron emission tomog. (PET) might be a powerful tool for guidance of therapy with anti-Met MAbs like the recently described MAb DN30 because it allows accurate quant. imaging of tumor targeting (immuno-PET).  We considered the potential of PET with either 89Zr-labeled (residualising radionuclide) or 124I-labeled (non-residualising radionuclide) DN30 for imaging of Met-expressing tumors.  The biodistribution of co-injected 89Zr-DN30 and iodine-labeled DN30 was compared in nude mice bearing either the human gastric cancer line GLT-16 (high Met expression) or the head-and-neck cancer line FaDu (low Met expression).  PET images were acquired in both xenograft models up to 4 days post-injection (p.i.) and used for quantification of tumor uptake.  Biodistribution studies in GTL-16-tumor-bearing mice revealed that 89Zr-DN30 achieved much higher tumor uptake levels than iodine-labeled DN30 (e.g. 19.6%ID/g vs 5.3%ID/g, 5 days p.i.), while blood levels were similar, indicating internalization of DN30.  Therefore, 89Zr-DN30 was selected for PET imaging of GLT-16-bearing mice.  Tumors as small as 11 mg were readily visualized with immuno-PET.  A distinctive lower 89Zr uptake was obsd. in FaDu compared to GTL-16 xenografts (e.g. 7.8%ID/g vs 18.1%ID/g, 3 days p.i.).  Nevertheless, FaDu xenografts were also clearly visualized with 89Zr-DN30 immuno-PET.  An excellent correlation was found between PET-image-derived 89Zr tumor uptake and ex-vivo-assessed 89Zr tumor uptake (R 2 = 0.98).  The long-lived positron emitter 89Zr seems attractive for PET-guided development of therapeutic anti-c-Met MAbs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8SV9_lqoBWLVg90H21EOLACvtfcHk0ljZi9RDMT8FpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFCjtbzI&md5=e566f34c1ac2e47cc990662d199819f3</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1007%2Fs00259-008-0774-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-008-0774-5%26sid%3Dliteratum%253Aachs%26aulast%3DPerk%26aufirst%3DL.%2BR.%26aulast%3DStigter-van%2BWalsum%26aufirst%3DM.%26aulast%3DVisser%26aufirst%3DG.%2BW.%26aulast%3DKloet%26aufirst%3DR.%2BW.%26aulast%3DVosjan%26aufirst%3DM.%2BJ.%26aulast%3DLeemans%26aufirst%3DC.%2BR.%26aulast%3DGiaccone%26aufirst%3DG.%26aulast%3DAlbano%26aufirst%3DR.%26aulast%3DComoglio%26aufirst%3DP.%2BM.%26aulast%3Dvan%2BDongen%26aufirst%3DG.%2BA.%26atitle%3DQuantitative%2520PET%2520imaging%2520of%2520Met-expressing%2520human%2520cancer%2520xenografts%2520with%252089Zr-labelled%2520monoclonal%2520antibody%2520DN30%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2008%26volume%3D35%26spage%3D1857%26epage%3D1867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Hay, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skinner, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustafson, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teh, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knudsen, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Resau, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waters, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vande Woude, G. F.</span><span> </span><span class="NLM_article-title">Nuclear imaging of Met-expressing human and canine cancer xenografts with radiolabeled monoclonal antibodies (MetSeek)</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">7064s</span><span class="NLM_x">–</span> <span class="NLM_lpage">7069s</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=7064s-7069s&author=R.+V.+Hayauthor=B.+Caoauthor=R.+S.+Skinnerauthor=Y.+Suauthor=P.+Zhaoauthor=M.+F.+Gustafsonauthor=C.+N.+Qianauthor=B.+T.+Tehauthor=B.+S.+Knudsenauthor=J.+H.+Resauauthor=S.+Shenauthor=D.+J.+Watersauthor=M.+D.+Grossauthor=G.+F.+Vande+Woude&title=Nuclear+imaging+of+Met-expressing+human+and+canine+cancer+xenografts+with+radiolabeled+monoclonal+antibodies+%28MetSeek%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHay%26aufirst%3DR.%2BV.%26aulast%3DCao%26aufirst%3DB.%26aulast%3DSkinner%26aufirst%3DR.%2BS.%26aulast%3DSu%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DP.%26aulast%3DGustafson%26aufirst%3DM.%2BF.%26aulast%3DQian%26aufirst%3DC.%2BN.%26aulast%3DTeh%26aufirst%3DB.%2BT.%26aulast%3DKnudsen%26aufirst%3DB.%2BS.%26aulast%3DResau%26aufirst%3DJ.%2BH.%26aulast%3DShen%26aufirst%3DS.%26aulast%3DWaters%26aufirst%3DD.%2BJ.%26aulast%3DGross%26aufirst%3DM.%2BD.%26aulast%3DVande%2BWoude%26aufirst%3DG.%2BF.%26atitle%3DNuclear%2520imaging%2520of%2520Met-expressing%2520human%2520and%2520canine%2520cancer%2520xenografts%2520with%2520radiolabeled%2520monoclonal%2520antibodies%2520%2528MetSeek%2529%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2005%26volume%3D11%26spage%3D7064s%26epage%3D7069s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Schroeder, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">An, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, Z. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cornelius, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gullo-Brown, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henley, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeyaseelan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamath, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manne, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oppenheimer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sack, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefanski, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tokarski, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trainor, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wautlet, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fargnoli, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borzilleri, R. M.</span><span> </span><span class="NLM_article-title">Discovery of <i>N</i>-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide (BMS-777607), a selective and orally efficacious inhibitor of the Met kinase superfamily</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1251</span><span class="NLM_x">–</span> <span class="NLM_lpage">1254</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm801586s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=1251-1254&author=G.+M.+Schroederauthor=Y.+Anauthor=Z.+W.+Caiauthor=X.+T.+Chenauthor=C.+Clarkauthor=L.+A.+Corneliusauthor=J.+Daiauthor=J.+Gullo-Brownauthor=A.+Guptaauthor=B.+Henleyauthor=J.+T.+Huntauthor=R.+Jeyaseelanauthor=A.+Kamathauthor=K.+Kimauthor=J.+Lippyauthor=L.+J.+Lombardoauthor=V.+Manneauthor=S.+Oppenheimerauthor=J.+S.+Sackauthor=R.+J.+Schmidtauthor=G.+Shenauthor=K.+Stefanskiauthor=J.+S.+Tokarskiauthor=G.+L.+Trainorauthor=B.+S.+Wautletauthor=D.+Weiauthor=D.+K.+Williamsauthor=Y.+Zhangauthor=J.+Fargnoliauthor=R.+M.+Borzilleri&title=Discovery+of+N-%284-%282-amino-3-chloropyridin-4-yloxy%29-3-fluorophenyl%29-4-ethoxy-1-%284-fluorophenyl%29-2-oxo-1%2C2-dihydropyridine-3-carboxamide+%28BMS-777607%29%2C+a+selective+and+orally+efficacious+inhibitor+of+the+Met+kinase+superfamily"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm801586s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801586s%26sid%3Dliteratum%253Aachs%26aulast%3DSchroeder%26aufirst%3DG.%2BM.%26aulast%3DAn%26aufirst%3DY.%26aulast%3DCai%26aufirst%3DZ.%2BW.%26aulast%3DChen%26aufirst%3DX.%2BT.%26aulast%3DClark%26aufirst%3DC.%26aulast%3DCornelius%26aufirst%3DL.%2BA.%26aulast%3DDai%26aufirst%3DJ.%26aulast%3DGullo-Brown%26aufirst%3DJ.%26aulast%3DGupta%26aufirst%3DA.%26aulast%3DHenley%26aufirst%3DB.%26aulast%3DHunt%26aufirst%3DJ.%2BT.%26aulast%3DJeyaseelan%26aufirst%3DR.%26aulast%3DKamath%26aufirst%3DA.%26aulast%3DKim%26aufirst%3DK.%26aulast%3DLippy%26aufirst%3DJ.%26aulast%3DLombardo%26aufirst%3DL.%2BJ.%26aulast%3DManne%26aufirst%3DV.%26aulast%3DOppenheimer%26aufirst%3DS.%26aulast%3DSack%26aufirst%3DJ.%2BS.%26aulast%3DSchmidt%26aufirst%3DR.%2BJ.%26aulast%3DShen%26aufirst%3DG.%26aulast%3DStefanski%26aufirst%3DK.%26aulast%3DTokarski%26aufirst%3DJ.%2BS.%26aulast%3DTrainor%26aufirst%3DG.%2BL.%26aulast%3DWautlet%26aufirst%3DB.%2BS.%26aulast%3DWei%26aufirst%3DD.%26aulast%3DWilliams%26aufirst%3DD.%2BK.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DFargnoli%26aufirst%3DJ.%26aulast%3DBorzilleri%26aufirst%3DR.%2BM.%26atitle%3DDiscovery%2520of%2520N-%25284-%25282-amino-3-chloropyridin-4-yloxy%2529-3-fluorophenyl%2529-4-ethoxy-1-%25284-fluorophenyl%2529-2-oxo-1%252C2-dihydropyridine-3-carboxamide%2520%2528BMS-777607%2529%252C%2520a%2520selective%2520and%2520orally%2520efficacious%2520inhibitor%2520of%2520the%2520Met%2520kinase%2520superfamily%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D1251%26epage%3D1254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan-Lefko, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rex, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriguchi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osgood, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coxon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reese, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgess, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dussault, I.</span><span> </span><span class="NLM_article-title">Identification of a novel recepteur d'origine nantais/c-met small-molecule kinase inhibitor with antitumor activity in vivo</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">6680</span><span class="NLM_x">–</span> <span class="NLM_lpage">6687</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=6680-6687&author=Y.+Zhangauthor=P.+J.+Kaplan-Lefkoauthor=K.+Rexauthor=Y.+Yangauthor=J.+Moriguchiauthor=T.+Osgoodauthor=B.+Mattsonauthor=A.+Coxonauthor=M.+Reeseauthor=T.+S.+Kimauthor=J.+Linauthor=A.+Chenauthor=T.+L.+Burgessauthor=I.+Dussault&title=Identification+of+a+novel+recepteur+d%27origine+nantais%2Fc-met+small-molecule+kinase+inhibitor+with+antitumor+activity+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DKaplan-Lefko%26aufirst%3DP.%2BJ.%26aulast%3DRex%26aufirst%3DK.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DMoriguchi%26aufirst%3DJ.%26aulast%3DOsgood%26aufirst%3DT.%26aulast%3DMattson%26aufirst%3DB.%26aulast%3DCoxon%26aufirst%3DA.%26aulast%3DReese%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DT.%2BS.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DA.%26aulast%3DBurgess%26aufirst%3DT.%2BL.%26aulast%3DDussault%26aufirst%3DI.%26atitle%3DIdentification%2520of%2520a%2520novel%2520recepteur%2520d%2527origine%2520nantais%252Fc-met%2520small-molecule%2520kinase%2520inhibitor%2520with%2520antitumor%2520activity%2520in%2520vivo%26jtitle%3DCancer%2520Res.%26date%3D2008%26volume%3D68%26spage%3D6680%26epage%3D6687" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegmund, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan-Lefko, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rex, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriguchi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berry, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teffera, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellon, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimanovich, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominguez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norman, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harmange, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dussault, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, T. S.</span><span> </span><span class="NLM_article-title">Discovery of a potent, selective, and orally bioavailable c-Met inhibitor: 1-(2-hydroxy-2-methylpropyl)-<i>N</i>-(5-(7-methoxyquinolin-4-yloxy)pyridin-2-yl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide (AMG 458)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">3688</span><span class="NLM_x">–</span> <span class="NLM_lpage">3691</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800401t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=3688-3691&author=L.+Liuauthor=A.+Siegmundauthor=N.+Xiauthor=P.+Kaplan-Lefkoauthor=K.+Rexauthor=A.+Chenauthor=J.+Linauthor=J.+Moriguchiauthor=L.+Berryauthor=L.+Huangauthor=Y.+Tefferaauthor=Y.+Yangauthor=Y.+Zhangauthor=S.+F.+Bellonauthor=M.+Leeauthor=R.+Shimanovichauthor=A.+Bakauthor=C.+Dominguezauthor=M.+H.+Normanauthor=J.+C.+Harmangeauthor=I.+Dussaultauthor=T.+S.+Kim&title=Discovery+of+a+potent%2C+selective%2C+and+orally+bioavailable+c-Met+inhibitor%3A+1-%282-hydroxy-2-methylpropyl%29-N-%285-%287-methoxyquinolin-4-yloxy%29pyridin-2-yl%29-5-methyl-3-oxo-2-phenyl-2%2C3-dihydro-1H-pyrazole-4-carboxamide+%28AMG+458%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm800401t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800401t%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DSiegmund%26aufirst%3DA.%26aulast%3DXi%26aufirst%3DN.%26aulast%3DKaplan-Lefko%26aufirst%3DP.%26aulast%3DRex%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DA.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DMoriguchi%26aufirst%3DJ.%26aulast%3DBerry%26aufirst%3DL.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DTeffera%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DBellon%26aufirst%3DS.%2BF.%26aulast%3DLee%26aufirst%3DM.%26aulast%3DShimanovich%26aufirst%3DR.%26aulast%3DBak%26aufirst%3DA.%26aulast%3DDominguez%26aufirst%3DC.%26aulast%3DNorman%26aufirst%3DM.%2BH.%26aulast%3DHarmange%26aufirst%3DJ.%2BC.%26aulast%3DDussault%26aufirst%3DI.%26aulast%3DKim%26aufirst%3DT.%2BS.%26atitle%3DDiscovery%2520of%2520a%2520potent%252C%2520selective%252C%2520and%2520orally%2520bioavailable%2520c-Met%2520inhibitor%253A%25201-%25282-hydroxy-2-methylpropyl%2529-N-%25285-%25287-methoxyquinolin-4-yloxy%2529pyridin-2-yl%2529-5-methyl-3-oxo-2-phenyl-2%252C3-dihydro-1H-pyrazole-4-carboxamide%2520%2528AMG%2520458%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D3688%26epage%3D3691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wislez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujimoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prudkin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Izzo, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uno, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanna, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langley, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wistuba, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurie, J. M.</span><span> </span><span class="NLM_article-title">A selective small molecule inhibitor of c-Met, PHA-665752, reverses lung premalignancy induced by mutant K-ras</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">952</span><span class="NLM_x">–</span> <span class="NLM_lpage">960</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm900803q&amp;key=10.1158%2F1535-7163.MCT-07-2045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm900803q&amp;key=18413809" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm900803q&amp;key=1%3ACAS%3A528%3ADC%252BD1cXks1Gmsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=952-960&author=Y.+Yangauthor=M.+Wislezauthor=N.+Fujimotoauthor=L.+Prudkinauthor=J.+G.+Izzoauthor=F.+Unoauthor=L.+Jiauthor=A.+E.+Hannaauthor=R.+R.+Langleyauthor=D.+Liuauthor=F.+M.+Johnsonauthor=I.+Wistubaauthor=J.+M.+Kurie&title=A+selective+small+molecule+inhibitor+of+c-Met%2C+PHA-665752%2C+reverses+lung+premalignancy+induced+by+mutant+K-ras"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">A selective small molecule inhibitor of c-Met, PHA-665752, reverses lung premalignancy induced by mutant K-ras</span></div><div class="casAuthors">Yang, Yanan; Wislez, Marie; Fujimoto, Nobukazu; Prudkin, Ludmila; Izzo, Julie G.; Uno, Futoshi; Ji, Lin; Hanna, Amy E.; Langley, Robert R.; Liu, Diane; Johnson, Faye M.; Wistuba, Ignacio; Kurie, Jonathan M.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">952-960</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The c-Met receptor tyrosine kinase has been implicated in cellular transformation induced by mutant Ras, a commonly activated proto-oncogene in non-small cell lung cancer (NSCLC).  However, the role of c-Met has not been defined in K-ras-mutant NSCLC, a disease for which no effective targeted therapeutic options currently exist.  To acquire a greater understanding of its role, we used genetic and pharmacol. approaches to inhibit c-Met in mice and cultured cells.  In KrasLA1 mice, which develop premalignant lung lesions that progress to multifocal lung adenocarcinomas owing to somatic mutations in K-ras, c-Met was expressed in multiple cell types within premalignant lung lesions, and high concns. of HGF were detected in bronchoalveolar lavage samples.  Short-term treatment with PHA-665752, a c-Met inhibitor, decreased the nos. of premalignant lung lesions and induced apoptosis in tumor cells and vascular endothelial cells within lesions.  In cell culture, PHA-665752 induced apoptosis of a lung adenocarcinoma cell line derived from KrasLA1 mice (LKR-13) and a murine lung endothelial cell line (MEC).  C-Met depletion by siRNA transfection induced apoptosis of MECs but not LKR-13 cells.  Collectively, these findings suggest that apoptosis was an on-target effect of PHA-665752 in MECs but not in LKR-13 cells.  We conclude that PHA-665752 inhibited lung tumorigenesis in KrasLA1 mice and may provide a novel therapeutic approach to the prevention of K-ras-mutant NSCLC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4lgtND1nnfbVg90H21EOLACvtfcHk0ljLBvONkBZGGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXks1Gmsb0%253D&md5=0d2ee01079be38dc194598c659bde3b5</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-07-2045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-07-2045%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DY.%26aulast%3DWislez%26aufirst%3DM.%26aulast%3DFujimoto%26aufirst%3DN.%26aulast%3DPrudkin%26aufirst%3DL.%26aulast%3DIzzo%26aufirst%3DJ.%2BG.%26aulast%3DUno%26aufirst%3DF.%26aulast%3DJi%26aufirst%3DL.%26aulast%3DHanna%26aufirst%3DA.%2BE.%26aulast%3DLangley%26aufirst%3DR.%2BR.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DJohnson%26aufirst%3DF.%2BM.%26aulast%3DWistuba%26aufirst%3DI.%26aulast%3DKurie%26aufirst%3DJ.%2BM.%26atitle%3DA%2520selective%2520small%2520molecule%2520inhibitor%2520of%2520c-Met%252C%2520PHA-665752%252C%2520reverses%2520lung%2520premalignancy%2520induced%2520by%2520mutant%2520K-ras%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2008%26volume%3D7%26spage%3D952%26epage%3D960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Chattopadhyay, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Naggar, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clayman, G. L.</span><span> </span><span class="NLM_article-title">Small molecule c-MET inhibitor PHA665752: effect on cell growth and motility in papillary thyroid carcinoma</span> <span class="citation_source-journal">Head Neck</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">991</span><span class="NLM_x">–</span> <span class="NLM_lpage">1000</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm900803q&amp;key=10.1002%2Fhed.20816" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm900803q&amp;key=18327775" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm900803q&amp;key=1%3ACAS%3A280%3ADC%252BD1cvptFemug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2008&pages=991-1000&author=C.+Chattopadhyayauthor=A.+K.+El-Naggarauthor=M.+D.+Williamsauthor=G.+L.+Clayman&title=Small+molecule+c-MET+inhibitor+PHA665752%3A+effect+on+cell+growth+and+motility+in+papillary+thyroid+carcinoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule c-MET inhibitor PHA665752: effect on cell growth and motility in papillary thyroid carcinoma</span></div><div class="casAuthors">Chattopadhyay Chandrani; El-Naggar Adel K; Williams Michelle D; Clayman Gary L</div><div class="citationInfo"><span class="NLM_cas:title">Head & neck</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">991-1000</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  c-Met is upregulated in papillary thyroid carcinoma (PTC) and can be an attractive therapeutic target.  We tested the effects of the small molecule c-met inhibitor PHA665752 in blocking c-met-dependent phenotypic effects in PTC cell lines.  METHODS:  PTC patient tissues and cell lines were evaluated for c-met expression.  The effect of PHA665752 on c-met phosphorylation, downstream signaling, hepatocyte growth factor (HGF)-dependent cell growth, and induction of apoptosis was studied.  The IC(50) of PHA665752 in c-met-expressing PTC cells was determined, and growth curves at 0.1x, 1x, and 10x IC(50) concentrations were obtained.  Poly(ADP-ribose) polymerase (PARP) and caspase-9-processing post-PHA665752 treatment were studied as markers of apoptosis, and assays analyzing HGF-dependent cell invasion and migration in the presence and absence of PHA665752 were done.  RESULTS:  c-Met was upregulated in most of the patient tissues with PTC and in many PTC cell lines.  PHA665752 specifically inhibited c-met phosphorylation, c-met-dependent cell growth, signal transduction, cell survival, cell invasion, and migration in PTC cells with high c-met.  CONCLUSIONS:  PHA665752 is an effective and specific inhibitor of c-met in PTC cells with high levels of c-met expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQGY_jMmnUJzEkUaC_kzhvyfW6udTcc2eazVg6Vo_WMVrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1cvptFemug%253D%253D&md5=788a9e87b01dc3d07343501fbcc89e50</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1002%2Fhed.20816&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhed.20816%26sid%3Dliteratum%253Aachs%26aulast%3DChattopadhyay%26aufirst%3DC.%26aulast%3DEl-Naggar%26aufirst%3DA.%2BK.%26aulast%3DWilliams%26aufirst%3DM.%2BD.%26aulast%3DClayman%26aufirst%3DG.%2BL.%26atitle%3DSmall%2520molecule%2520c-MET%2520inhibitor%2520PHA665752%253A%2520effect%2520on%2520cell%2520growth%2520and%2520motility%2520in%2520papillary%2520thyroid%2520carcinoma%26jtitle%3DHead%2520Neck%26date%3D2008%26volume%3D30%26spage%3D991%26epage%3D1000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Tseng, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dandekar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yaghoubi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muir, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vincent, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michaud, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gambhir, S. S.</span><span> </span><span class="NLM_article-title">Preclinical efficacy of the c-Met inhibitor CE-355621 in a U87 MG mouse xenograft model evaluated by 18F-FDG small-animal PET</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">129</span><span class="NLM_x">–</span> <span class="NLM_lpage">134</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2008&pages=129-134&author=J.+R.+Tsengauthor=K.+W.+Kangauthor=M.+Dandekarauthor=S.+Yaghoubiauthor=J.+H.+Leeauthor=J.+G.+Christensenauthor=S.+Muirauthor=P.+W.+Vincentauthor=N.+R.+Michaudauthor=S.+S.+Gambhir&title=Preclinical+efficacy+of+the+c-Met+inhibitor+CE-355621+in+a+U87+MG+mouse+xenograft+model+evaluated+by+18F-FDG+small-animal+PET"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTseng%26aufirst%3DJ.%2BR.%26aulast%3DKang%26aufirst%3DK.%2BW.%26aulast%3DDandekar%26aufirst%3DM.%26aulast%3DYaghoubi%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DChristensen%26aufirst%3DJ.%2BG.%26aulast%3DMuir%26aufirst%3DS.%26aulast%3DVincent%26aufirst%3DP.%2BW.%26aulast%3DMichaud%26aufirst%3DN.%2BR.%26aulast%3DGambhir%26aufirst%3DS.%2BS.%26atitle%3DPreclinical%2520efficacy%2520of%2520the%2520c-Met%2520inhibitor%2520CE-355621%2520in%2520a%2520U87%2520MG%2520mouse%2520xenograft%2520model%2520evaluated%2520by%252018F-FDG%2520small-animal%2520PET%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2008%26volume%3D49%26spage%3D129%26epage%3D134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Koon, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salgia, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welch, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berkowitz, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mok, S. C.</span><span> </span><span class="NLM_article-title">Effect of a c-Met-specific, ATP-competitive small-molecule inhibitor SU11274 on human ovarian carcinoma cell growth, motility, and invasion</span> <span class="citation_source-journal">Int. J. Gynecol. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">976</span><span class="NLM_x">–</span> <span class="NLM_lpage">984</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm900803q&amp;key=10.1111%2Fj.1525-1438.2007.01135.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm900803q&amp;key=18021219" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm900803q&amp;key=1%3ACAS%3A280%3ADC%252BD1cnjsVWlug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=976-984&author=E.+C.+Koonauthor=P.+C.+Maauthor=R.+Salgiaauthor=W.+R.+Welchauthor=J.+G.+Christensenauthor=R.+S.+Berkowitzauthor=S.+C.+Mok&title=Effect+of+a+c-Met-specific%2C+ATP-competitive+small-molecule+inhibitor+SU11274+on+human+ovarian+carcinoma+cell+growth%2C+motility%2C+and+invasion"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of a c-Met-specific, ATP-competitive small-molecule inhibitor SU11274 on human ovarian carcinoma cell growth, motility, and invasion</span></div><div class="casAuthors">Koon E C; Ma P C; Salgia R; Welch W R; Christensen J G; Berkowitz R S; Mok S C</div><div class="citationInfo"><span class="NLM_cas:title">International journal of gynecological cancer : official journal of the International Gynecological Cancer Society</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">976-84</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Increased expression of the receptor tyrosine kinase c-Met has been shown to correlate with enhanced cell proliferation, motility, and invasion.  The objectives of this study were to characterize total and activated c-Met expression in both normal and malignant human ovarian epithelial cells and to determine the effects of inhibiting the activation of c-Met on ovarian epithelial cell growth, motility, and invasion.  Total c-Met was overexpressed in 82 (68%) of 119 ovarian carcinomas, as shown by immunohistochemistry.  Quantitative reverse transcription-polymerase chain reaction and Western blot analyses revealed that ovarian carcinoma cell lines had higher levels of c-Met messenger RNA, total protein, and activated protein expression compared to normal ovarian epithelial cell cultures.  Using a specific adenosine triphosphate-competitive small-molecule inhibitor, SU11274, activated c-Met was decreased in normal and ovarian carcinoma cell lines. 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assays showed that cell growth inhibition directly correlated to the level of activated c-Met detected in each cell line (r =-0.87, P = 0.012).  Using modified Boyden chamber assays, ovarian carcinoma cells treated with SU11274 demonstrated significantly decreased cell motility and invasion compared to untreated cells (P = 0.003 and P < 0.001, respectively).  These data indicate that c-Met is overexpressed in the majority of malignant ovarian epithelial cells both in vivo and in vitro and that decreasing activated c-Met in vitro can significantly decrease ovarian carcinoma cell growth, motility, and invasion.  Developing therapies that specifically inhibit the activation of c-Met may represent a novel therapeutic modality for patients with ovarian carcinomas expressing high levels of c-Met.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR8AvUJS8-dyEHdcurJClFcfW6udTcc2ea6Ecwj5L-3krntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1cnjsVWlug%253D%253D&md5=9e2ffd432d52d0ac324816c8505633a0</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1111%2Fj.1525-1438.2007.01135.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1525-1438.2007.01135.x%26sid%3Dliteratum%253Aachs%26aulast%3DKoon%26aufirst%3DE.%2BC.%26aulast%3DMa%26aufirst%3DP.%2BC.%26aulast%3DSalgia%26aufirst%3DR.%26aulast%3DWelch%26aufirst%3DW.%2BR.%26aulast%3DChristensen%26aufirst%3DJ.%2BG.%26aulast%3DBerkowitz%26aufirst%3DR.%2BS.%26aulast%3DMok%26aufirst%3DS.%2BC.%26atitle%3DEffect%2520of%2520a%2520c-Met-specific%252C%2520ATP-competitive%2520small-molecule%2520inhibitor%2520SU11274%2520on%2520human%2520ovarian%2520carcinoma%2520cell%2520growth%252C%2520motility%252C%2520and%2520invasion%26jtitle%3DInt.%2520J.%2520Gynecol.%2520Cancer%26date%3D2008%26volume%3D18%26spage%3D976%26epage%3D984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Zou, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arango, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonnell, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamazaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koudriakova, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alton, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nambu, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Los, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bender, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mroczkowski, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, J. G.</span><span> </span><span class="NLM_article-title">An orally available small-molecule inhibitor of c-Met, PF-2341066, exhibits cytoreductive antitumor efficacy through antiproliferative and antiangiogenic mechanisms</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">4408</span><span class="NLM_x">–</span> <span class="NLM_lpage">4417</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm900803q&amp;key=10.1158%2F0008-5472.CAN-06-4443" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm900803q&amp;key=17483355" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm900803q&amp;key=1%3ACAS%3A528%3ADC%252BD2sXltVyrsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=4408-4417&author=H.+Y.+Zouauthor=Q.+Liauthor=J.+H.+Leeauthor=M.+E.+Arangoauthor=S.+R.+McDonnellauthor=S.+Yamazakiauthor=T.+B.+Koudriakovaauthor=G.+Altonauthor=J.+J.+Cuiauthor=P.+P.+Kungauthor=M.+D.+Nambuauthor=G.+Losauthor=S.+L.+Benderauthor=B.+Mroczkowskiauthor=J.+G.+Christensen&title=An+orally+available+small-molecule+inhibitor+of+c-Met%2C+PF-2341066%2C+exhibits+cytoreductive+antitumor+efficacy+through+antiproliferative+and+antiangiogenic+mechanisms"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">An Orally Available Small-Molecule Inhibitor of c-Met, PF-2341066, Exhibits Cytoreductive Antitumor Efficacy through Antiproliferative and Antiangiogenic Mechanisms</span></div><div class="casAuthors">Zou, Helen Y.; Li, Qiuhua; Lee, Joseph H.; Arango, Maria E.; McDonnell, Scott R.; Yamazaki, Shinji; Koudriakova, Tatiana B.; Alton, Gordon; Cui, Jingrong J.; Kung, Pei-Pei; Nambu, Mitchell D.; Los, Gerrit; Bender, Steven L.; Mroczkowski, Barbara; Christensen, James G.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4408-4417</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The c-Met receptor tyrosine kinase and its ligand, hepatocyte growth factor (HGF), have been implicated in the progression of several human cancers and are attractive therapeutic targets.  PF-2341066 was identified as a potent, orally bioavailable, ATP-competitive small-mol. inhibitor of the catalytic activity of c-Met kinase.  PF-2341066 was selective for c-Met (and anaplastic lymphoma kinase) compared with a panel of >120 diverse tyrosine and serine-threonine kinases.  PF-2341066 potently inhibited c-Met phosphorylation and c-Met-dependent proliferation, migration, or invasion of human tumor cells in vitro (IC50 values, 5-20 nmol/L).  In addn., PF-2341066 potently inhibited HGF-stimulated endothelial cell survival or invasion and serum-stimulated tubulogenesis in vitro, suggesting that this agent also exhibits antiangiogenic properties.  PF-2341066 showed efficacy at well-tolerated doses, including marked cytoreductive antitumor activity, in several tumor models that expressed activated c-Met.  The antitumor efficacy of PF-2341066 was dose dependent and showed a strong correlation to inhibition of c-Met phosphorylation in vivo.  Near-maximal inhibition of c-Met activity for the full dosing interval was necessary to maximize the efficacy of PF-2341066.  Addnl. mechanism-of-action studies showed dose-dependent inhibition of c-Met-dependent signal transduction, tumor cell proliferation (Ki67), induction of apoptosis (caspase-3), and redn. of microvessel d. (CD31).  These results indicated that the antitumor activity of PF-2341066 may be mediated by direct effects on tumor cell growth or survival as well as antiangiogenic mechanisms.  Collectively, these results show the therapeutic potential of targeting c-Met with selective small-mol. inhibitors for the treatment of human cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEAWtGPOBHC7Vg90H21EOLACvtfcHk0lje8Jr9hKPmqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXltVyrsbg%253D&md5=798bf93e6cf8d5e9897e27485cba9002</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-06-4443&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-06-4443%26sid%3Dliteratum%253Aachs%26aulast%3DZou%26aufirst%3DH.%2BY.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DArango%26aufirst%3DM.%2BE.%26aulast%3DMcDonnell%26aufirst%3DS.%2BR.%26aulast%3DYamazaki%26aufirst%3DS.%26aulast%3DKoudriakova%26aufirst%3DT.%2BB.%26aulast%3DAlton%26aufirst%3DG.%26aulast%3DCui%26aufirst%3DJ.%2BJ.%26aulast%3DKung%26aufirst%3DP.%2BP.%26aulast%3DNambu%26aufirst%3DM.%2BD.%26aulast%3DLos%26aufirst%3DG.%26aulast%3DBender%26aufirst%3DS.%2BL.%26aulast%3DMroczkowski%26aufirst%3DB.%26aulast%3DChristensen%26aufirst%3DJ.%2BG.%26atitle%3DAn%2520orally%2520available%2520small-molecule%2520inhibitor%2520of%2520c-Met%252C%2520PF-2341066%252C%2520exhibits%2520cytoreductive%2520antitumor%2520efficacy%2520through%2520antiproliferative%2520and%2520antiangiogenic%2520mechanisms%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26spage%3D4408%26epage%3D4417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Puri, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khramtsov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmed, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nallasura, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hetzel, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jagadeeswaran, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karczmar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salgia, R.</span><span> </span><span class="NLM_article-title">A selective small molecule inhibitor of c-Met, PHA665752, inhibits tumorigenicity and angiogenesis in mouse lung cancer xenografts</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">3529</span><span class="NLM_x">–</span> <span class="NLM_lpage">3534</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=3529-3534&author=N.+Puriauthor=A.+Khramtsovauthor=S.+Ahmedauthor=V.+Nallasuraauthor=J.+T.+Hetzelauthor=R.+Jagadeeswaranauthor=G.+Karczmarauthor=R.+Salgia&title=A+selective+small+molecule+inhibitor+of+c-Met%2C+PHA665752%2C+inhibits+tumorigenicity+and+angiogenesis+in+mouse+lung+cancer+xenografts"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPuri%26aufirst%3DN.%26aulast%3DKhramtsov%26aufirst%3DA.%26aulast%3DAhmed%26aufirst%3DS.%26aulast%3DNallasura%26aufirst%3DV.%26aulast%3DHetzel%26aufirst%3DJ.%2BT.%26aulast%3DJagadeeswaran%26aufirst%3DR.%26aulast%3DKarczmar%26aufirst%3DG.%26aulast%3DSalgia%26aufirst%3DR.%26atitle%3DA%2520selective%2520small%2520molecule%2520inhibitor%2520of%2520c-Met%252C%2520PHA665752%252C%2520inhibits%2520tumorigenicity%2520and%2520angiogenesis%2520in%2520mouse%2520lung%2520cancer%2520xenografts%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26spage%3D3529%26epage%3D3534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Smolen, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sordella, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muir, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohapatra, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barmettler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Archibald, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okimoto, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sgroi, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Settleman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haber, D. A.</span><span> </span><span class="NLM_article-title">Amplification of MET may identify a subset of cancers with extreme sensitivity to the selective tyrosine kinase inhibitor PHA-665752</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">2316</span><span class="NLM_x">–</span> <span class="NLM_lpage">2321</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=2316-2321&author=G.+A.+Smolenauthor=R.+Sordellaauthor=B.+Muirauthor=G.+Mohapatraauthor=A.+Barmettlerauthor=H.+Archibaldauthor=W.+J.+Kimauthor=R.+A.+Okimotoauthor=D.+W.+Bellauthor=D.+C.+Sgroiauthor=J.+G.+Christensenauthor=J.+Settlemanauthor=D.+A.+Haber&title=Amplification+of+MET+may+identify+a+subset+of+cancers+with+extreme+sensitivity+to+the+selective+tyrosine+kinase+inhibitor+PHA-665752"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSmolen%26aufirst%3DG.%2BA.%26aulast%3DSordella%26aufirst%3DR.%26aulast%3DMuir%26aufirst%3DB.%26aulast%3DMohapatra%26aufirst%3DG.%26aulast%3DBarmettler%26aufirst%3DA.%26aulast%3DArchibald%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DW.%2BJ.%26aulast%3DOkimoto%26aufirst%3DR.%2BA.%26aulast%3DBell%26aufirst%3DD.%2BW.%26aulast%3DSgroi%26aufirst%3DD.%2BC.%26aulast%3DChristensen%26aufirst%3DJ.%2BG.%26aulast%3DSettleman%26aufirst%3DJ.%26aulast%3DHaber%26aufirst%3DD.%2BA.%26atitle%3DAmplification%2520of%2520MET%2520may%2520identify%2520a%2520subset%2520of%2520cancers%2520with%2520extreme%2520sensitivity%2520to%2520the%2520selective%2520tyrosine%2520kinase%2520inhibitor%2520PHA-665752%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2006%26volume%3D103%26spage%3D2316%26epage%3D2321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Wang, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhan, Y. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, W. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yue, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsen, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, X.</span><span> </span><span class="NLM_article-title">SU5416 is a potent inhibitor of hepatocyte growth factor receptor (c-Met) and blocks HGF-induced invasiveness of human HepG2 hepatoma cells</span> <span class="citation_source-journal">J. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">267</span><span class="NLM_x">–</span> <span class="NLM_lpage">273</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm900803q&amp;key=10.1016%2Fj.jhep.2004.04.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm900803q&amp;key=15288476" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm900803q&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmt1KjsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2004&pages=267-273&author=S.+Y.+Wangauthor=B.+Chenauthor=Y.+Q.+Zhanauthor=W.+X.+Xuauthor=C.+Y.+Liauthor=R.+F.+Yangauthor=H.+Zhengauthor=P.+B.+Yueauthor=S.+H.+Larsenauthor=H.+B.+Sunauthor=X.+Yang&title=SU5416+is+a+potent+inhibitor+of+hepatocyte+growth+factor+receptor+%28c-Met%29+and+blocks+HGF-induced+invasiveness+of+human+HepG2+hepatoma+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">SU5416 is a potent inhibitor of hepatocyte growth factor receptor (c-Met) and blocks HGF-induced invasiveness of human HepG2 hepatoma cells</span></div><div class="casAuthors">Wang, Si Y.; Chen, Bing; Zhan, Yi Q.; Xu, Wang X.; Li, Chang Y.; Yang, Ri F.; Zheng, Hong; Yue, Pei B.; Larsen, Steven H.; Sun, Hui B.; Yang, Xiaoming</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hepatology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">267-273</span>CODEN:
                <span class="NLM_cas:coden">JOHEEC</span>;
        ISSN:<span class="NLM_cas:issn">0168-8278</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">SU5416 is a potent inhibitor of receptor tyrosine kinases, including those of the vascular endothelial growth factor receptor, stem cell factor receptor, and platelet-derived growth factor receptor.  Because of the overwhelming evidence favoring the role of aberrant hepatocyte growth factor (HGF)/Met signaling in the pathogenesis of various human cancers, various inhibitor strategies have been employed to therapeutically target this receptor.  Cell proliferation was detd. by incorporation of [3H] thymidine.  Invasiveness was assayed in Boyden Chambers with 8 μm Matrigel coated filters.  Phosphorylation of ERK1/2, Akt by HGF stimulation was detected by Western blotting.  We found that SU5416 inhibited motility scattering and the invasive activity of a hepatocellular carcinoma cell line HepG2 in vitro and growth in primary cultured hepatocytes induced by HGF.  Consequently, tyrosine autophosphorylation of the c-met induced by HGF was inhibited in these cells by SU5416 in a dose-dependent manner.  Furthermore, ERK1/2 and Akt phosphorylation, the signaling events down-stream of c-met activation were reduced.  Moreover, SU5416 caused reversion in NIH3T3 fibroblasts transformed by the oncogenic form of the receptor, Tpr-Met.  Inhibition of various solid tumors growth and metastasis by SU5416 may be partially attributed to blocking activation of the hepatocyte growth factor receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAnCngzAredrVg90H21EOLACvtfcHk0lj7tB3etvW4zQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmt1KjsLo%253D&md5=257971973a1e53bd95a2b1d4ced918dd</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.jhep.2004.04.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jhep.2004.04.013%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DS.%2BY.%26aulast%3DChen%26aufirst%3DB.%26aulast%3DZhan%26aufirst%3DY.%2BQ.%26aulast%3DXu%26aufirst%3DW.%2BX.%26aulast%3DLi%26aufirst%3DC.%2BY.%26aulast%3DYang%26aufirst%3DR.%2BF.%26aulast%3DZheng%26aufirst%3DH.%26aulast%3DYue%26aufirst%3DP.%2BB.%26aulast%3DLarsen%26aufirst%3DS.%2BH.%26aulast%3DSun%26aufirst%3DH.%2BB.%26aulast%3DYang%26aufirst%3DX.%26atitle%3DSU5416%2520is%2520a%2520potent%2520inhibitor%2520of%2520hepatocyte%2520growth%2520factor%2520receptor%2520%2528c-Met%2529%2520and%2520blocks%2520HGF-induced%2520invasiveness%2520of%2520human%2520HepG2%2520hepatoma%2520cells%26jtitle%3DJ.%2520Hepatol.%26date%3D2004%26volume%3D41%26spage%3D267%26epage%3D273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Christensen, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreck, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuruganti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruslim, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blake, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipson, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramphal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Do, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherrington, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendel, D. B.</span><span> </span><span class="NLM_article-title">A selective small molecule inhibitor of c-Met kinase inhibits c-Met-dependent phenotypes in vitro and exhibits cytoreductive antitumor activity in vivo</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">7345</span><span class="NLM_x">–</span> <span class="NLM_lpage">7355</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=7345-7355&author=J.+G.+Christensenauthor=R.+Schreckauthor=J.+Burrowsauthor=P.+Kurugantiauthor=E.+Chanauthor=P.+Leauthor=J.+Chenauthor=X.+Wangauthor=L.+Ruslimauthor=R.+Blakeauthor=K.+E.+Lipsonauthor=J.+Ramphalauthor=S.+Doauthor=J.+J.+Cuiauthor=J.+M.+Cherringtonauthor=D.+B.+Mendel&title=A+selective+small+molecule+inhibitor+of+c-Met+kinase+inhibits+c-Met-dependent+phenotypes+in+vitro+and+exhibits+cytoreductive+antitumor+activity+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChristensen%26aufirst%3DJ.%2BG.%26aulast%3DSchreck%26aufirst%3DR.%26aulast%3DBurrows%26aufirst%3DJ.%26aulast%3DKuruganti%26aufirst%3DP.%26aulast%3DChan%26aufirst%3DE.%26aulast%3DLe%26aufirst%3DP.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DRuslim%26aufirst%3DL.%26aulast%3DBlake%26aufirst%3DR.%26aulast%3DLipson%26aufirst%3DK.%2BE.%26aulast%3DRamphal%26aufirst%3DJ.%26aulast%3DDo%26aufirst%3DS.%26aulast%3DCui%26aufirst%3DJ.%2BJ.%26aulast%3DCherrington%26aufirst%3DJ.%2BM.%26aulast%3DMendel%26aufirst%3DD.%2BB.%26atitle%3DA%2520selective%2520small%2520molecule%2520inhibitor%2520of%2520c-Met%2520kinase%2520inhibits%2520c-Met-dependent%2520phenotypes%2520in%2520vitro%2520and%2520exhibits%2520cytoreductive%2520antitumor%2520activity%2520in%2520vivo%26jtitle%3DCancer%2520Res.%26date%3D2003%26volume%3D63%26spage%3D7345%26epage%3D7355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Christensen, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salgia, R.</span><span> </span><span class="NLM_article-title">c-Met as a target for human cancer and characterization of inhibitors for therapeutic intervention</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">225</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm900803q&amp;key=10.1016%2Fj.canlet.2004.09.044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm900803q&amp;key=15922853" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm900803q&amp;key=1%3ACAS%3A528%3ADC%252BD2MXks1Ggs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=225&publication_year=2005&pages=1-26&author=J.+G.+Christensenauthor=J.+Burrowsauthor=R.+Salgia&title=c-Met+as+a+target+for+human+cancer+and+characterization+of+inhibitors+for+therapeutic+intervention"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">c-Met as a target for human cancer and characterization of inhibitors for therapeutic intervention</span></div><div class="casAuthors">Christensen, James G.; Burrows, Jon; Salgia, Ravi</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">225</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-26</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Receptor tyrosine kinase (RTK) targeted agents such as trastuzumab, Imatinib, bevacizumab, and gefitinib inhibitors have illustrated the utility of targeting this protein class for treatment of selected cancers.  A unique member of the RTK family, c-Met, also represents an intriguing target for cancer therapy that is yet to be explored in a clin. setting.  The proto-oncogene, c-Met, encodes the high-affinity receptor for hepatocyte growth factor (HGF) or scatter factor (SF).  C-Met and HGF are each required for normal mammalian development and have been shown to be particularly important in cell migration, morphogenic differentiation, and organization of three-dimensional tubular structures (e.g. renal tubular cells, gland formation, etc.) as well as cell growth and angiogenesis.  Both c-Met and HGF have been shown to be deregulated in and to correlate with poor prognosis in a no. of major human cancers.  New data describing the constitutive phosphorylation of c-Met in a no. of human tumors is presented here along with a variety of mechanisms by which c-Met can become activated, including mutation and gene amplification.  In support of the clin. data implicating c-Met activation in the pathogenesis of human cancers, introduction of c-Met and HGF (or mutant c-Met) into cells conferred the properties of motility, invasiveness, and tumorigenicity to the transformed cells.  Conversely, the inhibition of c-Met with a variety of receptor antagonists inhibited the motility, invasiveness, and tumorigenicity of human tumor cell lines.  Consistent with this observation, small-mol. inhibitors of c-Met were developed that antagonized c-Met/HGF-dependent phenotypes and tumor growth in mouse models.  This review will address the potential for development of c-Met inhibitors for treatment of human cancers with particular emphasis on recent findings with small-mol. inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojTbSn0ouMILVg90H21EOLACvtfcHk0lj7tB3etvW4zQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXks1Ggs7c%253D&md5=106b145cbf442e9fec9667817697658d</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2004.09.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2004.09.044%26sid%3Dliteratum%253Aachs%26aulast%3DChristensen%26aufirst%3DJ.%2BG.%26aulast%3DBurrows%26aufirst%3DJ.%26aulast%3DSalgia%26aufirst%3DR.%26atitle%3Dc-Met%2520as%2520a%2520target%2520for%2520human%2520cancer%2520and%2520characterization%2520of%2520inhibitors%2520for%2520therapeutic%2520intervention%26jtitle%3DCancer%2520Lett.%26date%3D2005%26volume%3D225%26spage%3D1%26epage%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Kopka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faust, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keul, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breyholz, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holtke, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schober, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schafers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levkau, B.</span><span> </span><span class="NLM_article-title">5-Pyrrolidinylsulfonyl isatins as a potential tool for the molecular imaging of caspases in apoptosis</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6704</span><span class="NLM_x">–</span> <span class="NLM_lpage">6715</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm051217c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6704-6715&author=K.+Kopkaauthor=A.+Faustauthor=P.+Keulauthor=S.+Wagnerauthor=H.+J.+Breyholzauthor=C.+Holtkeauthor=O.+Schoberauthor=M.+Schafersauthor=B.+Levkau&title=5-Pyrrolidinylsulfonyl+isatins+as+a+potential+tool+for+the+molecular+imaging+of+caspases+in+apoptosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm051217c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm051217c%26sid%3Dliteratum%253Aachs%26aulast%3DKopka%26aufirst%3DK.%26aulast%3DFaust%26aufirst%3DA.%26aulast%3DKeul%26aufirst%3DP.%26aulast%3DWagner%26aufirst%3DS.%26aulast%3DBreyholz%26aufirst%3DH.%2BJ.%26aulast%3DHoltke%26aufirst%3DC.%26aulast%3DSchober%26aufirst%3DO.%26aulast%3DSchafers%26aufirst%3DM.%26aulast%3DLevkau%26aufirst%3DB.%26atitle%3D5-Pyrrolidinylsulfonyl%2520isatins%2520as%2520a%2520potential%2520tool%2520for%2520the%2520molecular%2520imaging%2520of%2520caspases%2520in%2520apoptosis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6704%26epage%3D6715" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Li, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, X. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, X. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, H. L.</span><span> </span><span class="NLM_article-title">Design, synthesis, antitumor evaluations and molecular modeling studies of novel 3,5-substituted indolin-2-one derivatives</span> <span class="citation_source-journal">Acta Pharmacol. Sin.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">140</span><span class="NLM_x">–</span> <span class="NLM_lpage">152</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm900803q&amp;key=10.1111%2Fj.1745-7254.2007.00473.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm900803q&amp;key=17184594" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm900803q&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnvVylug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2007&pages=140-152&author=H.+H.+Liauthor=X.+H.+Zhengauthor=J.+Z.+Tanauthor=L.+L.+Chenauthor=H.+Liuauthor=X.+M.+Luoauthor=X.+Shenauthor=L.+P.+Linauthor=K.+X.+Chenauthor=J.+Dingauthor=H.+L.+Jiang&title=Design%2C+synthesis%2C+antitumor+evaluations+and+molecular+modeling+studies+of+novel+3%2C5-substituted+indolin-2-one+derivatives"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis, antitumor evaluations and molecular modeling studies of novel 3,5-substituted indolin-2-one derivatives</span></div><div class="casAuthors">Li, Hai-hong; Zhang, Xiu-hua; Tan, Jin-zhi; Chen, Li-li; Liu, Hong; Luo, Xiao-min; Shen, Xu; Lin, Li-ping; Chen, Kai-xian; Ding, Jian; Jiang, Hua-liang</div><div class="citationInfo"><span class="NLM_cas:title">Acta Pharmacologica Sinica</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">140-152</span>CODEN:
                <span class="NLM_cas:coden">APSCG5</span>;
        ISSN:<span class="NLM_cas:issn">1671-4083</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Asia Pty Ltd.</span>)
        </div><div class="casAbstract">To design and synthesize a novel class of antitumor agents, featuring the 3,5-substituted indolin-2-one framework.  Based on enzyme binding features of (Z)-SU5402, introducing a β-pyrrole group at the 3-position of the indolin-2-one core, a series of novel 3,5-substituted indolin-2-ones were designed and synthesized.  Four human carcinoma cell lines of A-431, A-549, MDA-MB-468, and Autosomal Dominant Polycystic Kidney disease were chosen for the cell proliferation assay.  Twenty new compds. (1a-t) with E configuration have been designed, synthesized and bioassayed.  Their structural features were detd. by NMR spectra, low- and high-resoln. mass spectra, and confirmed by x-ray crystallog.  Although the enzyme assay showed a weak inhibition effect against the epidermal growth factor receptor, vascular endothelial growth factor receptor, fibroblast growth factor receptor and platelet-derived growth factor receptor tyrosine kinases, the cell-based antitumor activity was promising.  Compds. 1h (I) and its NO2 deriv. 1g showed higher inhibitory activity toward the A-549 and MDA-MB-468 cell lines with IC50 of 0.065-9.4 μmol/L.  This study provides a new template for further development of potent antitumor drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEOip0mRUA1LVg90H21EOLACvtfcHk0lgxr_EfCLPvNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnvVylug%253D%253D&md5=839cf37d1f58fb5c042a03ea4af5cdfc</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1111%2Fj.1745-7254.2007.00473.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1745-7254.2007.00473.x%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DH.%2BH.%26aulast%3DZheng%26aufirst%3DX.%2BH.%26aulast%3DTan%26aufirst%3DJ.%2BZ.%26aulast%3DChen%26aufirst%3DL.%2BL.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DLuo%26aufirst%3DX.%2BM.%26aulast%3DShen%26aufirst%3DX.%26aulast%3DLin%26aufirst%3DL.%2BP.%26aulast%3DChen%26aufirst%3DK.%2BX.%26aulast%3DDing%26aufirst%3DJ.%26aulast%3DJiang%26aufirst%3DH.%2BL.%26atitle%3DDesign%252C%2520synthesis%252C%2520antitumor%2520evaluations%2520and%2520molecular%2520modeling%2520studies%2520of%2520novel%25203%252C5-substituted%2520indolin-2-one%2520derivatives%26jtitle%3DActa%2520Pharmacol.%2520Sin.%26date%3D2007%26volume%3D28%26spage%3D140%26epage%3D152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Sun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shirazian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukuda, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nematalla, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sistla, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luu, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, C.</span><span> </span><span class="NLM_article-title">Discovery of 5-[5-fluoro-2-oxo-1,2- dihydroindol-(3<i>Z</i>)-ylidenemethyl]-2,4- dimethyl-1<i>H</i>-pyrrole-3-carboxylic acid (2-diethylaminoethyl)amide, a novel tyrosine kinase inhibitor targeting vascular endothelial and platelet-derived growth factor receptor tyrosine kinase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">1116</span><span class="NLM_x">–</span> <span class="NLM_lpage">1119</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0204183" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm900803q&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhslSlsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=1116-1119&author=L.+Sunauthor=C.+Liangauthor=S.+Shirazianauthor=Y.+Zhouauthor=T.+Millerauthor=J.+Cuiauthor=J.+Y.+Fukudaauthor=J.+Y.+Chuauthor=A.+Nematallaauthor=X.+Wangauthor=H.+Chenauthor=A.+Sistlaauthor=T.+C.+Luuauthor=F.+Tangauthor=J.+Weiauthor=C.+Tang&title=Discovery+of+5-%5B5-fluoro-2-oxo-1%2C2-+dihydroindol-%283Z%29-ylidenemethyl%5D-2%2C4-+dimethyl-1H-pyrrole-3-carboxylic+acid+%282-diethylaminoethyl%29amide%2C+a+novel+tyrosine+kinase+inhibitor+targeting+vascular+endothelial+and+platelet-derived+growth+factor+receptor+tyrosine+kinase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 5-[5-Fluoro-2-oxo-1,2- dihydroindol-(3Z)-ylidenemethyl]-2,4- dimethyl-1H-pyrrole-3-carboxylic Acid (2-Diethylaminoethyl)amide, a Novel Tyrosine Kinase Inhibitor Targeting Vascular Endothelial and Platelet-Derived Growth Factor Receptor Tyrosine Kinase</span></div><div class="casAuthors">Sun, Li; Liang, Chris; Shirazian, Sheri; Zhou, Yong; Miller, Todd; Cui, Jean; Fukuda, Juri Y.; Chu, Ji-Yu; Nematalla, Asaad; Wang, Xueyan; Chen, Hui; Sistla, Anand; Luu, Tony C.; Tang, Flora; Wei, James; Tang, Cho</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1116-1119</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">To improve the antitumor properties and optimize the pharmaceutical properties including soly. and protein binding of indolin-2-ones, a series of different basic and weakly basic pyrrolylmethylidene indolinones I [R1 = H, F, Cl, Br; R2 = Et2NCH2CH2, pyridin-4-ylmethyl, 2-(1,2,3-triazol-1-yl)ethyl, etc.] were designed and synthesized.  Indolinone I [R1 = F, R2 = Et2NCH2CH2 (II)] showed the best overall profile in terms of potency for the VEGF-R2 and PDGF-Rβ tyrosine kinase at biochem. and cellular levels, soly., protein binding, and bioavailability.  II is currently in phase I clin. trials for the treatment of cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptdQJ1VSPq8bVg90H21EOLACvtfcHk0lgxr_EfCLPvNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhslSlsbg%253D&md5=f6570cfa1ae4e31703c741d90fe65382</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjm0204183&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0204183%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DL.%26aulast%3DLiang%26aufirst%3DC.%26aulast%3DShirazian%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DMiller%26aufirst%3DT.%26aulast%3DCui%26aufirst%3DJ.%26aulast%3DFukuda%26aufirst%3DJ.%2BY.%26aulast%3DChu%26aufirst%3DJ.%2BY.%26aulast%3DNematalla%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DSistla%26aufirst%3DA.%26aulast%3DLuu%26aufirst%3DT.%2BC.%26aulast%3DTang%26aufirst%3DF.%26aulast%3DWei%26aufirst%3DJ.%26aulast%3DTang%26aufirst%3DC.%26atitle%3DDiscovery%2520of%25205-%255B5-fluoro-2-oxo-1%252C2-%2520dihydroindol-%25283Z%2529-ylidenemethyl%255D-2%252C4-%2520dimethyl-1H-pyrrole-3-carboxylic%2520acid%2520%25282-diethylaminoethyl%2529amide%252C%2520a%2520novel%2520tyrosine%2520kinase%2520inhibitor%2520targeting%2520vascular%2520endothelial%2520and%2520platelet-derived%2520growth%2520factor%2520receptor%2520tyrosine%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D1116%26epage%3D1119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Bell, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stirdivant, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahern, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Culberson, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darke, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinsmore, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drakas, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallicchio, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heimbrook, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hua, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kett, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kornienko, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munshi, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quigley, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reid, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trotter, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waxman, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zartman, C. B.</span><span> </span><span class="NLM_article-title">Biochemical and structural characterization of a novel class of inhibitors of the type 1 insulin-like growth factor and insulin receptor kinases</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">9430</span><span class="NLM_x">–</span> <span class="NLM_lpage">9440</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi0500628" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2005&pages=9430-9440&author=I.+M.+Bellauthor=S.+M.+Stirdivantauthor=J.+Ahernauthor=J.+C.+Culbersonauthor=P.+L.+Darkeauthor=C.+J.+Dinsmoreauthor=R.+A.+Drakasauthor=S.+N.+Gallicchioauthor=S.+L.+Grahamauthor=D.+C.+Heimbrookauthor=D.+L.+Hallauthor=J.+Huaauthor=N.+R.+Kettauthor=A.+S.+Kimauthor=M.+Kornienkoauthor=L.+C.+Kuoauthor=S.+K.+Munshiauthor=A.+G.+Quigleyauthor=J.+C.+Reidauthor=B.+W.+Trotterauthor=L.+H.+Waxmanauthor=T.+M.+Williamsauthor=C.+B.+Zartman&title=Biochemical+and+structural+characterization+of+a+novel+class+of+inhibitors+of+the+type+1+insulin-like+growth+factor+and+insulin+receptor+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fbi0500628&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi0500628%26sid%3Dliteratum%253Aachs%26aulast%3DBell%26aufirst%3DI.%2BM.%26aulast%3DStirdivant%26aufirst%3DS.%2BM.%26aulast%3DAhern%26aufirst%3DJ.%26aulast%3DCulberson%26aufirst%3DJ.%2BC.%26aulast%3DDarke%26aufirst%3DP.%2BL.%26aulast%3DDinsmore%26aufirst%3DC.%2BJ.%26aulast%3DDrakas%26aufirst%3DR.%2BA.%26aulast%3DGallicchio%26aufirst%3DS.%2BN.%26aulast%3DGraham%26aufirst%3DS.%2BL.%26aulast%3DHeimbrook%26aufirst%3DD.%2BC.%26aulast%3DHall%26aufirst%3DD.%2BL.%26aulast%3DHua%26aufirst%3DJ.%26aulast%3DKett%26aufirst%3DN.%2BR.%26aulast%3DKim%26aufirst%3DA.%2BS.%26aulast%3DKornienko%26aufirst%3DM.%26aulast%3DKuo%26aufirst%3DL.%2BC.%26aulast%3DMunshi%26aufirst%3DS.%2BK.%26aulast%3DQuigley%26aufirst%3DA.%2BG.%26aulast%3DReid%26aufirst%3DJ.%2BC.%26aulast%3DTrotter%26aufirst%3DB.%2BW.%26aulast%3DWaxman%26aufirst%3DL.%2BH.%26aulast%3DWilliams%26aufirst%3DT.%2BM.%26aulast%3DZartman%26aufirst%3DC.%2BB.%26atitle%3DBiochemical%2520and%2520structural%2520characterization%2520of%2520a%2520novel%2520class%2520of%2520inhibitors%2520of%2520the%2520type%25201%2520insulin-like%2520growth%2520factor%2520and%2520insulin%2520receptor%2520kinases%26jtitle%3DBiochemistry%26date%3D2005%26volume%3D44%26spage%3D9430%26epage%3D9440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Manley, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalman, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conway, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ball, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Havens, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaidyanathan, R.</span><span> </span><span class="NLM_article-title">Early amidation approach to 3-[(4-amido)pyrrol-2-yl]-2-indolinones</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">6447</span><span class="NLM_x">–</span> <span class="NLM_lpage">6450</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo034304q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2003&pages=6447-6450&author=J.+M.+Manleyauthor=M.+J.+Kalmanauthor=B.+G.+Conwayauthor=C.+C.+Ballauthor=J.+L.+Havensauthor=R.+Vaidyanathan&title=Early+amidation+approach+to+3-%5B%284-amido%29pyrrol-2-yl%5D-2-indolinones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjo034304q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo034304q%26sid%3Dliteratum%253Aachs%26aulast%3DManley%26aufirst%3DJ.%2BM.%26aulast%3DKalman%26aufirst%3DM.%2BJ.%26aulast%3DConway%26aufirst%3DB.%2BG.%26aulast%3DBall%26aufirst%3DC.%2BC.%26aulast%3DHavens%26aufirst%3DJ.%2BL.%26aulast%3DVaidyanathan%26aufirst%3DR.%26atitle%3DEarly%2520amidation%2520approach%2520to%25203-%255B%25284-amido%2529pyrrol-2-yl%255D-2-indolinones%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2003%26volume%3D68%26spage%3D6447%26epage%3D6450" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Sun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nematalla, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, J.</span><span> </span><span class="NLM_article-title">Rational design of 4,5-disubstituted-5,7-dihydro-pyrrolo[2,3-<i>d</i>]pyrimidin-6-ones as a novel class of inhibitors of epidermal growth factor receptor (EGF-R) and Her2(p185(erbB)) tyrosine kinases</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">2153</span><span class="NLM_x">–</span> <span class="NLM_lpage">2157</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=2153-2157&author=L.+Sunauthor=J.+Cuiauthor=C.+Liangauthor=Y.+Zhouauthor=A.+Nematallaauthor=X.+Wangauthor=H.+Chenauthor=C.+Tangauthor=J.+Wei&title=Rational+design+of+4%2C5-disubstituted-5%2C7-dihydro-pyrrolo%5B2%2C3-d%5Dpyrimidin-6-ones+as+a+novel+class+of+inhibitors+of+epidermal+growth+factor+receptor+%28EGF-R%29+and+Her2%28p185%28erbB%29%29+tyrosine+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DL.%26aulast%3DCui%26aufirst%3DJ.%26aulast%3DLiang%26aufirst%3DC.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DNematalla%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DTang%26aufirst%3DC.%26aulast%3DWei%26aufirst%3DJ.%26atitle%3DRational%2520design%2520of%25204%252C5-disubstituted-5%252C7-dihydro-pyrrolo%255B2%252C3-d%255Dpyrimidin-6-ones%2520as%2520a%2520novel%2520class%2520of%2520inhibitors%2520of%2520epidermal%2520growth%2520factor%2520receptor%2520%2528EGF-R%2529%2520and%2520Her2%2528p185%2528erbB%2529%2529%2520tyrosine%2520kinases%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D2153%26epage%3D2157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Tang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barkauskas, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molter, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flask, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dowlati, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halmos, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kern, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, P. C.</span><span> </span><span class="NLM_article-title">Dual MET-EGFR combinatorial inhibition against T790M-EGFR-mediated erlotinib-resistant lung cancer</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">911</span><span class="NLM_x">–</span> <span class="NLM_lpage">922</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm900803q&amp;key=10.1038%2Fsj.bjc.6604559" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm900803q&amp;key=19238632" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm900803q&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtV2jurrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2008&pages=911-922&author=Z.+Tangauthor=R.+Duauthor=S.+Jiangauthor=C.+Wuauthor=D.+S.+Barkauskasauthor=J.+Richeyauthor=J.+Molterauthor=M.+Lamauthor=C.+Flaskauthor=S.+Gersonauthor=A.+Dowlatiauthor=L.+Liuauthor=Z.+Leeauthor=B.+Halmosauthor=Y.+Wangauthor=J.+A.+Kernauthor=P.+C.+Ma&title=Dual+MET-EGFR+combinatorial+inhibition+against+T790M-EGFR-mediated+erlotinib-resistant+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Dual MET-EGFR combinatorial inhibition against T790M-EGFR-mediated erlotinib-resistant lung cancer</span></div><div class="casAuthors">Tang, Z.; Du, R.; Jiang, S.; Wu, C.; Barkauskas, D. S.; Richey, J.; Molter, J.; Lam, M.; Flask, C.; Gerson, S.; Dowlati, A.; Liu, L.; Lee, Z.; Halmos, B.; Wang, Y.; Kern, J. A.; Ma, P. C.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">911-922</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Despite clin. approval of erlotinib, most advanced lung cancer patients are primary non-responders.  Initial responders invariably develop secondary resistance, which can be accounted for by T790M-EGFR mutation in half of the relapses.  We show that MET is highly expressed in lung cancer, often concomitantly with epidermal growth factor receptor (EGFR), including H1975 cell line.  The erlotinib-resistant lung cancer cell line H1975, which expresses L858R/T790M-EGFR in-cis, was used to test for the effect of MET inhibition using the small mol. inhibitor SU11274.  H1975 cells express wild-type MET, without genomic amplification (CNV=1.1).  At 2 μ, SU11274 had significant in vitro pro-apoptotic effect in H1975 cells, 3.9-fold (P=0.0015) higher than erlotinib, but had no effect on the MET and EGFR-neg. H520 cells.  In vivo, SU11274 also induced significant tumor cytoredn. in H1975 murine xenografts in our bioluminescence mol. imaging assay.  Using small-animal microPET/MRI, SU11274 treatment was found to induce an early tumor metabolic response in H1975 tumor xenografts.  MET and EGFR pathways were found to exhibit collaborative signalling with receptor cross-activation, which had different patterns between wild type (A549) and L858R/T790M-EGFR (H1975).  SU11274 plus erlotinib/CL-387,785 potentiated MET inhibition of downstream cell proliferative survival signalling.  Knockdown studies in H1975 cells using siRNA against MET alone, EGFR alone, or both, confirmed the enhanced downstream inhibition with dual MET-EGFR signal path inhibition.  Finally, in our time-lapse video-microscopy and in vivo multimodal mol. imaging studies, dual SU11274-erlotinib concurrent treatment effectively inhibited H1975 cells with enhanced abrogation of cytoskeletal functions and complete regression of the xenograft growth.  Together, our results suggest that MET-based targeted inhibition using small-mol. MET inhibitor can be a potential treatment strategy for T790M-EGFR-mediated erlotinib-resistant non-small-cell lung cancer.  Furthermore, optimized inhibition may be further achieved with MET inhibition in combination with erlotinib or an irreversible EGFR-TKI.  British Journal of Cancer (2008) 99, 911-922. doi:10.1038/sj.bjc.6604559 www.bjcancer.com Published online 26 August 2008.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDTEFxM4PPcrVg90H21EOLACvtfcHk0lg4t6Nv_6JFNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtV2jurrI&md5=c7f20d0e22b5358c6196d57f466d8ea1</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6604559&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6604559%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DZ.%26aulast%3DDu%26aufirst%3DR.%26aulast%3DJiang%26aufirst%3DS.%26aulast%3DWu%26aufirst%3DC.%26aulast%3DBarkauskas%26aufirst%3DD.%2BS.%26aulast%3DRichey%26aufirst%3DJ.%26aulast%3DMolter%26aufirst%3DJ.%26aulast%3DLam%26aufirst%3DM.%26aulast%3DFlask%26aufirst%3DC.%26aulast%3DGerson%26aufirst%3DS.%26aulast%3DDowlati%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DLee%26aufirst%3DZ.%26aulast%3DHalmos%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DKern%26aufirst%3DJ.%2BA.%26aulast%3DMa%26aufirst%3DP.%2BC.%26atitle%3DDual%2520MET-EGFR%2520combinatorial%2520inhibition%2520against%2520T790M-EGFR-mediated%2520erlotinib-resistant%2520lung%2520cancer%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2008%26volume%3D99%26spage%3D911%26epage%3D922" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Langstrom, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundqvist, H.</span><span> </span><span class="NLM_article-title">The preparation of <sup>11</sup>C-methyl iodide and its use in the synthesis of <sup>11</sup>C-methyl-<span class="smallcaps smallerCapital">l</span>-methionine</span> <span class="citation_source-journal">Int. J. Appl. Radiat. Isot.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1976</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">357</span><span class="NLM_x">–</span> <span class="NLM_lpage">363</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Fjm900803q&amp;key=10.1016%2F0020-708X%2876%2990088-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Fjm900803q&amp;key=955739" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm900803q&amp;key=1%3ACAS%3A528%3ADyaE28XlvVylsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1976&pages=357-363&author=B.+Langstromauthor=H.+Lundqvist&title=The+preparation+of+11C-methyl+iodide+and+its+use+in+the+synthesis+of+11C-methyl-l-methionine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">The preparation of carbon-11-labeled methyl iodide and its use in the synthesis of carbon-11-labeled methyl-L-methionine</span></div><div class="casAuthors">Langstrom, B.; Lundqvist, H.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Applied Radiation and Isotopes</span>
        (<span class="NLM_cas:date">1976</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">357-63</span>CODEN:
                <span class="NLM_cas:coden">IJARAY</span>;
        ISSN:<span class="NLM_cas:issn">0020-708X</span>.
    </div><div class="casAbstract">Irradn. with protons of B2O3 (10-20 MeV) or H2O (70 MeV) produced 11CO2 in hot chem. reactions.  The CO2 was used as the starting material for the synthesis of H311CI which is useful for labeling biochem. mols. with 11C-Me.  An example is the methylation of the Na salt of homocysteine which gives L-methionine specifically labeled in the Me group.  The process was completed in <80 min, i.e. 4 half-lives of 11C.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7HFYJkLDhVbVg90H21EOLACvtfcHk0lhcWwN8GAekEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE28XlvVylsLY%253D&md5=2270e5e03e98a7b54e173337e2478f47</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2F0020-708X%2876%2990088-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0020-708X%252876%252990088-0%26sid%3Dliteratum%253Aachs%26aulast%3DLangstrom%26aufirst%3DB.%26aulast%3DLundqvist%26aufirst%3DH.%26atitle%3DThe%2520preparation%2520of%252011C-methyl%2520iodide%2520and%2520its%2520use%2520in%2520the%2520synthesis%2520of%252011C-methyl-l-methionine%26jtitle%3DInt.%2520J.%2520Appl.%2520Radiat.%2520Isot.%26date%3D1976%26volume%3D27%26spage%3D357%26epage%3D363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Ma, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tretiakova, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacKinnon, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramnath, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dietrich, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seiwert, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jagadeeswaran, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krausz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vokes, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Husain, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salgia, R.</span><span> </span><span class="NLM_article-title">Expression and mutational analysis of MET in human solid cancers</span> <span class="citation_source-journal">Genes, Chromosomes Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1025</span><span class="NLM_x">–</span> <span class="NLM_lpage">1037</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm900803q&amp;key=10.1002%2Fgcc.20604" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm900803q&amp;key=18709663" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm900803q&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlWns7vE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=1025-1037&author=P.+C.+Maauthor=M.+S.+Tretiakovaauthor=A.+C.+MacKinnonauthor=N.+Ramnathauthor=C.+Johnsonauthor=S.+Dietrichauthor=T.+Seiwertauthor=J.+G.+Christensenauthor=R.+Jagadeeswaranauthor=T.+Krauszauthor=E.+E.+Vokesauthor=A.+N.+Husainauthor=R.+Salgia&title=Expression+and+mutational+analysis+of+MET+in+human+solid+cancers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Expression and mutational analysis of MET in human solid cancers</span></div><div class="casAuthors">Ma, Patrick C.; Tretiakova, Maria S.; MacKinnon, Alexander C.; Ramnath, Nithya; Johnson, Candace; Dietrich, Sascha; Seiwert, Tanguy; Christensen, James G.; Jagadeeswaran, Ramasamy; Krausz, Thomas; Vokes, Everett E.; Husain, Aliya N.; Salgia, Ravi</div><div class="citationInfo"><span class="NLM_cas:title">Genes, Chromosomes & Cancer</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1025-1037</span>CODEN:
                <span class="NLM_cas:coden">GCCAES</span>;
        ISSN:<span class="NLM_cas:issn">1045-2257</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">MET receptor tyrosine kinase and its ligand hepatocyte growth factor (HGF) regulate a variety of cellular functions, many of which can be dysregulated in human cancers.  Activated MET signaling can lead to cell motility and scattering, angiogenesis, proliferation, branching morphogenesis, invasion, and eventual metastasis.  We performed systematic anal. of the expression of the MET receptor and its ligand HGF in tumor tissue microarrays (TMA) from human solid cancers.  Std. immunohistochem. (IHC) and a computerized automated scoring system were used.  DNA sequencing for MET mutations in both nonkinase and kinase domains was also performed.  MET was differentially overexpressed in human solid cancers.  The ligand HGF was widely expressed in both tumors, primarily intratumoral, and nonmalignant tissues.  The MET/HGF likely is functional and may be activated in autocrine fashion in vivo.  MET and stem cell factor (SCF) were found to be pos. stained in the bronchioalevolar junctions of lung tumors.  A no. of novel mutations of MET were identified, particularly in the extracellular semaphorin domain and the juxtamembrane domain.  MET-HGF pathway can be assayed in TMAs and is often overexpressed in a wide variety of human solid cancers.  MET can be activated through overexpression, mutation, or autocrine signaling in malignant cells.  Mutations in the nonkinase regions of MET might play an important role in tumorigenesis and tumor progression.  MET would be an important therapeutic antitumor target to be inhibited, and in lung cancer, MET may represent a cancer early progenitor cell marker.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjnenTNgIcAbVg90H21EOLACvtfcHk0lhcWwN8GAekEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlWns7vE&md5=cf53884177f20939300673fb034ac91f</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1002%2Fgcc.20604&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fgcc.20604%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DP.%2BC.%26aulast%3DTretiakova%26aufirst%3DM.%2BS.%26aulast%3DMacKinnon%26aufirst%3DA.%2BC.%26aulast%3DRamnath%26aufirst%3DN.%26aulast%3DJohnson%26aufirst%3DC.%26aulast%3DDietrich%26aufirst%3DS.%26aulast%3DSeiwert%26aufirst%3DT.%26aulast%3DChristensen%26aufirst%3DJ.%2BG.%26aulast%3DJagadeeswaran%26aufirst%3DR.%26aulast%3DKrausz%26aufirst%3DT.%26aulast%3DVokes%26aufirst%3DE.%2BE.%26aulast%3DHusain%26aufirst%3DA.%2BN.%26aulast%3DSalgia%26aufirst%3DR.%26atitle%3DExpression%2520and%2520mutational%2520analysis%2520of%2520MET%2520in%2520human%2520solid%2520cancers%26jtitle%3DGenes%252C%2520Chromosomes%2520Cancer%26date%3D2008%26volume%3D47%26spage%3D1025%26epage%3D1037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i28"><a href="/doi/suppl/10.1021/jm900803q">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_02124"></div></div></div></div></div><hr /></hr><p class="last">Table listing the analytical data for compounds <b>7</b>−<b>13</b>; spectra of HPLC, HRMS, <sup>1</sup>HNMR, and <sup>13</sup>C NMR. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm900803q/suppl_file/jm900803q_si_001.pdf">jm900803q_si_001.pdf (2.61 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm900803q&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2010.53.issue-1%3Barticle%3Aarticle%3A10.1021%2Fjm900803q" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm900803q" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677a7dca9a6a3c94","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
